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Abstract 
 
Pest insects cause significant losses of crops in terms of both yield and quality. 
Currently chemical pesticides are heavily relied upon for pest control, however the use 
of these chemicals is being restricted, primarily due to health and environmental 
concerns. Therefore, it is important to develop alternative control techniques and 
integrated pest management (IPM) approaches. Entomopathogenic fungi (EPF) infect 
and kill insects and have a large potential for use in IPM. Cordyceps militaris 
(Ascomycota, Hypocreales) is an EPF that naturally infects Lepidoptera pupae. It 
synthesizes the secondary metabolite cordycepin (3’-deoxyadenosine), which has 
been investigated for its anti-inflammatory and anti-cancer properties in human 
medicine, however, little is known about its natural function. The first aim of this 
project was to elucidate the natural function of cordycepin and the second aim was to 
develop it as a potential biopesticide. A series of bioassays and RT-qPCR analyses 
were carried out in Galleria mellonella and Drosophila melanogaster S2r+ cells to 
determine the impact of application of cordycepin and EPF, both alone and in 
combination, on the expression of immune-related genes. It was found that cordycepin 
inhibits the immune response by reducing the expression of immune-related genes, 
including anti-microbial peptides (AMPs). It was hypothesised that cordycepin has a 
role in facilitating the natural infection of insects by C. militaris through inhibition of 
the host immune response. Bioassays were also performed to quantify the effect of 
foliar applications of cordycepin, both alone and in combination with EPF, against the 
Lepidopteran pest Plutella xylostella. Cordycepin alone was found to cause mortality 
of this insect, while at some doses EPF and cordycepin were found to interact 
synergistically to increase mortality. This suggests that there is potential to develop 
cordycepin as a biopesticide for use in IPM. 
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Chapter 1- Introduction  
 
1. 1 The importance of effective crop protection for global 
food production 
 
The development of more sustainable methods of crop production is a major challenge 
for human society. By 2050, global food production may need to increase by as much 
as 70% above current levels in order to support the needs of an expanding population 
(United Nations 2015, Crist et al., 2017). At the same time, the crop production 
systems used in modern farming to achieve high yields are also a significant cause of 
global environmental harm, including loss of biodiversity and greenhouse gas 
emissions (Cole et al., 1997; Altieri, 1999; Robinson and Sutherland, 2002). 
Therefore, it is necessary that agriculture becomes more sustainable, whereby it does 
not have a negative impact on the environment, society or human health (Pretty and 
Bharucha 2014). Some experts have called for the ‘sustainable intensification’ of 
agriculture, with the aim of increasing food production without causing further 
environmental damage (Crist et al., 2017), although the precise mechanisms by which 
this could be achieved are still a matter of debate (Tilman et al., 2002; Loos et al., 
2014; Pretty and Bharucha, 2014).  
 
One area of agriculture where there is significant potential for improvement is in the 
protection of crops from arthropod (i.e. insect and mite) pests. It is estimated that 
globally arthropod pests cause 18-26% reduction in crop yields each year (Culliney, 
2014), despite the use of large amounts of plant protection products and other tools by 
farmers and growers (Popp et al., 2013). Furthermore, it is predicted that crop yield 
losses due to insects will increase dramatically as a result of global warming (Deutsch 
et al., 2018). Since the start of the Green Revolution in the 1960s (Pimentel, 1996; 
Tilman, 1998), the standard method of crop protection against arthropod pests has 
been the application of synthetic chemical pesticides. For example, in the U.K it is 
estimated that since 1990 at least 4.5 million ha of crops have been treated annually 
with insecticides (FERA, 2016). However, the excessive use of synthetic chemical 
pesticides can be harmful to the environment and non-target beneficial organisms 
(Wood and Goulson, 2017), as well as a threat to the health of farmworkers exposed 
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to the undiluted pesticide (Pimentel, 1996). Historically, chemical pesticides have 
been developed in succession, with newer products increasing in efficacy and 
improving human safety (Sugavanam, 1996). ‘Old’ insecticide chemistries such as 
organochlorines and organophosphates have gradually been replaced by newer 
compounds such as pyrethroids that offer many benefits (Miyamoto, 1976; Maroni et 
al., 2000; Tanabe, 2002), including reduced mammalian toxicity and shorter 
environmental persistence (Maroni et al., 2000). Concerns remain about adverse 
impacts on the environment and human health, particularly in less developed countries 
where ‘old’ insecticides are still being used and farm workers do not have access to 
adequate safety equipment, storage facilities and training (Ecobichon, 2001). 
Problems also occur through the evolution of heritable resistance to pesticides in target 
pest populations. Since the first documented case of insecticide resistance in 1914, the 
number of species exhibiting insecticide resistance had increased to 586 species in 
2014 (Sparks and Nauen, 2015). Additionally, there are concerns about the evolution 
of pest populations to all chemical pesticides, for example, the peach potato aphid 
(Myzus persicae) has developed high levels of insecticide resistance through multiple 
mechanisms (overexpression of esterase, super-Kdr genotypes and MACE), which 
reduces the number of pesticides available for its control (Criniti et al., 2008; Bass et 
al., 2014).  
 
A combination of health concerns, environmental impacts and insecticide resistance 
has led to the increasing withdrawal of pesticide products from the market (Chandler 
et al., 2011). In 2009 the European Union introduced regulation (EC 1107/2009; 
European Parliament, 2009) that applied more stringent requirements for pesticide 
registration, where they have to meet more exacting toxicological, environmental and 
safety standards (Jess et al., 2014). It was estimated that this legislation would lead to 
the withdrawal of 20% of active ingredients in pesticides by 2015 (Hillocks, 2012), 
however the overall sales of pesticides remained the same between 2011-2015 
(European Environment Agency, 2017). There is not yet data available to determine 
whether sales of harmful pesticides were replaced with those less harmful (European 
Environment Agency, 2017). It is likely that, with the globalisation of food standards, 
other regions will also place more restrictions on the use of conventional chemical 
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pesticides. A more sustainable solution for crop protection is needed as a matter of 
priority (Pimentel et al., 1992; Pimentel, 1996; Tilman et al., 2011).  
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1.2 Crop protection and Integrated Pest Management  
 
Most experts agree that the most effective way to make pest control more sustainable 
is through Integrated Pest Management (IPM) (Perrin, 1997; Tilman et al., 2002). IPM 
is the coordinated use of different pest management tools to minimise negative impacts 
on society and the environment, whilst providing maximum benefit to the producers 
(Kogan, 1998). Chandler et al., (2011) describe IPM as the combined use of 
complementary crop protection methods including:  
• Choosing chemical pesticides that have minimal health and environmental 
impacts and using them sparingly to reduce the risk of resistance emerging. 
• Selective breeding of crops for pest resistance. 
• Maintaining good cultivation practices such as crop rotations. 
• Physical controls. 
• Using natural products as pest control agents, in some cases these natural 
products can be the basis for synthetic insecticides (Gerwick and Sparks, 2014) 
e.g. spinosad and pyrethrum (Dayan et al., 2009). 
• Using biological control, such as pathogenic microorganisms or natural 
enemies.  
• Decision support tools, such as pest forecasts, to determine the best time to use 
control methods. 
 
IPM strategies have been adopted in many countries with varying levels of success. 
Of the 62 IPM initiatives studied by Pretty (2008), greater than 80% showed reduced 
pesticide usage and approximately 60% showed a reduction in pesticide use and 
increase in crop yield. Farmers may not yet have adopted IPM strategies due to a lack 
of understanding or unfavourable attitude towards changing farming practices 
(Tscharntke et al., 2012; Barzman et al., 2015), but the government incentives 
described in Section 1.1 and increasing research may change this.  
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1.3 The use of entomopathogens as biopesticides in IPM 
 
Biopesticides are an important aspect of IPM. While the definition of a biopesticide 
has not been formally agreed, it generally refers to microbial organisms or natural 
products that are used to control pests (Chandler et al., 2011). Others may extend it to 
include genetically transformed crops, insect pheromones and natural enemies 
(Copping and Menn, 2000). An increasingly important aspect of IPM is the use of 
microbial biopesticides based on entomopathogenic microorganisms including 
bacteria, fungi and viruses. These microbial pathogens cause lethal infections in 
insects and other arthropods and can be used as pest control agents (Table 1.1). The 
global biopesticide industry is rapidly growing, between 2013-2015 the biological 
inputs industry grew on average 16.7% each year, with biochemical and microbial 
products growing on average 40.9% and 20.9% each year respectively (IBMA, 2016). 
There are currently commercially available biopesticides with activity against insects, 
nematodes and fungi (Table 1.1). 
 
Most microbial biopesticides are applied to crops as part of an inundation biological 
control strategy, whereby a high concentration/volume is applied to kill a maximum 
number of the target pest. Other common biological control strategies include 
classical, inoculation and conservation control. Classical control is the release of a 
non-native biological control agent with the aim that it establishes and gives long-term 
pest control. Inoculation control is similar, but the biological control agent does not 
establish or give permanent control (Eilenberg et al., 2001). Finally, conservation 
control protects or enhances the population of existing natural enemies to reduce the 
pest population, such as through modification of the environment to favour these 
species (Eilenberg et al., 2001).  
 
Microbial biopesticides can be used in conjunction with other pest control techniques 
such as conventional chemical pesticides, to give a greater reduction in pest numbers 
(Glare et al., 2012). As an example, codling moth (Cydia pomonella; Lepidoptera) an 
economically important pest of apples, can be managed successfully using a 
combination of pheromone mediated mating disruption and Cydia pomonella 
granulosis virus (CpGV) (Lacey et al., 2008). This has been used successfully in North 
American organic farms (Lacey et al., 2008). 
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Table 1.1- Examples of commercially available biopesticides 1.  
 
1 Biopesticides that are commercially available worldwide, based on Chandler et al., (2011), Seiber et 
al., (2014) and Arthurs and Dara, (2018). 
 
One of the most widely used biopesticides is Bacillus thuringiensis (Bt), an 
entomopathogenic bacteria for control of a number of Lepidoptera, Coleoptera and 
Diptera pests including: Colorado potato beetle, beet armyworm, tobacco hornworm, 
mosquitos and European corn borer (MacIntosh et al., 1990). Bacillus thuringiensis 
produces a protein crystal (the Bt ¶-endotoxin) during spore formation that, following 
ingestion by a susceptible insect, disrupts the integrity of the midgut resulting in rapid 
Category of 
biopesticide 
Type of 
biopesticide Active ingredient 
Activity  
against 
Type of active 
ingredient Target 
 
Microorganism Insecticide 
Bacillus thuringiensis 
subsp. Kurstaki 
Insects Bacteria Caterpillars 
 
Insecticide 
 
Bacillus sphaeicus 
 
Insects 
 
Bacteria 
 
Mosquito larvae 
Insecticide 
 
Chromobacterium 
subtsugae 
 
Insects Bacteria Broad spectrum 
Nematicide Pasteuria spp. 
 
Nematodes Bacteria Plant parasitic nematodes 
Fungicide Bacillus subtilis 
 
Fungi Bacteria Botrytis spp. 
 
Insecticide 
 
Beauveria bassiana 
 
Insects 
 
Fungus 
 
Thrips, aphids 
and whiteflies 
Insecticide Metarhizium brunneum 
 
 
Insects Fungus 
 
Thrips, 
whiteflies and 
weevils  
Nematicide 
 
Purpureocillium 
lilacinum 
 
Nematodes Fungus Plant parasitic nematodes 
Fungicide 
 
Coniothyrium 
minitans 
 
Fungi Fungus Sclerotinia spp. 
Insecticide 
 
Cydia pomonella 
granulosis virus 
 
Insects Virus Codling moth 
Insecticide 
 
Spodoptera exigua 
nucleopolyhedrovirus 
 
Insects Virus Beet armyworm 
 
Biochemical Insecticide 4-allyanisol (basil oil) 
 
Insects Natural biochemical Beetles 
Fungicide Reynoutria sachalinensis 
 
 
Fungi 
Natural 
biochemical 
Powdery 
mildew, downy 
mildew and 
Botrytis.  
Nematicide Quillaja saponaria 
 
Nematodes Natural biochemical 
Plant-parasitic 
nematodes 
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death (Gill et al., 1992). Spores of B. thuringiensis, or purified ¶-endotoxin, can be 
applied to crops as a spray Chandler et al., (2011) or plants can be genetically 
transformed to produce the toxin (Wünn et al., 1996). Resistance to Bt toxin began to 
emerge in pest species, particularly diamondback moth (Plutella xylostella), in the 
1990s (Tabashnik, 1994). This highlights the need for IPM techniques, where the use 
of multiple control methods could reduce the risk of resistance emerging (Phillips et 
al., 1989).  
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1.4 Entomopathogenic fungi and their use as biopesticides 
 
Fungal pathogens of arthropods, commonly referred to as entomopathogenic fungi 
(EPF) are natural regulators of a wide range of insect and mite species (Quesada-
Moraga et al., 2007). There are estimated to be 750-1000 known species (Vega et al., 
2012), but there is also significant genetic variation within species, with most species 
consisting of a wide range of strains that vary in pathogenicity related characteristics. 
EPF are predominantly found within two distinct taxa of the fungal kingdom; the order 
Hypocreales (Ascomycota, Sordariomycetes) and the Entomophthorales 
(Entomophthoromycota) (Figure 1.1). EPF have been used in classical, augmentation 
and inundation biocontrol strategies (Section 1.3) (Shah and Pell, 2003). 
 
Figure 1.1-Phylogenetic tree showing major groups of fungi. Based on the classification by Hibbett 
et al., (2007) from Roy et al. (2010). Groups containing EPF species are highlighted in bold.  
Pezizomycotina
Saccharomycotina
Taphrinomycotina
Agaricomycotina
Ustillagomycotina
Urediniomycotina
Glomeromycota
Mucoromycotina
Olpidium
Kickxellomycotina
Entomophtoromycotina
Zoopagomycotina
Blastocladiomycota
Chytridales
Spizellomycetales
Monoblepharidales
Neocallimastigomycota
Microsporidia
Rozella
Mesomycetozoa
Ascomycota
Basidiomycota
Chytridiomycota
Kingdom Fungi
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The Entomophthorales cause natural epizootics in insect and mite populations but they 
are not used as biopesticides because they are generally difficult to grow in culture 
and so are not economically viable to produce (Jaronski, 2014). Strategies to exploit 
entomophthoralean EPF for biological pest control have involved conservation of 
natural populations (Ekesi et al., 2005), the development of forecasts of natural 
epizootics (Hollingsworth et al., 1995), and inoculative applications such as lure and 
kill methods. For example, forecasting methods have been developed by 
Hollingsworth et al., (1995) to predict the prevalence of Neozygites fresenii 
(Entomophthorales, Neozygitacaea) in cotton aphids (Aphis gossypii), to inform 
pesticide application timings. An example of the lure and kill method has been 
developed by Furlong et al., (1995) in which a pheromone trap delivered Zoophthora 
radicans (Entomophthorales, Zygomycetes) conidia to Plutella xylostella (diamond 
back moth); infected P. xylostella then transferred conidia to other individuals in the 
field. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The majority of known species of EPF occur within three families in the Hypocreales 
within the phylum Ascomycota (Figure 1.1), these are Cordycipitaceae, 
Clavicipitaceae and Ophiocordycipitaceae (Figure 1.2). These families contain species 
Figure 1.2- Phylogenetic tree showing Fungal families in the order Hypocreales. 
From Roy et al., (2010).  
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that are in their teleomorphic or anamorphic states. Teleomorphs reproduce sexually, 
whereas anamorphs reproduce asexually and a particular species can have both a 
teleomorphic and anamorphic state (Lacey, 2016). Currently teleomorphs and 
anamorphs of the same species may be classified as separate species, but this is being 
resolved through molecular phylogenetic techniques (Kepler et al., 2014). For 
example, Metarhizium anisopliae sensu lato (in the broad sense) was reclassified in 
2009 into nine separate species through phylogenetic analysis (Bischoff et al., 2009). 
The authors sequenced multiple housekeeping genes and investigated morphology to 
identify differences within the complex (Bischoff et al., 2009). The commercially 
important strain F52 was formerly classified as M. anisopliae, but was reclassified to 
M. brunneum. The families Clavicipitaceae and Ophiocordycipitaceae contain species 
that can use animals, plants or other fungi as a nutrition source, whereas species in the 
family Cordycipitaceae can only obtain nutrition from arthropods (Humber, 2008). 
The main entomopathogenic species in these families include (Lacey, 2016): 
‘Clavicipitaceae. Teleomorphs: Hypocrella, Metacordyceps, Regiocrella, 
Torrubiella. Anamorphs: Aschersonia, Metarhizium, Nomuraea, some 
Paecilomyces-like fungi excluded from Isaria s.s.’ 
‘Cordycipitaceae. Teleomorphs: Cordyceps, Torrubiella. Anamorphs: Beauveria, 
Microhilum, Engyodentium, Isaria, Mariannaea-like species, Lecanicillium, 
Simplicillium.’  
‘Ophiocordycipitaceae. Teleomorphs: Ophiocordyceps, Elaphocordyceps. 
Anamorphs: Haptocillium, Harposporium, Hirsutella, Hymenostilbe, some 
Paecilomyces-like species, Paraisaria, Sorosporella, Syngliocladium, 
Tolypocladium.’ 
 
Many of the anamorphic entomopathogenic Hypocreales can be readily mass 
produced and they are also amenable to formulation and application using 
conventional spray technologies, so they are popular choices for biopesticides (Feng 
et al., 1994b; Kassa et al., 2008). In addition, their conidia can persist in the 
environment and may infect insects at a later time (Lomer et al., 2001). Furthermore, 
it has been shown that secondary infection by infected insects is an important aspect 
of pest control with biopesticides (Thomas et al., 1995). Because EPF infect through 
the host cuticle they are also useful as control agents of sap feeding pests that would 
not acquire pathogens that infect via ingestion. At present, all commercial 
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biopesticides based on EPF come from a relatively small number of genera within this 
group: Beauveria, Metarhizium, Isaria, Lecanicillium (de Faria and Wraight, 2007). 
Strains are selected as biopesticides if they have characteristics such as high virulence 
against the target pest and the ability to be mass produced (Feng et al., 1994). 
 
Most of the teleomorphic species within the EPF Hypocreales cannot yet be grown in 
culture easily, in part due to their restricted host range (Hesketh et al., 2010) and so 
are not used as biopesticides. One exception is Cordyceps militaris, which can be 
grown in culture relatively easily (see Section 1.6 for more details). However, they are 
increasingly being studied because of their role as natural regulators of insect 
populations, and in particular because of their adaptations to their host life cycles, 
which can also involve manipulation of host behaviour to improve fungal infection 
and transmission. For example, in tropical rainforests Ophiocordyceps unilateralis 
infects and manipulates the behaviour of ants and it is being used as a model to 
understand the diversity of fungal interactions in tropical forests (Evans et al., 2011). 
 
1.4.1 Use of anamorphic hypocrealean EPF as biopesticides in IPM 
 
Anamorphic hypocrealean EPF are employed as biopesticides as part of IPM, 
providing pest control with minimal risk to the environment. They are not thought to 
pose a high risk to beneficial organisms (Garrido-Jurado et al., 2011), although low-
level infection of non-target species has been observed in the field (Zimmermann, 
2007a; Zimmermann, 2007b). Different fungal strains have different host specificities, 
so strain selection impacts on the risk posed to non-target species (Zimmermann, 
2007a).  
 
In 2007 Beauveria bassiana accounted for 33.9% of commercial EPF biopesticides 
while M. anisopliae s.l. accounted for 35.7% (de Faria and Wraight, 2007). EPF 
products are predominantly used for control of greenhouse pests, but have also been 
successfully used in the field. For example, M. anisopliae s.l. has been used to control 
the leaf sugarcane spittlebug (Mahanarva posticata) in Brazil giving between 30-60% 
control (Li et al., 2010). There are currently four biopesticide products based on EPF 
that are registered for use in the U.K (Table 1.2), these are based on either B. bassiana, 
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M. brunneum or Lecanicillium muscarium. Most are used predominantly in protected 
environments against a limited range of pests including glasshouse whitefly 
(Trialeurodes vaporarum) and western flower thrips (Frankliniella occidentalis). 
 
 
Table 1.2- EPF authorized as biopesticides in the U.K. Strains of EPF registered for use in the U.K, 
from the Pesticides Register Database, Health and Safety executive (2018). Information on the target 
species obtained from the product label.   
Strain Product Marketing Company Target Examples of Crops 
Beauveria bassiana 
ATCC-74040 
 
 
Naturalis-L Fargro Ltd 
(U.K) 
Glasshouse whitefly 
(Trialeurodes 
vaporariorum) and western 
flower thrips (Frankliniella 
occidentalis) 
Protected edibles 
and protected 
ornamentals 
Beauveria bassiana 
GHA 
Botanigard 
WP 
 
 
 
 
Certis (USA) 
Glasshouse whitefly 
(Trialeurodes 
vaporariorum) 
Protected 
ornamentals, 
protected 
aubergine, 
protected cucumber 
and protected 
squash 
  
Metarhizium 
brunneum Met 52 
 
 
 
 
 
Fargro Ltd 
(U.K) 
 
Black vine weevil 
(Otiorhynchus spp.) 
Ornamentals, 
blackberry, 
blackcurrant, 
strawberry, 
protected 
cucumber, garlic, 
onion and protected 
aubergine 
  
Lecanicillium 
muscarium Mycotal 
Koppert BV 
(The 
Netherlands) 
Glasshouse whitefly 
(Trialeurodes 
vaporariorum), western 
flower thrips (Frankliniella 
occidentalis) and two-
spotted spider mite 
(Tetranychus urticae) 
Protected 
aubergine, 
protected 
cucumber, 
protected lettuce 
and protected broad 
bean 
 
 
EPF are more sensitive to environmental conditions (temperature, water availability, 
UV light) than traditional synthetic pesticides, which has been found to impact their 
efficacy in the field and this has limited their adoption for pest control. The influence 
of temperature on EPF has been widely investigated and it has been found to impact 
their germination and growth in a strain-dependent manner (Fargues et al., 1997; 
Ouedraogo et al., 1997; Yeo et al., 2003). EPF have an optimum temperature for 
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growth, with growth rates reducing above or below this value and growth being 
inhibited at extreme temperatures (Fargues et al., 1997; Ouedraogo et al., 1997; Yeo 
et al., 2003). Temperature also affects the susceptibility of the host insect and the 
condition of the plant being fed upon, which may further impact EPF virulence 
(Thomas and Blanford, 2003). Humidity is another factor that has been found to affect 
EPF, with conidia requiring high humidity for germination (Gillespie and Crawford, 
1986). UV radiation affects EPF germination in the field, with different strains having 
different UV tolerances (Braga et al., 2001a; Braga et al., 2001b; Fernandes et al., 
2007). There are opportunities to select or breed strains of EPF with good tolerance to 
these environmental stressors and there has also been progress in genetic engineering 
strains for this purpose (Fang et al., 2005; Fang et al., 2009; Shang et al., 2012).  
 
When using EPF for pest management there is often a lag between treatment and 
population reduction (Johnson and Goettel, 1993; Jaros-Su et al., 1999; Benjamin et 
al., 2002; Peng et al., 2008). This lag and a lower lethality in comparison to chemical 
pesticides are current limitations of their use as biopesticides. However, their use in 
conjunction with other treatments as part of an IPM could help give a high level of 
control through synergistic interactions (expanded on in Chapter 6). The potential of 
these synergistic interactions has been explored in some cases, but more detailed 
research is needed. For example, imidacloprid was found to act synergistically with B. 
bassiana and M. anisopliae s.l. to increase mortality of citrus root weevil (Diaprepes 
abbreviatus), a pest of citrus fruit (Quintela and McCoy, 1998). But other 
biopesticides have been found to act antagonistically, for example Shapiro-Ilan et al., 
(2004) observed antagonistic relationships between entomopathogenic nematodes and 
entomopathogenic fungi on mortality of pecan weevil (Curculio caryae).  
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1.5 Hypocrealean Entomopathogenic fungi; fungal life cycle 
and mechanisms of infection of arthropod hosts 
 
Hypocrealean EPF are important for use as biopesticides in IPM, as such, it is 
important to understand their biology. Broadly the life cycle of these EPF is as follows 
(Figure 1.3); firstly, conidia adhere to the insect and then in favourable conditions they 
germinate and penetrate the host cuticle using an infection peg. The EPF then 
proliferates within the host, eventually killing the insect. Following this, the EPF 
grows externally, producing conidia which may then disperse thorough wind, rain or 
insect activity (Meyling and Eilenberg, 2007). The EPF may also exhibit endophytic 
interactions that could aid in the infection of insects. This has been best characterised 
for B. bassiana and M. anisopliae s.l. (Section 1.5.4).  
 
 
 
Adherence of conidia to 
insect cuticle
Penetration of the 
insect cuticle
Proliferation within the 
insect
Insect death
External production 
of conidia
Endophytic 
interactions
Dispersal of conidia
Figure 1.3- Life cycle of EPF. The lifecycle of a typical hypocrealean EPF beginning with adherence of fungal 
conidia to the host insect, followed by germination of the conidia and penetration of the cuticle. The EPF then 
proliferate in the insect, depleting the nutrients in the host ultimately causing its death. Some EPF such as 
Metarhizium anisopliae s.l. and Beauveria bassiana also exhibit endophytic interactions (Section 1.5.4).   
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1.5.1 Attachment of conidia to the host integument and penetration of the cuticle   
 
Insects are infected by EPF following adherence of conidia (asexual spores) to the 
cuticle (Hajek and St. Leger, 1994). This cuticle is a major barrier to infection 
composed of the epicuticle and procuticle which contains multiple layers of chitin and 
proteins, it is also coated with a waxy lipid-rich outer layer (Andersen, 1979; Vincent 
and Wegst 2004). In order to infect an insect, the EPF must first pass through the 
cuticle which is achieved using a combination of mechanical and chemical processes.  
 
Under favourable conditions EPF conidia will produce structures to penetrate the host 
cuticle and secrete degrative enzymes. Many EPF such as Metarhizium spp. develop 
appressoria, which are specialised cells that adhere to the cuticle. These cells produce 
infection pegs that use high turgor pressure to penetrate the cuticle (Howard et al., 
1991) and allow focused release of cuticle-degrading enzymes (Hajek and St. Leger, 
1994). Chitinases and proteases are particularly important for degrading the cuticle 
(Ortiz-Urquiza and Keyhani, 2013) and have been shown to be important virulence 
determinants in B. bassiana and M. anisopliae s.l. For example, these EPF have been 
engineered to overexpress or express more effective proteases or chitinases and this 
increased their virulence (Fan et al., 2007; Zhang et al., 2008; Boldo et al., 2009; Fang 
et al., 2009). Proteases are believed to be more important than chitinases because 
chitin in the cuticle is surrounded by protein which must first be degraded to permit 
chitin degradation (Blackwell and Weih, 1980; Fang et al., 2009).    
 
1.5.2 Growth of EPF within the host insect  
 
Following penetration of the cuticle, EPF need to evade or subvert the cellular immune 
response. To do this they change morphology in the haemocoel to become 
blastospores. These cells lack cell wall components such as b-1,3-glucan, which may 
help prevent recognition by the insect immune system (Jiang et al., 2010). In the case 
of M. anisopliae s.l. it was found that the MC1 protein allows immune subversion, as 
blastospores lacking this protein are rapidly attacked by haemocytes. It is thought that 
MC1 prevents adhesion of haemocytes as it hides the cell wall structure (Wang and 
St. Leger, 2006). In some cases, EPF blastospores may still be recognised by the insect 
immune system and encased in nodules or phagocytosed. It has been reported that B. 
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bassiana blastospores are still be able to germinate within Spodoptera exigua 
haemocytes, whereas fungi that are not pathogenic to insects (Candida albicans) are 
not able to grow as rapidly under these conditions (Hung et al., 1993).   
 
EPF also produce a number of compounds in the insect that interfere with its immune 
system, particularly secondary metabolites, some of which are thought to aid in the 
infection process (Zimmermann, 2007a). The function of secondary metabolites is 
discussed in detail in Section 1.8, but in general they are thought to facilitate host 
infection and colonisation while repressing the growth of other microorganisms 
(Zimmermann, 2007a). Insects produce anti-microbial peptides (AMPs) in response 
to infection (Section 1.7.2.4), but EPF may be resistant to their activity. For example, 
while cecropins inhibit the growth of Sacchromyces cerevisiae, Dipodascopsis 
uninucleate and Geotrichum candidum, some B. bassiana strains are entirely resistant 
to this AMP (Ekengren and Hultmark, 1999). Also, destruxin A (a secondary 
metabolite produced by Metarhizium spp.) suppresses the expression of some AMPs 
in Drosophila melanogaster (Pal et al., 2007), which may allow Metarhizium spp. to 
colonise the host more rapidly. There is also evidence the EPF can directly sense and 
respond to AMPs during infection; in culture Metarhizium robertsii has been observed 
to synthesise proteolytic enzymes at higher levels when the anti-fungal AMP 
Metchnikowin is present in the culture medium, compared to control medium 
(Mukherjee and Vilcinskas, 2018). 
 
1.5.3 Host death and EPF transmission 
 
Host death following EPF infection is caused by the EPF consuming nutrients from 
the insect’s haemolymph or fat body and producing toxins (Zimmermann, 2007a). The 
time taken for insect death to occur depends on multiple factors including: species of 
the host, condition of the host, environmental conditions and strain of the fungus 
(Zimmermann, 2007b). Following host death, the EPF grows outside the host and 
produces conidia or ascospores (sexual spores) that can infect other insects. Insects 
can come into contact with the conidia directly from the infected insect cadaver or in 
the environment if the conidia have dispersed e.g. on plant surfaces or in the soil 
(Hesketh et al., 2010).  
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Hypocrealean EPF are semelparous parasites that must kill the host insect in order for 
transmission to occur (Ebert and Weisser, 1997; Chouvenc and Su, 2012), because of 
this there are complex interactions between the host and parasite during infection. It 
is thought that there is a trade-off between virulence and transmission of EPF. A higher 
virulence would be beneficial for initial infection, but would cause premature death of 
the host insect (Boomsma et al., 2014). A longer period of infection would result in a 
greater accumulation of EPF biomass and hence more conidia being produced after 
host death (Ebert and Weisser, 1997).   
 
1.5.4 Endophytic interactions of EPF  
 
Some EPF such as M. anisopliae s.l. and B. bassiana have been found to be associated 
with plants. Infection of plants with B. bassiana can help protect the plant against 
herbivorous insects (Bing and Lewis, 1991; Meyling and Eilenberg, 2007) and this 
fungal species has been observed as an endophyte in many species including cocoa 
(Posada and Vega, 2005), poppy (Quesada-Moraga et al., 2006), tomato and cotton 
(Ownley et al., 2008). Metarhizium anisopliae s.l. has also been found to be 
endophytic and is particularly associated with plant roots (Meyling and Eilenberg, 
2007). This has been observed in tomato (Sasan and Bidochka, 2012), oilseed rape 
(Batta, 2013) and broad bean (Jaber and Enkerli, 2016). In light of the discovery of 
these endophytic interactions, it has been suggested that association with plants is an 
important part of the EPF lifecycle, especially for B. bassiana and M. anisopliae s.l. 
(Meyling and Eilenberg, 2007).   
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1.6 Biology of Cordyceps militaris  
 
C. militaris is an EPF in the family Cordycipitaceae (Figure 1.2) that is predominantly 
a pathogen of Lepidoptera (Shrestha et al. 2012b). It is distributed throughout the 
northern hemisphere (Zheng et al., 2011), but most notably occurs in East Asia. Here 
it is used as a traditional herbal medicine, purportedly having lung and kidney benefits 
(Das et al., 2010b). More recently, C. militaris and its chemical constituents have been 
investigated for their medicinal properties (summarised in Table 1.3). The focus of 
this project is cordycepin (3’-deoxyadenosine, Section 1.8.4). Due to its relevance to 
the pharmaceutical industry a number of mass production techniques have been 
developed to culture large quantities of C. militaris relatively cheaply (Kim et al., 
2003; Masuda et al., 2007; Das et al., 2008; Das et al., 2010a).   
 
  
Table 1.3- Medicinal effects of Cordyceps militaris and its products. 
Medicinal effect Effective C. militaris constituent Reference 
Anti- angiogenic Whole fungal extract Yoo et al., (2004) 
Anti-ageing Extracted polysaccharide Yu et al., (2007) 
Anti-bacterial Nucleoside analogue (Cordycepin) Ahn et al., (2000) 
Anti-fungal Peptide (Cordymin) Wong et al., (2011) 
Anti-tumour Whole fungal extract Zhao-Long et al., (2000) 
Hepatoprotective Whole fungal extract Jung et al., (2004) 
Immunomodulatory Whole fungal extract Shin et al., (2010) 
 
C. militaris is able to produce both sexual (ascospores) and asexual (conidia) spores. 
Conidia are produced from phialides (specialised cells that produce conidia) and 
ascospores from the club-shaped fruiting body (Shrestha et al., 2012b). This fungus 
has been observed to be both heterothallic and homothallic, although heterothallism is 
thought to predominate (Shrestha et al., 2012b). Heterothallic individuals require a 
partner of a different mating type to reproduce sexually, whereas a homothallic 
individual can reproduce sexually without a partner. The C. militaris genome is 
haploid and there are different mating types, of which only certain combinations are 
compatible (Shrestha et al., 2004; Yokoyama et al., 2006; Zheng et al., 2011). 
Homothallic strains have been occasionally observed (Shrestha et al., 2004; Shrestha 
et al., 2012b), which may be due to mating type switching, the production of 
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heterokaryotic cells, production of diploids or two compatible mating types appearing 
on the chromosomes (Shrestha et al., 2012b). 
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1.7 The role of the insect immune system in defence against 
microbial infection 
 
Extensive homologies exist between the innate immune response in vertebrates and 
the humoral response in invertebrates (Kimbrell and Beutler, 2001). Because of this, 
insects have been used to elucidate human immune pathways and to assess the impact 
of human pathogens on the innate immune system (Kimbrell and Beutler, 2001; 
Ramarao et al., 2012). 
 
 
Insects defend themselves against infection by microorganisms present in the 
environment and have evolved complex immune responses to do this. These responses 
can be broadly classified into two categories, the humoral response and the cellular 
response. Although the broad principles of the immune response to EPF are known 
(Pal et al., 2007; Wojda et al., 2009) the details are yet to be elucidated. These include 
differences in the immune signalling pathways and effectors between different insect 
Figure 1.4- Outline of insect anatomy. Overview Lepidoptera physiology showing the a) foregut, b) 
midgut, c) hindgut, d) fat body, e) haemolymph, f) cuticle and g) haemocytes. Adapted from Strand, 
(2008). 
Anterior  
Posterior  
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groups (Strand, 2008). One of the main knowledge gaps concerns how the EPF is able 
to overcome the insect immune system.  
 
1.7.1 The cellular immune response of insects  
 
The cellular immune response is mediated by haemocytes; blood cells that reside in 
the insect’s haemolymph (Lemaitre and Hoffmann, 2007). In Drosophila 
melanogaster there are predominantly three types of haemocytes: plasmatocytes are 
the most numerous (~90%), followed by crystal cells (<5%) and lamellocytes (rarely 
observed in healthy insects) (Lanot et al., 2001). The main role of plasmatocytes is to 
phagocytose dead cells and pathogens (Lemaitre and Hoffmann, 2007) and if a 
pathogen or object is too large to be phagocytosed it can be encapsulated by 
lamellocytes. Crystal cells are involved in the melanisation pathway (Lemaitre and 
Hoffmann, 2007), which is described in detail in Section 1.7.2.6.  
 
In Lepidoptera there are four types of haemocytes (Figure 1.4): granulocytes, 
oenocytoids, spherule cells and plasmatocytes (Strand, 2008). Granulocytes are the 
most numerous (Strand, 2008) and are thought to be responsible for phagocytosis of 
pathogens (Strand et al., 2006). Oenocytoids are thought to be involved in the 
melanisation pathway (Lavine and Strand, 2002), while spherule cells may transport 
integument peptides to the cuticle (Sass et al., 1994). The main role of plasmatocytes 
in Lepidoptera is to encapsulate pathogens and foreign objects (Lavine and Strand, 
2002) which contrasts with their role in D. melanogaster where they mainly 
phagocytose pathogens. 
 
1.7.2 The humoral immune response in insects 
 
The humoral response in insects involves the release of soluble effector proteins into 
the haemocoel in response to infection (Strand, 2008). These include anti-microbial 
peptides (AMPs), small peptides mainly produced in the fat body (Lemaitre and 
Hoffmann, 2007) following activation of either the Toll or IMD pathways by fungi 
or bacteria (Section 1.7.2.1). The prophenol-oxidase cascade (Section 1.7.2.6) can 
also be categorised as part of the humoral response as during this reaction, enzymes 
are released into the haemocoel to drive melanisation and clotting. Finally, the Jak-
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STAT pathway is stimulated by stress, tissue damage and viral infection, it results in 
the production of anti-viral proteins and cell signalling molecules (Section 1.7.2.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5- Diagram illustrating the humoral immune response in insects. Fungi and gram-positive 
bacteria are detected by the Toll pathway. Fungal PAMPs are detected by β-GRPs and gram-positive 
bacteria PAMPs by PGRP-SAs. These then bind to the Toll receptor via the protein Spatzle. This 
activates a protein cascade in the cytoplasm that ends in DIF being released from the inhibitory protein 
Cactus. DIF then diffuses into the nucleus where it acts as a transcription factor activating AMPs. Gram-
negative bacteria are detected by the PGRP-LC receptor, which triggers a protein cascade in the 
cytoplasm that ends in the activation of the transcription factor Relish. Relish then diffuses into the 
nucleus and activates transcription of AMPs. The Jak-Stat pathway detects Upd/Upd2/Upd3, which are 
expressed in response to tissue damage or viral infection. This triggers a cascade that activates the 
transcription factor Stat92E which causes expression of stress response proteins, anti-viral proteins or 
cell signaling molecules. Adapted from Lemaitre and Hoffmann, (2007) and Myllymäki and Rämet, 
(2014). 
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1.7.2.1 The Toll pathway 
 
The Toll pathway (Figure 1.5) responds to fungi and gram-positive bacteria to trigger 
the transcription of AMPs (these are described in more detail in Section 1.7.2.4) and 
other immune-related genes (Ganesan et al., 2010). This pathway has been best 
characterised in D. melanogaster which has been adopted as a model organism to 
elucidate insect immune responses and improve understanding of the innate immune 
response in humans. This pathway is activated through recognition of peptidoglycans 
(PGN) by PGRP-SA (Michel et al., 2001), PGRP-SD (Leone et al., 2008) or GNBP1 
proteins (Rolff and Reynolds, 2009; Ganesan et al., 2010). It is also activated by fungal 
cell wall components; for example the receptor GNBP3 recognises b-(1,3)-glucans 
(Gottar et al., 2006). EPF avoid recognition by GNBP3, possibly by evasion of this 
receptor or inhibition of the Toll pathway, but are thought to trigger the Toll pathway 
through recognition of virulence factors (Gottar et al., 2006; El Chamy et al., 2008). 
For example, the enzyme PR1A, produced during penetration of the host cuticle by M. 
anisopliae s.l. (Leger et al., 1989), activates the Toll pathway independently of 
GNBP3 (Gottar et al., 2006).    
 
Activation of the Toll pathway following pathogen associated molecular pattern 
(PAMP) recognition triggers a cascade that results in the degradation of Cactus, a 
protein that prevents the transport of the transcription factors DIF and Dorsal (in the 
NFkB transcription factor family) into the nucleus (Ganesan et al., 2010). Following 
Cactus degradation DIF or Dorsal can dimerise and activate the transcription of 
immune-related genes in the nucleus. In D. melanogaster DIF and Dorsal have 
redundant functions in the immune response (Manfruelli et al., 1999; Meng et al., 
1999). In adult D. melanogaster, DIF alone appears to respond to fungal or gram-
positive bacterial infection (Rutschmann et al., 2000). In other insect species there 
appears to be a loss of one of these genes; Bombyx mori and Anopheles gambiae have 
only one gene from the dorsal/DIF gene family (Tanaka et al., 2008).  
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1.7.2.2 The IMD pathway 
 
The IMD pathway (Figure 1.5) responds mainly to gram-negative bacteria through the 
detection of PGNs containing diaminopimelic acid (DAP). It is detected by the 
receptors PGRP-LC and PGRP-LE (Choe et al., 2002; Takehana et al., 2004), which 
trigger a cascade that results in activation of the IKK signalling complex and Dredd 
(Lemaitre and Hoffmann, 2007). IKK is thought to phosphorylate Relish (a 
transcription factor in the NFkB family), which may trigger its cleavage by the 
caspase-like protein Dredd (Stöven et al., 2003). This cleavage removes an N-terminal 
domain from Relish, which enables it to dimerise (Han and Ip, 1999) and be 
transported to the nucleus to drive the transcription of immune-related genes, in 
association with other co-activator proteins (Goto et al., 2008). 
 
1.7.2.3 Cross-talk between immune pathways 
 
The humoral immune response in insects has been found to be more complicated than 
initially believed, as cross-talk has been identified between different pathways. This 
cross-talk is not fully understood but has been shown to occur in response to certain 
bacteria or fungi. For example, the fungus Geotrichum candidum activates the IMD 
pathway (normally activated by gram-negative bacteria) in D. melanogaster to trigger 
AMP expression (Hedengren-Olcott et al., 2004). Furthermore, the expression of 
some AMPs may be controlled by both the Toll and IMD pathways, for example 
cecropin (an anti-bacterial AMP) expression may be triggered by either pathway (Han 
and Ip, 1999).  
 
There is also evidence that DIF, Dorsal and Relish can form heterodimers with each 
other (Han and Ip, 1999; Tanji et al., 2010). DIF-Relish heterodimers have been 
detected in the D. melanogaster fat body and haemocytes (Tanji et al., 2010). It is 
thought that DIF-Relish dimers can efficiently drive drosomycin (anti-fungal AMP) 
transcription and Dorsal-Relish dimers can drive defensin (AMP active against gram-
positive bacteria) transcription (Han and Ip, 1999). However, the regulation of these 
heterodimers is not clear. For example, it has not been resolved whether both Toll and 
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IMD pathways need to be activated simultaneously to allow Cactus degradation and 
Relish inhibitory domain cleavage (Tanji et al., 2010). 
 
1.7.2.4 The role of AMPs in insect immunity 
 
AMPs are well characterised effector molecules in the immune response to pathogens. 
They are small peptides (typically less than 10kDa) with anti-bacterial or anti-fungal 
activity (Lemaitre and Hoffmann, 2007). AMPs vary greatly between insect taxa as 
there has been rapid evolution of these genes, with different taxa often having unique 
AMPs (Juneja and Lazzaro, 2009).  
 
In D. melanogaster 20 AMPs have been identified, which are classified into seven 
groups (Table 1.4). The other species used in this project (Galleria mellonella and 
Plutella xylostella) also produce AMPs (Table 1.4), some of which show homology to 
those in D. melanogaster, e.g. Cecropins and Defensins. G. mellonella and P. 
xylostella are pest species in the order Lepidoptera and are described in detail in later 
chapters. Although some of these AMPs are homologous, they may have activity 
against different pathogens (Table 1.4). AMPs are predominantly produced in the 
insect fat body then secreted into the haemolymph where they exert their antimicrobial 
activity (Meister et al., 1997). 
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Table 1.4- AMPs of model insect species. The groups of AMPs present in different insect species and 
the microbes that they are active against. 
Species AMP Activity Reference 
D. melanogaster Attacin Gram-negative bacteria, fungi 
Lemaitre and Hoffmann, 
(2007) 
De Gregorio et al., (2002) 
D. melanogaster Cecropin Gram-negative bacteria Lemaitre and Hoffmann, (2007) 
D. melanogaster Defensin Gram-positive bacteria Lemaitre and Hoffmann, (2007) 
D. melanogaster Diptericin Gram-negative bacteria Lemaitre and Hoffmann, (2007) 
D. melanogaster Drosocin Gram-negative bacteria Lemaitre and Hoffmann, (2007) 
D. melanogaster Drosomycin Fungi Lemaitre and Hoffmann, (2007) 
D. melanogaster Metchnikowin Fungi Lemaitre and Hoffmann, (2007) 
G. mellonella Cecropin Gram-negative bacteria and Gram-positive bacteria Wojda, (2016) 
G. mellonella Defensin Fungi Wojda, (2016) 
G. mellonella Galiomicin Fungi Lee et al., (2004) 
G. mellonella Gallerimycin Fungi Langen et al., (2006) 
G. mellonella Gloverin Gram-negative bacteria and Gram-positive bacteria Cheng et al., (2006) 
G. mellonella Moricin-like peptide 
Fungi, Gram-negative bacteria 
and Gram-positive bacteria Wojda, (2016) 
P. xylostella Cecropin Gram-negative bacteria Xiaofeng et al., (2015) 
P. xylostella Gloverin Gram-positive bacteria Xiaofeng et al., (2015) 
P. xylostella Moricin Gram-negative bacteria Xiaofeng et al., (2015) 
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1.7.2.5 The Jak-Stat pathway 
 
The Jak-Stat pathway (Figure 1.5) has been best characterised in D. melanogaster, 
however some aspects of its function remain unknown. It is activated by Upd, Upd2 
or Upd3 and the expression of these proteins is induced by tissue damage and viral 
infection (Myllymäki and Rämet, 2014). These ligands bind to the external domain of 
a Dome dimer, which interacts with Hop (in the Jak family). This then phosphorylates 
and activates the transcription factor STAT92E, (Agaisse and Perrimon, 2004) which 
upregulates the expression of genes including tep1 and totA (Agaisse and Perrimon, 
2004). 
 
The expression of totA is increased by septic injury through activation of the Jak-Stat 
pathway and it appears to protect against heat stress (Agaisse et al., 2003). Tep1 is 
involved in promoting phagocytic activity in mosquito (Anopheles gambiae) 
haemocytes (Levashina et al., 2001) and this may be its function in other insects. 
Another feature of Jak-Stat activation is that it promotes differentiation of 
lamellocytes (Agaisse and Perrimon, 2004), although the mechanism behind this is 
unknown. This pathway also responds to viral infection, although the mechanism 
behind this is not known, it along with other immune pathways induce vir-1 expression 
(Dostert et al., 2005). VIR-1 is a protein induced by viral infection, but its function is 
also not known (Myllymäki and Rämet, 2014).  
 
1.7.2.6 The prophenol-oxidase cascade 
 
Phenol-oxidase (PO) is initially synthesised as the inactive precursor prophenol-
oxidase (PPO). It is converted to its active form through the PPO cascade, which is 
primarily mediated by crystal cells in D. melanogaster and oenocytoids in 
Lepidoptera. Release of PPO from crystal cells/oenocytoids is triggered by recognition 
of PAMPs (Cerenius et al., 2008) or tissue damage (Galko and Krasnow, 2004). In the 
haemolymph PPO is cleaved to PO by a serine protease cascade and active PO drives 
the reactions that cause melanisation. This is the formation of melanin around a foreign 
body or wound, which appears as a dark pigment in the affected insect (Gillespie and 
et al., 1997) (Figure 1.6).  
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It is thought that the function of melanisation is to facilitate wound healing by 
stimulating clot formation and this also isolates pathogens (Gillespie and et al., 1997). 
PO produces other toxic compounds that may adversely affect the pathogen (Cerenius 
et al., 2008). These anti-microbial chemicals include 5, 6-dihydroxyindole (DHI) and 
quinones (Zhao et al., 2007). DHI has anti-bacterial, anti-fungal and antiviral activity 
and also has activity against parasitic wasps (Zhao et al., 2011). In addition, the PPO 
cascade produces peroxinectin, an opsonin that binds to pathogens to promote 
phagocytosis by haemocytes (Cerenius et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
1.7.3 The role of lysozyme in insect immunity  
 
Lysozyme is an enzyme that cleaves the b-1,4-glycosidic bonds in the peptidoglycan 
cell wall of bacteria (Jollès and Jollès, 1984) and is a key component of the immune 
response in certain insects. It is also thought to have anti-fungal properties, but the 
mechanism behind this is less clear. High concentrations of human lysozyme kills 
Candida albicans, possibly through cell wall interactions (Wu et al., 1999), and insect 
lysozymes may display a similar activity. Evidence of the anti-fungal activity of insect 
lysozyme was found by Wojda et al., (2009). They monitored the activity of this 
enzyme in G. mellonella in response to B. bassiana infection and found that increasing 
fungal concentration caused increased lysozyme activity (Wojda et al., 2009). The 
mechanism of lysozyme activity against fungi is not well understood, but it is thought 
Figure 1.6- Melanisation in Galleria mellonella. 
Arrows indicate patches of melanisation in G. mellonella 
caused by penetration of B. bassiana conidia.  
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to promote apoptosis of fungal cells in G. mellonella (Sowa-Jasiłek et al., 2016). There 
is also evidence that lysozyme from G. mellonella may work synergistically with 
AMPs such as cecropins to kill pathogens (Cytryńska et al., 2001). 
 
In contrast to other insects, lysozyme expression in Drosophila spp. is not thought to 
be associated with immunity. Daffre et al., (1994) monitored expression of lysozyme 
in D. melanogaster and determined that its expression is localised to the digestive 
system, in particular the gut and salivary glands. In addition to this it was not found to 
be expressed in the fat body or by haemocytes, therefore in D. melanogaster lysozyme 
is thought to be mainly involved in digestion of bacteria (Daffre et al., 1994). In fact 
there is evidence that lysozyme genes have diverged in Diptera to function 
predominantly as digestive enzymes (Regel et al., 1998). 
 
1.7.4 The wounding response in insects  
 
The response to wounding in insects integrates multiple pathways to prevent infection 
and promote wound healing. Understanding this response is particularly important as 
insect bioassays often introduce bacteria or fungi through injection and the immune 
response to wounding can complicate interpretation of the bioassay results (Erler et 
al., 2011). 
 
A principal response to wounding is the activation of the PPO cascade (Section 
1.7.2.6) and components of this pathway are involved in the formation of a scab over 
the wound. The role of the PPO cascade in wound healing varies between species, in 
D. melanogaster the PPO response is localised whereas in G. mellonella PPO 
activation is more systemic (Bidla et al., 2009). The JAK-STAT pathway (Section 
1.7.2.5) also responds to wounding. Sterile or septic injury increases totA expression 
(Agaisse et al., 2003); TotA is part of the general stress response and its expression is 
also triggered by bacterial infection, heat stress and UV light (Ekengren and Hultmark, 
2001). Finally, wounding triggers the production of AMPs (Section 1.7.2.4). In the 
bumblebee Bombus terrestris wounding induced the expression of three AMPs, but at 
lower levels than that caused by a bacterial challenge (Erler et al., 2011). This was 
also the case for D. melanogaster, where injury increased expression of five AMPs at 
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lower levels than those following bacterial and fungal challenge (Lemaitre et al., 
1997).  
 
1.7.5 The immune response to EPF in insects 
 
There has been limited investigation into the insect cellular response to EPF infection 
and most has focused on the response of haemocytes, in particular their phagocytic 
activity and morphological changes. For example, B. bassiana blastospores were seen 
to evade detection by Spodoptera exigua haemocytes (Pendland et al., 1993) and G. 
mellonella haemocytes became round and developed swollen nuclei upon M. 
anisopliae s.l. infection (Gillespie et al., 2000). Additionally, studies into the humoral 
signalling pathway in response to fungal infection in insects have not often been done 
with EPF. Early studies to elucidate the components of the Toll and IMD pathways 
often used either bacteria or non-insect pathogenic fungi such as Escherichia coli or 
Aspergillus fumigatus to elicit an immune response (Lemaitre et al., 1996; Ferrandon 
et al., 1998). Since these studies, more research has been done to understand the 
impact of EPF on humoral immunity. For example, Wojda et al. (2009) observed the 
impact of B. bassiana on AMP expression in G. mellonella and Vilcinskas and Matha, 
(1997) observed the impact of this EPF on the lysozyme and antibacterial activity of 
G. mellonella haemolymph. Some EPF secondary metabolites are thought to play a 
key role in insect infection (Vilcinskas et al., 1997c), although this is not well 
understood. A major knowledge gap is how these metabolites facilitate infection and 
whether they do this through interaction with the immune system (discussed further in 
Section 1.8). 
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1.8 Metabolites of entomopathogenic fungi: role in insect 
infection and use as novel natural products   
 
1.8.1 Classes of EPF secondary metabolites 
 
Keller et al., (2005) describe four classes of secondary metabolites produced by fungi: 
polyketides (PKs), non-ribosomal peptides (NRPs), terpenes and indole alkaloids. The 
largest class of metabolites are the PKs and they are synthesised by polyketide 
synthases (PKSs) (Molnár et al., 2010). Oosporein (Figure 1.7) is an example of a 
nonreduced PK produced by Beauveria spp. (Molnár et al., 2010), that is thought to 
disturb membrane integrity (Jeffs and Khachatourians, 1997). The second group of 
metabolites is the NRPs, which are synthesised by multienzyme complexes called 
non-ribosomal peptide synthetases (NRPSs) (Moffitt and Neilan, 2000). Destruxins (a 
group of metabolites of Metarhizium spp.) and beauverolides (a group of metabolites 
of Beauveria spp.) are in a subclass of NRPs called cyclic nonribosomal peptides 
(Molnár et al., 2010). They are thought to be involved in the virulence of EPF 
(Vilcinskas et al., 1997c; Vilcinskas et al., 1999).  
 
 
 
 
 
 
 
 
 
 
Fungal terpenes and indole alkaloids are smaller classes of secondary metabolites and 
have been less researched than PKs and NRPs. Common terpenes include diterpenes 
and carotenoids (Keller et al., 2005). The most widely investigated indole alkaloid is 
ergotamine which was first discovered due to its toxicity towards humans, but has 
since been developed as a medicine for conditions such as migraines (Tfelt-Hansen et 
al., 2000).   
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Figure 1.7-Chemical structures of EPF secondary metabolites. Oosporein (left), destruxin A 
(centre) and beauverolide L (right). Adapted from Suzuki et al., (1966), Eyal et al., (1994) and 
Jegorov et al., (1994). Made using ChemDraw Professional Ver 16 (PerkinElmer Inc). 
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Fungal genes encoding for secondary metabolites are often co-located within the 
genome (Sbaraini et al., 2016); the members of these biosynthetic gene clusters 
(BGCs) are normally co-regulated (Keller et al., 2005) and contain different functional 
classes including PKSs and NRPSs (Sbaraini et al., 2016). Clusters can be identified 
using bioinformatics, particularly through the identification of putative NRPS and 
PKS genes (Keller et al., 2005). This identification has been facilitated by the whole 
genome sequencing of B. bassiana (Xiao et al., 2012), C. militaris (Zheng et al., 2011) 
and M. anisopliae (Gao et al., 2011). In B. bassiana 13 NRPS genes and 12 PKS genes 
have been identified (Xiao et al., 2012), M. anisopliae was found to have 14 NRPS 
and 24 PKS genes (Gao et al., 2011), while 5 NRPS and 9 PKS genes have been 
identified in C. militaris (Zheng et al., 2011). This large number of biosynthetic gene 
clusters suggests that only a small fraction of secondary metabolites from these EPF 
have been identified so far. 
 
1.8.2 The role of EPF metabolites in insect infection 
 
The current levels of understanding of the natural function of EPF metabolites is poor 
and it is likely that many metabolites have yet to be discovered. It is difficult to identify 
secondary metabolites necessary for infection as they may be transiently produced or 
only produced in low quantities during infection (Soukup et al., 2016). Experimentally 
it is also difficult to determine the effect of individual metabolites, as increasing 
expression or knocking out the genes to produce one metabolite may have effects on 
other downstream pathways or there may be redundancy in virulence factors 
(Stergiopoulos and de Wit, 2009).  
 
Broadly there have been two categories of experiments that have been used to 
determine the natural function of EPF metabolites. Firstly, there are those which 
observe the effect of introduction of a metabolite (usually at a high concentration) into 
either a whole insect or a specific insect tissue/cell type. Mortality, behaviour, 
morbidity or changes in cell structure can then be monitored to determine the impact 
of the metabolite. Although this type of experiment does begin to unravel the function 
of a metabolite, the high concentrations used are unlikely to be representative of what 
would occur in nature. It is also possible that any results seen are secondary effects 
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due to the impact of the metabolite on other pathways. The second type of experiment 
relies on the metabolite synthesis genes having been discovered. These genes can then 
be knocked out or overexpressed through genetic manipulation and the impact on 
virulence assessed. This has the advantage of being able to determine whether a 
metabolite is necessary for virulence but does not establish how the metabolite acts to 
confer virulence.  
 
The EPF metabolites that have been investigated most thoroughly include those 
produced by B. bassiana and M. anisopliae s.l. The B. bassiana metabolites 
bassianolide and beauvericin have been found to be virulence factors that facilitate 
infection of G. mellonella, Corn Earworm (Helicoverpa zea) and Beet Armyworm 
(Spodoptera exigua) (Xu et al., 2008; Xu et al., 2009). The genes responsible for the 
production of these metabolites were knocked out in a strain of B. bassiana and 
resulted in a significant reduction in virulence, although a low level of virulence 
remained (Xu et al., 2008; Xu et al., 2009). The conclusions drawn from this were that 
bassianolide and beauvericin contribute to B. bassiana virulence in nature, however 
they may also have other functions. Previous experiments have identified bassianolide 
and beauvericin as being insecticidal if administered alone (Hamill et al., 1969; Suzuki 
et al., 1977). Therefore, they could be important in endophytic interactions, as 
production of insecticidal chemicals by EPF following colonisation of a plant may 
reduce insect herbivory. Another B. bassiana metabolite that has begun to be 
characterised is beauverolide, which has been found to inhibit the phagocytic activity 
of G. mellonella plasmatoytes, but not cause significant mortality of these larvae 
(Vilcinskas et al., 1999).  
 
M. anisopliae s.l. also produces secondary metabolites that appear to facilitate 
infection, the best understood being destruxins. Destruxins have been reported to have 
multiple activities in insects (Samuels et al., 1988; James et al., 1993; Vilcinskas et 
al., 1997c; Pal et al., 2007) including effects on the immune system. For example, 
destruxins A and E have been found to inhibit phagocytic activity of plasmatocytes in 
G. mellonella, and at high doses they cause paralysis and eventual death of larvae 
(Vilcinskas et al., 1997c). Additionally, these toxins have been found to inhibit 
attachment and spreading of plasmatocytes (Vilcinskas et al., 1997b). Destruxins A, 
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B and E also facilitated infection of Phaedon cochleariae by M. anisopliae s.l. (Amiri 
et al., 1999). However, this was thought to be due to destruxins causing increased 
stress in insects, as opposed to a direct impact on the insect immune system. A 
subsequent study on destruxin A countered this hypothesis as it determined that 
destruxin A inhibits the IMD immune pathway in D. melanogaster (Pal et al., 2007).   
 
1.8.3 Medicinal uses of EPF metabolites   
 
Whilst the natural function of EPF metabolites is not well understood, more research 
has been carried out into their potential for use as pharmaceuticals. An example of this 
is cyclosporine, a secondary metabolite produced by Tolypocladium niveum (Weber 
et al., 1994), which is used following organ transplant as an immunosuppressant to 
reduce the risk of organ rejection (Merion et al., 1984; Ponticelli et al., 1988). 
Metabolites of EPF that are used commercially for biopesticides have also been 
investigated for their medicinal potential. Destruxin B (produced by Metarhizium 
spp.) suppresses the expression of a surface antigen of the hepatitis B virus (HBV) and 
may have potential to be developed into an anti-HBV drug (Chen et al., 1997). 
Beauvericin (produced by Beauveria spp.) stimulates the influx of calcium ions into 
human leukaemia cells, which results in the death of these cells (Chen et al., 2006). 
Therefore the research that has previously been carried out into the medicinal function 
of metabolites can potentially inform understanding of their natural function. 
 
1.8.4 Cordycepin: A secondary metabolite of C. militaris  
 
The nucleoside analogue cordycepin (3’-deoxyadenosine; Figure 1.8) is a secondary 
metabolite produced by C. militaris, which has been found to have a wide range of 
biological properties (Table 1.5). The majority of work published to date concerns 
fundamental studies on the effect of cordycepin on transcription in eukaryotes, or on 
its potential as a novel human medicine. One of the first investigations of cordycepin 
concerned inhibition of transcription (Chu and Edelman, 1972). This inhibition occurs 
as cordycepin cannot be distinguished from adenosine by certain enzymes (Figure 
1.8). Therefore, during transcription cordycepin is incorporated into the poly(A) tail 
of mRNA, preventing addition of further adenosine residues and reducing the stability 
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of the transcript (Kondrashov et al., 2012). This poly (A) chain termination appears to 
primarily affect inflammatory mRNAs rather than housekeeping mRNAs 
(Kondrashov et al., 2012). Although the reason for this is not clear, it may be linked 
to the relative turnover rates of the mRNAs or the affinity of different classes of 
poly(A) polymerases for cordycepin (Kondrashov et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
Another notable aspect of cordycepin is its anti-cancer properties. It has been found to 
promote apoptosis in cancerous cell lines, including human colorectal cancer cells, 
breast cancer cells and neuroblastoma cells (He et al., 2010; Choi et al., 2011; Baik et 
al., 2012), which reduces the proliferation of these cells. It also exerts the same effect 
by halting the cell cycle at key checkpoints (Wu et al., 2007, Lee et al., 2009, Jung et 
al., 2012). Cordycepin has been found to have anti-metastatic activity by reducing the 
ability of cells to move through the extracellular matrix and by inhibiting angiogenesis 
(Tuli et al., 2013).   
 
The anti-inflammatory properties of cordycepin are thought to contribute to many of 
its medicinal benefits. Jeong et al., (2010) found that cordycepin inhibits the 
production of inflammatory molecules such as nitric oxide and pro-inflammatory 
cytokines in mouse microglial cells. They hypothesised that this was due to inhibition 
of the NFkB, AKT and MAPK signalling pathways. The NFkB and AKT pathways 
were also found to be inhibited by cordycepin in macrophage cells (Kim et al. 2006).  
Figure 1.8- Structure of cordycepin and adenosine. The molecular structure of cordycepin (3’-
deoxyadenosine) (left) and adenosine (right). 
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Cordycepin also possesses anti-microbial properties. It has been observed to have 
activity against Candida spp., reducing mortality of mice treated with these fungi if 
co-administered with pentostatin, a chemical that prevents the breakdown of 
cordycepin (Sugar and McCaffrey, 1998). Cordycepin also inhibits the growth of B. 
subtilis, which is thought to be due to prevention of purine synthesis (Rottman and 
Guarino, 1964).  
 
While the medicinal properties of cordycepin are beginning to be investigated, there 
has been little research into its natural function, i.e. its role in the infection cycle of C. 
militaris. As discussed previously, some EPF secondary metabolites may have 
immuno-suppressive functions in insects, but this has not been confirmed for 
cordycepin. A number of pathways for the synthesis of cordycepin have been 
suggested (Zheng et al., 2011; Xiang et al., 2014; Kato et al., 2017), but it is only 
recently that the genes involved in its production have been elucidated (Xia et al., 
2017). Three enzymes involved in cordycepin biosynthesis and one putative 
transporter have been identified, while the production of cordycepin has been shown 
to be coupled to the production of pentostatin. This is an inhibitor of adenosine 
deaminase, an enzyme that converts cordycepin to inosine. Other fungal species have 
been shown to also produce cordycepin including Cordyceps kyusyuensis and 
Aspergillus nidulans (Xia et al., 2017). It has also been shown that Ophiocordyceps 
sinensis, which was previously thought to produce cordycepin (Huang et al., 2003; Li 
et al., 2004), did not in fact produce this molecule (Xia et al., 2017). This may be due 
to the misidentification of O. sinensis in other studies or differences between strains, 
reflecting the importance of verifying the identity of organisms under study. 
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Table 1.5- Activity of cordycepin. The activity of cordycepin in different organisms or tissues.  
Activity of 
cordycepin Organism/Tissue Reference 
Anti-angiogenic Human HepG2 cells Lu et al., (2014) 
Anti-tumour 
Mice  Yoshikawa et al., (2004)  
Mouse melanoma cells  Nakamura et al., (2006) 
Mouse Lewis lung carcinoma cells  Nakamura et al., (2006) 
Anti-metastasis 
Human bladder cancer cells Lee et al., (2010) 
Mouse melanoma cells  Nakamura et al., (2005)  
Induction of 
apoptosis 
Mouse tumour cells  Jen et al., (2011) 
Human colorectal cancer cells  He et al., (2010) 
Human breast cancer cells  Choi et al., (2011) 
Human leukemia cells  Jeong et al., (2011) 
Anti-malarial Plasmodium knowlesi in vitro, Plasmodium berghei in vivo Trigg et al., (1971) 
Anti-fungal Mice  Sugar and McCaffrey, (1998) 
Anti-bacterial Bacillus subtilis  Rottman and Guarino, (1964)  
Anti-inflammatory 
Mouse microglial cells  Jeong et al. (2010) 
Mouse RAW cell line  Kim et al., (2006b)  
Rats Zhang et al., (2014) 
Mice  Yang et al., (2015) 
Anti-depressant Mice  Tianzhu et al., (2014) 
Anti-viral 
Epstein-Barr virus Ryu et al., (2014) 
HIV Mueller et al., (1991) 
Anti-diabetic Mice  Ma et al., (2015) 
Anti-arthritic Human chondrocytes Hu et al., (2014) Human chondrocytes Ying et al., (2014) 
Anti-ageing Rats Ramesh et al., (2012) 
 
Insecticidal 
  
 
Plutella xylostella  
  
Kim et al., (2002)  
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1.8.5 The potential of cordycepin as a novel pest control agent 
 
To date, very little research has been done on the natural function of cordycepin, i.e. 
its role in the C. militaris infection process, in particular its interaction with the insect 
immune system. If cordycepin operates as an EPF virulence factor, then it may have 
potential as a novel plant protection product (PPP), given that: 
• Cordycepin is known to inhibit the mammalian innate immune system (Table 
1.5), and therefore is likely to impact on insect immune function, because core 
functions of innate signalling pathways are conserved across insects and 
mammals.  
• It is possible that cordycepin would be low risk for human health, since C. 
militaris is widely used as a herbal medicine (Das et al., 2010b) with no reports 
of ill effects, and cordycepin itself is being studied as a novel human medicine 
(Table 1.5).  
 
The potential of cordycepin as a novel biopesticide has been explored by Kim et al. 
(2002), who found that feeding P. xylostella larvae cordycepin caused significant 
mortality. Leaves were dipped in cordycepin solution, hence the exact dose 
administered could not be determined and the mode of action of cordycepin was not 
elucidated, although it was thought to be gut-acting. It is important to determine its 
mode of action and interactions with other biopesticides before developing cordycepin 
further as a biopesticide. If this research was performed, cordycepin could be 
incorporated into IPM, for example it could be coapplied with EPF biopesticides that 
do not themselves produce cordycepin such as B. bassiana and M. brunneum. This has 
potential to increase the speed of kill by these EPF-based biopesticides, which is a 
significant limiting factor in their use (Section 1.4.1). 
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1.9 Aims and Objectives 
 
The main aims of this project were to improve understanding of the natural function 
of cordycepin and identify whether it has potential as a biopesticide, either alone or in 
conjunction with EPF. In general, there has been a lack of research into the natural 
functions of EPF secondary metabolites and it is likely that many remain to be 
discovered. These compounds have potential to be used as biopesticides and this 
project also aims to provide techniques and experimental protocols by which their 
natural function and potential as biopesticides can be assessed. These aims were 
achieved through the following objectives in each chapter: 
• Assess the impact of EPF and cordycepin individually on the model insect G. 
mellonella. 
• Monitor immune-related gene expression in G. mellonella in response to EPF. 
This was necessary to develop experimental protocols and improve 
understanding of the natural infection process of EPF.  
• Measure the impact of cordycepin on immune-related gene expression in G. 
mellonella. Identify interactions between EPF and cordycepin to evaluate its 
potential as a biopesticide. 
• Examine the effect of cordycepin on immune-related gene expression in a D. 
melanogaster cell culture. This was done because D. melanogaster is a well-
studied model organism with thoroughly characterized immune pathways.  
• Assess the potential of cordycepin as a biopesticide in the pest species P. 
xylostella, both on its own and in conjunction with EPF.  
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Chapter 2 - Determining the effect of 
entomopathogenic fungi and cordycepin on the 
survival of Galleria mellonella 
 
2.1 Background 
 
2.1.1 The model insect G. mellonella   
 
Galleria mellonella (Lepidoptera, Pyralidae) is becoming increasingly popular as a 
laboratory model for investigating microbial infections in animals (Mylonakis et al., 
2005; Bergin et al., 2006; Ramarao et al., 2012; Harding et al., 2013). In nature it is a 
pest of beehives where the larvae feed on pollen and wax (Hussein et al., 2012), which 
can lead to weak colonies being completely destroyed (Shimanuki, 1981). It can be 
reared between 20-30 ˚C and infection studies are performed over a wide range of 
environmentally relevant temperatures (15 ˚ C-37 ˚ C) (Ramarao et al., 2012). The large 
size of the larvae facilitates injection, which permits known doses of chemicals or 
microorganisms to be delivered into the insect (Glavis-Bloom et al., 2012). Recently 
a draft G. mellonella genome sequence was published (Lange et al., 2018), which will 
enable genetic manipulation and allow comparisons to other species. G. mellonella is 
particularly useful for studying the innate immune response against human pathogens 
(Mylonakis et al., 2005; Mukherjee et al., 2010; Harding et al., 2013), partly because 
of the conserved nature of the vertebrate and invertebrate innate immune systems 
(Vilmos and Kurucz, 1998) and also because studies can be performed at 37 ˚C. G. 
mellonella could also act as a useful tool for development of new control methods for 
Lepidopteran pests since the Pyralidae family contains a large number of species that 
are pests of a range of agricultural crops.  
 
G. mellonella is very susceptible to EPF infection, possibly because beehives are a 
very clean environment due to the production of antimicrobial chemicals such as 
propolis by bees (Grange and Davey, 1990). As a result, there may not have been 
selection pressure for G. mellonella larvae to possess a robust immune system. 
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Because of this, they can also be used as ‘bait’ to acquire new isolates of 
entomopathogenic fungi and nematodes from soil (Chandler et al., 1997). 
 
The immune response of G. mellonella after infection with EPF has been reasonably 
well studied. Plasmatocytes isolated from G. mellonella treated with M. anisopliae s.l. 
were found to exhibit morphological and cytoskeletal changes upon infection 
(Vilcinskas et al., 1997b), in addition to impaired phagocytic activity (Vilcinskas et 
al., 1997c). Beauveria bassiana infection has also been studied in G. mellonella, 
particularly the effect of this EPF on the systemic antifungal immune response 
(Vilcinskas and Matha, 1997; Wojda et al., 2009). This is discussed in more detail in 
later chapters. 
 
2.1.2 Laboratory bioassays investigating the infection of insects by EPF 
Due to the use of EPF as biological control agents their interaction with insects has 
been studied extensively using laboratory bioassays. In particular, B. bassiana and M. 
brunneum have been widely investigated (Copping and Menn, 2000), with isolates of 
both having been licenced for use as pest control agents (Section 1.4). In the U.K, two 
commercial products based on these species are B. bassiana in BotaniGard (Certis, 
USA) and M. brunneum in Met52 (Fargro, U.K).  
In a bioassay EPF can be applied to insects through injection or surface application, 
with either conidia or blastospores. Conidia are the infectious stage of the fungal 
lifecycle commonly found in nature (Figure 1.3), whereas blastospores are vegetative 
cells that are produced during fungal growth in the insect haemolymph (Pendland and 
Boucias, 1997). Previous studies have treated G. mellonella by injection of B. bassiana 
blastospores into the haemolymph to monitor its impact on the expression of immune-
related genes using RT-qPCR or to monitor its impact on the cellular immune response 
(Vilcinskas and Matha, 1997; Wojda et al., 2009). Injection allows treatment of insects 
with an accurate dose of pathogen, but is not necessarily informative about EPF 
virulence as the ability to penetrate the cuticle is a major virulence determinant (Lacey, 
2012).   
Various techniques have been used for the surface application of conidia onto insects. 
Firstly, insects can be infected by direct contact with the fungus. For example, 
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Vertyporokh and Wojda, (2017) infected G. mellonella with B. bassiana by rolling the 
larvae onto the sporulating fungus in an agar plate. Alternatively, insects can be 
immersed in a suspension of conidia (Lacey, 2012). A disadvantage of these 
techniques is that the dose of EPF received by an insect cannot be measured precisely. 
EPF can also be applied topically using an apparatus such as a Potter tower air 
atomising sprayer (Bateman, 1999), where a rotary atomiser is used to apply uniform 
droplets to insects. The final technique to apply conidia to the insect surface is to place 
a droplet of spore suspension onto the insect (Lacey, 2012). This enables a precise 
dose to be administered, but is only possible for use with some larger insects. 
 
2.1.3 Galleria mellonella as a tool for studying the effect of fungal secondary 
metabolites on insects 
 
In addition to its use to study EPF-insect interactions, G. mellonella has also been used 
as a model to study the impact of secondary metabolites on insects. Beauverolides 
have been found to have contrasting effects on the G. mellonella immune system 
following injection (Vilcinskas et al., 1999), having immunosuppressive and 
immunostimulatory effects depending on the quantification method. Injection of this 
metabolite stimulated lysozyme and antibacterial activity in vivo but inhibited 
phagocytic activity of plasmatocytes in vitro (Vilcinskas et al., 1999). Another study 
(Fiolka, 2008) found that cyclosporins (a secondary metabolite of Tolypocladium 
inflatum) have a strong immunosuppressive activity in G. mellonella.  
 
Cordycepin, a secondary metabolite of the EPF C. militaris, is lethal when fed to P. 
xylostella larvae (Kim et al., 2002). It has also been reported to cause deformity when 
injected into G. mellonella pupae (Roberts, 1981). However, detailed studies on its 
mode of action have not been carried out and the reason for mortality and deformity 
have not been determined.  
 
2.1.4 The insect gut as a barrier to infection 
 
The cuticle of the external integument is a major barrier to EPF infection. One way in 
which pathogenic microorganisms may bypass this barrier is by entering the insect 
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through the gut following feeding. Lepidoptera have defensive mechanisms to prevent 
this route of infection, including a very low gut pH, digestive enzymes to prevent the 
growth of microorganisms, and the production of reactive oxygen species (ROS) 
(Vallet-Gely et al., 2008). If a potentially pathogenic microorganism is able to persist, 
AMP production may be triggered in the gut epithelial cells via the Toll (Ferreira et 
al., 2014) or IMD pathways (Tzou et al., 2000). AMP production has been found to 
be critical in resisting oral infection, for example D. melanogaster lacking an IMD 
pathway are more susceptible to oral infection by bacteria than wild-type flies (Liehl 
et al., 2006). 
 
Commensal bacteria also reside in the insect gut and are thought to have beneficial 
functions such as aiding in the digestion of some materials (Breznak and Switzer, 
1986; Prem Anand et al., 2010), modulating development/ growth (Shin et al., 2011) 
and protecting against pathogenic microorganisms (Dillon and Charnley, 2002; Engel 
and Moran, 2013). The reason that these commensals are not targeted by the immune 
system in the gut is not clear (Vallet-Gely et al., 2008). In D. melanogaster it is thought 
that in gut epithelial cells the transcription factor Caudal acts as a master regulator for 
AMP expression, preventing overexpression of AMPs (Ryu et al., 2008) and allowing 
commensal organisms to survive. Bacteria have been isolated from the guts of healthy 
G. mellonella, which suggests that there are either commensal bacteria or pathogens 
that are kept in check by the innate immune system (Bucher and Williams, 1967). 
 
2.1.5 Aims  
 
The first aim of this component of the Ph.D. was to quantify survival of G. mellonella 
larvae in response to treatment with EPF and the secondary metabolite cordycepin. In 
order to do this, it was necessary to develop an assay that could be used to reliably 
infect G. mellonella and monitor their survival. The second aim was to elucidate the 
cause of larval death when treated with cordycepin. 
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2.2 Materials and methods 
 
2.2.1 Insect material  
 
G. mellonella larvae were purchased from Wazp Brand UK Ltd. (Yorkshire, U.K) 
where larvae were cold-treated to slow down their development. Final instar larvae 
were maintained at 15 ˚C in darkness without feeding prior to experiments. Larvae 
were used for experiments within seven days of delivery and weighed between 200 
and 300 mg.  
 
2.2.2 Fungal material 
 
The fungal isolates used are detailed in Table 2.1. The isolates of B. bassiana and M. 
brunneum were from the Warwick Crop Centre culture collection, where they were 
maintained for long term storage on porous cryotolerant plastic beads in liquid 
nitrogen. The isolate of C. militaris was obtained from the Agricultural Research 
Service Collection of Entomopathogenic Fungal Cultures (ARESF Agriculture, 2016). 
For this project all fungi were maintained on Sabouraud dextrose agar (SDA; Oxoid, 
USA) slopes at 5 ˚C. Prior to experiments, fungi were subcultured onto SDA in 9 cm 
Petri dishes (SARSTEDT, Germany) and incubated at 23 ˚C in darkness for 10-14 
days.  
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Table 2.1- Origins of fungal isolates used during this project 
 
In order to observe spore morphology, chitin was stained with lactophenol cotton blue 
(Pro-Lab Diagnostics, Canada). Approximately 20 µl of spore suspension was placed 
onto a glass microscope slide, stained with 20 µl of lactophenol cotton blue then sealed 
with a cover slip and clear nail varnish. The slide was visualized under a Leica DMi 
inverted microscope imaging system (Leica microsystems, Germany) at 100x 
magnification and photographed using a 5-megapixel camera (Leica MC170 HD). 
 
2.2.3 Preparing conidial suspensions  
 
Conidial suspensions were prepared (Figure 2.1) by pipetting 10 ml of 0.01% Triton 
X-100 (Merck, Germany) onto fungal plates and agitating with an ‘L’-shaped spreader 
(Greiner bio-one, Austria) for approximately 2 min. This suspension was then filtered 
through two layers of sterile milk filter paper (Goat Nutrition Ltd, U.K) to remove 
mycelial fragments. The suspension was diluted 1 in 10 and the number of conidia 
counted using an Improved Neubauer haemacytometer. Following this, 10 ml aliquots 
were made using 0.01% Triton X-100 ranging from 1x107 to 1x103 conidia ml-1. 
 
 
 
Species 
Accession 
number in 
Crop Centre 
Collection 
Source Origin Commercial use 
Beauveria 
bassiana 433.99 
Bemisia sp. 
(Hemiptera: 
Aleyrodidae) 
 
USA 
Active ingredient in 
‘BotaniGard’ (Mycotech 
Corporation, PO Box 4109, 
Butte, MT 59702, USA) 
 
Metarhizium 
brunnuem 275.86 
Cydia pomonella 
(Lepidoptera: 
Tortricidae) Germany 
Active ingredient in ‘Met52’ 
(Novozymes, Krogshoejvej 
36, 2880 Bagsvaerd, 
Denmark) 
 
Cordyceps 
militaris 
 
ARSEF 11703 Lepidoptera, unknown species China - 
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2.2.4 Confirmation of fungal species identity using nucleotide sequences 
 
Mycelia were scraped off fungal SDA plates grown in the dark for approximately 10 
days using a sterile scalpel and ground in liquid nitrogen using a sterile mortar and 
pestle. DNA was extracted using a Qiagen DNeasy plant mini kit (Qiagen, The 
Netherlands) following the manufacturer’s guidelines and the quality and quantity of 
DNA was assessed using a NanoDrop ® ND-100 Spectrophotometer (ThermoFisher 
Scientific, USA). The 20 µl PCR reactions were prepared using 1 µl of template DNA, 
RedTaq Ready Mix (Sigma-Aldrich, USA) and forwards and reverse primers (10 µM 
each) for the ITS region, large ribosomal subunit rRNA (LR) or translation elongation 
factor (EF) 1a gene (Table 2.2) following the manufacturer’s guidelines and ran on a 
GeneAmp ® PCR System 9700 (Applied Biosystems, USA). The PCR conditions for 
ITS primers were: initial denaturation of 94 ˚C for 1 min followed by 35 cycles of 94 
˚C for 45s, 55 ˚C for 30s and 72 ˚C for 1 min. All PCRs were followed by a final 
amplification of 7 min at 72 ˚C unless otherwise stated. The conditions for LR primers 
Figure 2.1-Preparation of conidial suspension. Preparation of a Beauveria bassiana 433.99 
conidia suspension. Firstly, Triton X-100 is pipetted onto conidia, then agitated with an ‘L’ shaped 
spreader. This is filtered through two sterile milk filters. 
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were: initial denaturation of 94 ˚C for 1 min followed by 30 cycles of 94 ˚C for 1 min, 
50 ˚C for 45s and 72 ˚C for 1 min. The conditions for EF primers were: initial 
denaturation of 94 ˚C for 30s followed by 35 cycles of 94 ˚C for 30s, 56 ˚C for 30s 
and 72 ˚C for 1 min, then a final elongation for 10 min at 72 ˚C.  
 
The PCR products were separated on a 1.2% agarose gel (Sigma-Aldrich, USA) 
prepared with Tris-Acetate EDTA (Fisher Scientific, USA) containing 2 µl GelRed ® 
(Biotium, USA) per 100 ml. This was run in Tris-Acetate EDTA at 90 V for 1 h in a 
submerged horizontal electrophoresis cell (BIO-RAD, USA) and visualised using a 
UV transilluminator (G:BOX, Synegene, U.K). The PCR product was purified using 
a QIAquick PCR purification kit (Qiagen, The Netherlands) and sequenced by GATC 
Biotech using the forward primer (5 µM) for each gene. 
 
Table 2.2- Primers used for fungal identification.  
Gene Primer name Primer sequence (5'-3') Reference 
Large ribosomal 
subunit 
LROR ACCCGCTGAACTTAAGC Vilgalys and Hester 
(1990) LR5 TCCTGAGGGAAACTTCG 
Elongation factor 
1- alpha  
EF1-983F GCYCCYGGHCAYCGTGAYTTYAT Rehner and 
Buckley (2005) EF1-1567R ACHGTRCCRATACCACCRATCTT 
ITS ITS1 TCCGTAGGTGAACCTGCGG White et al., (1990) ITS4 TCCTCCGCTTATTGATATGC 
 
A phylogenetic tree was constructed in MEGA6 (Tamura et al., 2013) including 18 
reference sequences for type species (Appendix A.1) obtained from the National 
Center for Biotechnology Information (NCBI, 2017). The maximum likelihood 
method was used to construct the tree, based on the Kimura 2-parameter model with 
gamma distribution for ITS and EF1a genes. A Tamura-Nei 93 model with gamma 
distribution was used for the LR gene and a bootstrap value of 1000 was used for all 
three genes.  
 
2.2.5 Galleria mellonella bioassay- fungal injection 
 
Conidial suspensions of three EPF isolates (Table 2.1) were prepared as described in 
Section 2.2.3 at the following concentrations: 1x107, 1x106, 1x105, 1x104 and 1x103 
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conidia ml-1. Final instar G. mellonella larvae were cooled on ice for 5 min prior to 
injection of 30 µl of fungal suspension into the right front proleg using a 0.3 ml 
microfine insulin syringe (BD, USA). Control larvae were injected with 30 µl of 
0.01% Triton X-100. The injection platform was assembled using filter paper and a 
1000 µl pipette tip (Figure 2.2). Ten larvae were treated at each dose and the 
experiment replicated on three occasions. Larvae injected with the same dose were 
placed together in a 9 cm Petri dish lined with filter paper (Whatman, GE Healthcare, 
U.K). They were maintained in an environmental test chamber (Sanyo, Japan) at 20 
˚C and 16:8 h light:dark cycle and their survival was monitored for seven days. A 
model was fitted to the survival on day seven using the DRC package (Ritz et al., 
2015) in R (RStudio, 2017) and used to calculate the LC50 (concentration that causes 
50% mortality) for each EPF. 
 
2.2.6 Galleria mellonella bioassay- fungal topical application  
 
Conidial suspensions of three EPF isolates (Table 2.1) were prepared as described in 
Section 3.2.3 at the following concentrations: 1x107, 1x106, 1x105, 1x104 and 1x103 
conidia ml-1. Final instar G. mellonella were cooled on ice for 5 min. Groups of 10 
larvae per concentration for each isolate were placed on filter paper (Whatman, GE 
Healthcare, U.K) in a 9 cm Petri dish lid and sprayed with 4 ml of conidia suspension 
using a Potter tower air atomising sprayer (Potter, 1952) at 34.5 KPa. Controls were 
sprayed with 0.01% Triton X-100 prior to any fungal application to prevent 
contamination. The experiment was replicated on three occasions. Larvae were 
allowed to recover at room temperature for 30 min before being transferred to a new 
9 cm Petri dish lined with damp filter paper and sealed with Parafilm ‘M’ ® (Bemis, 
USA) to maintain a humid environment. The Petri dishes were maintained in an 
environmental test chamber (Sanyo, Japan) at 20 ˚C and 16:8 h light:dark cycle and 
the survival was recorded over seven days. A model was fitted to the survival on day 
seven using the DRC package as described in Section 2.2.5. 
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2.2.7 Galleria mellonella bioassay- cordycepin injection 
 
A stock solution of cordycepin was prepared by dissolving 100 mg of cordycepin 
(Sigma-Aldrich, USA) in 1 ml of DMSO (Fisher Scientific, USA). This was diluted 
using DEPC-treated water (Fisher Scientific, USA) to the following concentrations: 
1, 1.82, 3.3, 6 and 11 mg ml-1. These concentrations were selected as they are 
equidistant on a log2 scale. Final instar G. mellonella were cooled on ice for 5 min 
prior to injection with 30 µl of the solution in the right front proleg (Figure 2.2) using 
a 0.3 ml microfine insulin syringe (BD, USA). Controls were injected with a 0.01% 
Triton X-100/DMSO mixture. Ten larvae were treated at each dose and the experiment 
was replicated on three occasions. Larvae injected with the same dose were placed 
together in a 9 cm Petri dish lined with filter paper (Whatman, GE Healthcare, U.K). 
Dishes were maintained in an environmental test chamber (Sanyo, Japan) at 20 ˚C and 
16:8 h light:dark cycle and the survival was monitored daily for seven days. Survival 
was analysed in SPSS Statistics (Version 24, IBM) using a Kaplan-Meier estimator. 
A log-rank test was carried out during this analysis to determine whether there was 
any significant difference between replicates (Kleinbaum and Klein, 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.8 Identification of bacteria isolated from G. mellonella cadavers 
 
Unexplained death was observed in the cordycepin injection bioassays (Section 2.2.7). 
In order to identify the causal agent, final instar G. mellonella were injected with 11 
Figure 2.2- Injection of final instar Galleria mellonella larvae. Injection 
platform constructed from filter paper and a 1000 µl pipet tip to allow 
immobilization of larvae and injection with a 30 µl syringe.   
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mg ml-1 cordycepin or a control solution as described in Section 2.2.7. Haemolymph 
was extracted from larvae on day seven by piercing the abdomen and squeezing the 
larvae until a droplet formed. The droplet was collected using a 2 µl pipette and 1 µl 
of the haemolymph was diluted 1000-fold in sterile distilled water. A 100 µl aliquot 
of this was spread onto a 9 cm Petri dish containing 1% nutrient agar using an ‘L’-
shaped spreader (Greiner bio-one, Austria) and the plates were incubated for 24 h at 
25 ˚C in darkness. Individual colonies were isolated and spread onto new 1% nutrient 
agar plates as previously described and incubated for a further 24 h. Bacterial DNA 
was extracted using the Qiagen DNeasy Blood and Tissue DNA extraction kit, 
following the gram-positive bacteria DNA extraction protocol. DNA (1 µl) was used 
as a template for PCR (GeneAmp ® PCR System 9700, Applied Biosystems, USA) 
using RedTaq Ready Mix (Sigma-Aldrich, USA) and the 16S rRNA primers and 
conditions described in Weisburg et al., (1991). Following amplification PCR 
products were ran on a gel as described in Section 2.2.4 and purified using the 
QIAquick PCR purification kit (Qiagen, The Netherlands). Purified DNA was 
sequenced by GATC Biotech (Germany) using the forward primer (5 µM). A 
phylogenetic tree was constructed in MEGA6 (Tamura et al., 2013) including 
reference sequences (Appendix A.2) from the National Center for Biotechnology 
Information (NCBI, 2017) using the maximum likelihood method based on the Jukes-
Cantor model and a bootstrap value of 1000.  
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2.3 Results 
 
2.3.1 Confirmation of fungal species identity 
 
The identity of EPF isolates was confirmed using lactophenol cotton blue staining of 
conidia, observation of EPF physiology and gene sequencing. Physiology of all 
isolates cultured on SDA was consistent with description by Brady (1979). Following 
lactophenol cotton blue staining M. brunneum 275.86 conidia appeared to be 
elongated and oval, approximately 10 µm long and 3 µm in diameter (Figure 2.3), 
which is consistent with the description from Petch (1935). The conidia of C. militaris 
11703 ranged from spherical to ‘pear shaped’ and were approximately 4 µm in 
diameter, this is consistent with the description from Brady (1979). B. bassiana 433.99 
conidia appeared spherical and 3 µm in diameter, which is consistent with those 
described by de Hoog (2000).  
 
 
 
 
 
 
 
 
 
Figure 2.3- Microscopic visualization of EPF conidia stained with lactophenol cotton blue. A) Conidia of 
Metarhizium brunneum 275.86, B) Cordyceps militaris 11703 and C) Beauveria bassiana 433.99 stained with 
lactophenol blue. Black bars are 20 µm.  
  60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 - Phylogenetic tree constructed using ITS gene. Tree constructed using ITS gene 
sequences and the Kimura 2-parameter model with gamma distribution. Bootstrap values are 1000. 
Isolates marked with an * are sequences from the isolates used in this project, all other sequences 
were obtained from the National Center for Biotechnology (NCBI, 2017). Constructed using 
MEGA6 software. 
Figure 2.5- Phylogenetic tree constructed using elongation factor 1 alpha gene. Tree constructed 
using elongation factor 1 alpha gene sequences and the Kimura 2-parameter model with invariant 
sites. Bootstrap values are 1000. Isolates marked with an * are sequences from the isolates used in 
this project, all other sequences were obtained from the National Center for Biotechnology 
Information (NCBI, 2017). Constructed using MEGA6 software. 
 Beauveria bassiana 433.99 *
 Beauveria bassiana isolate Bb 2016 120
 Lecanicillium muscarium strain IRAN 684C
 Cordyceps militaris 11703 *
 Cordyceps militaris strain Minfu30
 Isaria japonica strain BCC 2787
 Metarhizium brunneum 275.86
 Metarhizium brunneum strain KVL16-25
 Aspergillus niger isolate CICR CBE
100
100
99
87
78
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 Beauveria bassiana 433.99 *
 Beauveria bassiana strain 4362
 Metarhizium brunneum 275.86 *
 Metarhizium brunneum strain EAMb 09/01-Su
 Lecanicillium muscarium strain Vl 11
 Isaria fumosorosea strain CHE-CNRCB 393
 Cordyceps militaris 11703 *
 Cordyceps militaris strain ATCC 34164
 Aspergillus niger strain CBS 101697
100
99
85
45
52
42
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All three genes tested from the three EPF isolates used during this project clustered 
with expected sequences (Figures 2.4, 2.5 and 2.6), confirming the identity of these 
isolates. However, the three trees (Figures 2.4, 2.5 and 2.6) were not congruent with 
each other which could indicate differences in the evolution of genes or errors in the 
identity of sequences in the NCBI database. In particular this could be the case for 
Isaria spp. and Lecanicillium spp., which have been reclassified on multiple occasions 
(Sung et al., 2007). There were a low number of average substitutions per site in 
comparison to reference sequences for all of the genes investigated, genetically 
confirming the identification of the isolates. The differences between the ITS genes 
was a mean of 0.003, <0.001 and <0.001 base substitutions per site for C. militaris 
11703, B. bassiana 433.99 and M. brunneum 275.86, respectively. The differences 
between the elongation factor 1 alpha genes was a mean of <0.001, 0.022 and 0.009 
base substitutions per site for C. militaris 11703, B. bassiana 433.99 and M. brunneum 
275.86, respectively. The differences between the large ribosomal subunit rRNA 
Figure 2.6- Phylogenetic tree constructed using large ribosomal subunit rRNA gene. Tree constructed 
using large ribosomal subunit rRNA gene sequences and the Tamura-Nei 93 model with gamma distribution. 
Bootstrap values are 1000. Isolates marked with an * are sequences from the isolates used in this project, all 
other sequences were obtained from the National Center for Biotechnology Information (NCBI, 2017). 
Constructed using MEGA6 software. 
 Beauveria bassiana unknown strain
 Beauveria bassiana 433.99 *
 Cordyceps militaris 11703 *
 Cordyceps militaris strain ATCC 34164
 Isaria farinosa strain MY01338
 Lecanicillium muscarium strain CBS 143.62
 Metarhizium brunneum 275.86 *
 Metarhizium anisopliae isolate 5B
 Aspergillus niger
97
98
99
85
67
88
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genes was a mean of <0.001, 0.003 and 0.001 base substitutions per site for C. militaris 
11703, B. bassiana 433.99 and M. brunneum 275.86, respectively.  
 
2.3.2 G. mellonella bioassay techniques 
 
During the bioassays described in Sections 2.25 to 2.27, a number of problems were 
encountered. Table 2.3 summarises these problems and the solutions found to 
overcome them. 
 
Table 2.3- Problems encountered during the development of Galleria mellonella bioassays and 
the techniques used to overcome them. 
 
 
2.3.3 G. mellonella bioassay- fungal injection 
 
Dose responses were observed when G. mellonella were injected with EPF and the 
best fitting model for all EPF was a two-parameter log-logistic model (Figure 2.7). 
This was used to calculate the LC50 on day six (Table 2.4) as being 3.57x103, 4.03x104 
and 6.96x103 conidia ml-1 for B. bassiana 433.99, C. militaris 11703 and M. brunneum 
275.86, respectively. This is equivalent to LD50 values of 1.1x102, 1.2x103 and 
2.1x102 conidia per larva for B. bassiana 433.99, C. militaris 11703 and M. brunneum 
275.86, respectively. The LC50 values of all three isolates were significantly different 
Problem Cause Solution 
 
High control mortality Bacterial infection • Surface sterilise larvae with 70% ethanol before 
treatment. Fungal infection 
Internal injury from 
injection 
• Inject larvae in the front right proleg 
• Inject no more than 30 µl into each larva 
Low mortality 
following EPF 
spraying 
Low humidity • Maintain larvae in Petri dish lined with damp filter paper and seal with parafilm 
Inconsistent mortality 
following EPF 
spraying 
  
Insects moving during 
spraying  
• Chill larvae on ice for approximately five 
minutes before spraying  
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(p<0.001 for B. bassiana 433.99 v C. militaris 11703, p=0.006 for B. bassiana 433.99 
v M. brunneum 275.86 and p=0.009 for M. brunneum 275.86 v C. militaris 11703). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
             Table 2.4 - Estimates of the LC50 following injection of EPF 1,2.  
Fungus LC50 
(conidia ml-1) 
95% confidence limits 
Lower bound Upper bound 
B. bassiana 433.99 3.57x103 a 1.72x103 5.42x103 
C. militaris 11703 4.03x104 b 2.05x104 5.81x104 
M. brunneum 275.86 6.96x103 c 4.04x103 9.98x103 
 
1 Estimate of the LC50 following injection of G. mellonella with C. militaris 11703, B. bassiana 433.99 
and M. brunneum 275.86 conidia.  
2 The LC50 was calculated by fitting an LL.2 model in RStudio and significant differences determined 
using a T-test. Significant differences between LC50 are denoted with letters (p<0.05). 
 
Figure 2.7 - The proportion mortality of Galleria mellonella injected with EPF. The proportion 
mortality of G. mellonella larvae (n=30) injected with B. bassiana 433.99, M. brunneum 275.86 or 
C. militaris 11703 conidia at six concentrations on day six after treatment. A two-parameter log-
logistic model is fitted to the responses.  
B. bassiana 
M. brunneum
C. militaris
1e+03 1e+04 1e+05 1e+06 1e+07
Concentration 
(conidia ml-1)
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2.3.4 Topical application of EPF conidia onto G. mellonella 
 
Dose responses were also observed when EPF were topically applied to G. mellonella 
larvae and the best fitting model for G. mellonella mortality was a two-parameter 
Weibull function (Figure 2.8). This was used to calculate the LC50 on day six (Table 
2.5) as being 9.57x104, 1.73x106 and 1.03x105 conidia ml-1 for B. bassiana 433.99, C. 
militaris 11703and M. brunneum 275.86, respectively. The LC50 of C. militaris 11703 
was significantly higher than for the other isolates tested (p<0.001 in comparison to 
B. bassiana 433.99 and p=0.008 in comparison to M. brunneum 275.86). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8 - The proportion mortality of Galleria mellonella sprayed with EPF. The proportion 
mortality of G. mellonella larvae (n=30) sprayed with B. bassiana 433.99, M. brunneum 275.86 or C. 
militaris 11703 conidia at six concentrations on day six after treatment. A two-parameter Weibull 
function is fitted to the responses. 
 
 
 
 
 
 
B. bassiana 
M. brunneum
C. militaris
1e+03 1e+04 1e+05 1e+06 1e+07
Concentration 
(conidia ml-1)
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           Table 2.5- Estimates of the LC50 following topical application of EPF 1,2.  
 
Fungus LC50 (conidia ml-1) 
95% confidence limits 
Lower bound Upper bound 
B. bassiana 433.99 9.57x104 a 5.78x104 1.33x105 
C. militaris 11703 1.73x106 b 9.43x105 2.53x106 
M. brunneum 275.86 1.03x105 a 4.86x104 1.58x105 
    
1 Estimate of the LC50 following spraying of G. mellonella with C. militaris 11703, B. bassiana 433.99 
and M. brunneum 275.86 conidia at day six after treatment.  
2 The LC50 was calculated by fitting a model in RStudio and significant differences determined using 
a T-test. Significant differences between LC50 are denoted with letters (p<0.05). 
 
2.3.5 Effect of cordycepin on survival of G. mellonella 
 
In order to assess the impact of cordycepin on the survival of G. mellonella, final instar 
larvae were injected with cordycepin and the survival of three replicates was 
monitored (Figure 2.9). At 11 mg ml-1 and 6 mg ml-1 cordycepin (330 µg and 180 µg 
per larva, respectively), a significant difference was observed in the survival of larvae 
between three replicates. At 11 mg ml-1 in replicate two there was 100% mortality 
after three days, but for replicates one and three there was 50% and 70% mortality, 
respectively, at day seven. A similar variation was observed at 6 mg ml-1, where in 
replicate two there was 100% mortality after four days, but for replicates one and three 
there was 50% and 40% mortality, respectively, after day seven. At all other 
concentrations of cordycepin (3.3, 1.82, 1 and 0 mg ml-1) there was no significant 
difference in survival of G. mellonella larvae between replicates. It was therefore not 
possible to calculate a dose response for cordycepin as the mean of the replicates 
obtained at 6 mg ml-1 and 11 mg ml-1 would be unreliable. The survival curves for all 
cordycepin doses are shown in Figure 2.9. The mean survival of larvae on day seven 
was 87%, 93%, 100% and 97% following treatment with 3.3, 1.82, 1 and 0 mg ml-1, 
respectively.    
 
Where death occurred, particularly at higher doses of cordycepin, larvae exhibited 
distinctive symptoms prior to death and had atypical cadavers. Between 24-48 h prior 
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to death insects became grey and movement was reduced. After death, cadavers were 
black and their abdomen appeared fluid-filled (Figure 2.10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9- Kaplan-Meier plots showing the effect of cordycepin on Galleria 
mellonella survival. Cumulative survival of G. mellonella following treatment with 
A) 11, B) 6, C) 3.3, D) 1.82, E) 1 and F) 0 mg ml-1 of cordycepin. Survival of each 
replicate is shown for each treatment, with ten individuals treated per treatment per 
replicate. A log-rank test was done for each replicate and the p-values are shown. 
Figure was produced using SPSS Statistics (Version 24, IBM).  
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2.2.6 Identification of bacteria isolated from G. mellonella  
 
Bacteria were isolated from the haemolymph (Figure 2.11) of ten G. mellonella larvae 
that were treated with cordycepin following surface sterilisation with ethanol. One 
species was isolated from each of eight larvae and two species from two individuals. 
No bacteria were isolated from control individuals as haemolymph is sterile in healthy 
individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11- Bacteria isolated from Galleria 
mellonella haemolymph. Example of the bacterial 
colonies obtained from the haemolymph of G. 
mellonella that had been treated with 11 mg ml-1 
cordycepin.  
Figure 2.10- Photograph of Galleria mellonella 
cadavers. G. mellonella cadavers that had died following 
treatment with cordycepin.  
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The 16S rRNA sequences from all 12 species of bacteria isolated from G. mellonella 
cadavers showed homology to sequenced bacteria and clustered into multiple groups 
(Table 2.6; Figure 2.12). The differences between isolates from cordycepin-treated G. 
mellonella and isolates from the NCBI database ranged from 1-7% (Table 2.6).  
 
Table 2.6- Bacteria isolated from Galleria mellonella treated with cordycepin. The similarity of 
16S sequences of bacteria isolated from G. mellonella treated with 11 mg ml -1 cordycepin to the top 
BLAST hit in the NCBI database. 
 
Both gram-positive (nine isolates) and gram-negative (three isolates) bacteria were 
identified. The most common genera were Enterobacter, followed by Pantoea, 
Serratia and Bacillus. These are in the phyla Proteobacter or Firmicutes, both of which 
contain gut-resident bacteria that have previously been isolated from insects (Yun et 
al., 2014).  
 
 
 
 
 
 
 
 
Bacterial 
Isolate 
Top NCBI BLAST hit/ Accession 
number 
Percentage similarity/ range 
(bp) 
1 Pantoea agglomerans/MH158730 99% / 1012 
2 Pantoea vagans/ MH141452 99% /1053 
3 Bacillus cereus/ KX069360 99% /799 
4 Bacillus thuringiensis/ MF083059 98%/ 751 
5 Enterobacter xiangfangensis/ CP024908 99%/ 1021 
6 Enterococcus faecalis/ MH150804 99% /540 
7 Enterobacter hormaechei/ MH396771 98% /774 
8 Enterobacter cloacae/ MF471480 99% / 804 
9 Serratia liquefaciens/ KY458800 99% / 637 
10 Enterobacter cloacae/ KX450937 93%/ 756 
11 Serratia liquefaciens/ KY458800 99% / 756 
12 Enterobacter asburiae / EU239468 95% / 772 
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Figure 2.12- Phylogenetic analysis of 16S rRNA gene sequences to identify haemolymph bacteria. 
Phylogenetic tree constructed using 16S rRNA gene sequences and the Jukes-Cantor model, bootstrap 
values are 1000. Isolates marked with * were extracted from G. mellonella that had been treated with 
cordycepin, all other sequences were obtained from the National Center for Biotechnology Information 
(NCBI, 2017). Constructed using MEGA6 software. 
 
 1*
 2*
 Pantoea vagans strain HMF2842
 Pantoea sp. CanR-85
 Pantoea agglomerans strain PGHL1
 Pantoea agglomerans strain NSI
 Pantoea agglomerans strain NSF
 Serratia liquefaciens strain B7
 Serratia liquefaciens strain LZ-24
 Serratia liquefaciens strain ZMT-1
 11*
 9*
 10*
 12*
 Enterobacter sp. Sn-08
 Enterobacter sp. strain M03
 Enterobacter sp. V16
 5*
 7*
  8*
 Lactococcus lactis strain BIHB 331
 Enterococcus mundtii strain M-4
 Enterococcus mundtii strain NT-1
 6*
  4*
 3*
 Bacillus cereus strain S8
 Bacillus thuringiensis strain yy-23
100
48
24
40
99
50
100
19
9
9
99
83
14
5
3
5
74
89
60
10
1
2
3
7
96
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2.4 Discussion 
 
The development of a good bioassay system for testing EPF is difficult, as results must 
be reproducible and insects need to be easy to observe. Bioassays with G. mellonella 
have been performed by Wojda et al. (2009), Mukherjee et al. (2010) and Harding et 
al. (2013) who treated larvae by injection of pathogens (Mukherjee et al., 2010; 
Harding et al., 2013) or topical application of EPF (Wojda et al., 2009). G. mellonella 
is related to several key crop pest species, therefore it is a useful model to investigate 
the impact of pesticides and other pest control methods. The innate immune system of 
G. mellonella is similar to that of mammals and larvae can be maintained at human 
body temperature (37 ˚C), so it is also useful for the study of human pathogens.    
 
The bioassay system developed in this chapter provided a reproducible means of 
treating G. mellonella that minimised control mortality, was quick to set up and 
facilitated observation of larvae. The inoculation bioassay was similar to that 
described by Harding et al. (2013), but larvae were surface sterilised more thoroughly, 
inoculated with a different volume, weighed prior to inoculation and maintained at a 
lower temperature. An important finding during this bioassay development process 
was the requirement to maintain a clean environment when injecting and spraying as 
G. mellonella were highly susceptible to infection by opportunistic fungi and bacteria. 
As G. mellonella larvae naturally occur in the relatively sterile environment of 
beehives (Dickman, 1933), they may have lost some of their immune response 
capability compared with other Lepidoptera. 
 
Mortality caused by EPF varied depending on the mode of application, with larvae 
inoculated by injection of EPF appearing to have a higher rate of mortality than when 
EPF were applied topically. However, direct comparison between the mortality of 
topically treated or injected larvae was not possible as the number of conidia in each 
larva was not quantified following topical application. It is likely that any differences 
were because conidia must penetrate the insect cuticle when applied topically 
(Andersen, 1979), but would bypass this if inoculated. Penetration of the cuticle is a 
time consuming and energy-expensive process due to the production of cuticle-
degrading enzymes (Ortiz-Urquiza and Keyhani, 2013) and appressoria (Howard et 
al., 1991) by EPF. The mortality of G. mellonella following B. bassiana, C. militaris 
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and M. brunneum infection has been assessed by other studies. Wojda et al., (2009) 
found that injection of G. mellonella with 1x104 B. bassiana isolate 80.2 blastopores 
caused 100% mortality of larvae after three days, whereas the work described here 
found that injection with a similar dose (3x104 conidia per larva, 30 µl of 1x106 conidia 
ml-1) caused 100% mortality after five days. The differences in mortality could be due 
to isolate variation (Ekesi et al., 1999) or differences in virulence between blastospores 
and aerial conidia (Hegedus et al., 1992). Most other studies into EPF virulence in G. 
mellonella applied EPF conidia topically (Ment et al., 2012; Kryukov et al., 2015; 
Ríos-Moreno et al., 2017), so it is difficult to compare the results of these studies to 
the results in this chapter due to the different methods for conidia application. 
 
G. mellonella were less susceptible to infection by C. militaris 11703 than either B. 
bassiana 433.99 or M. brunneum 275.86. Fungal virulence is a result of complex 
interactions between insect host and the EPF and can be influenced by EPF isolate, 
host species, temperature (Thomas and Blanford, 2003), humidity (Gillespie and 
Crawford, 1986) and UV light exposure (Braga et al. 2001a). It has been reported that 
the optimum temperature for C. militaris is in the range of 20 ˚C to 28 ˚C (Lin and 
Chiang, 2008), 20 to 30 ˚C for B. bassiana (Fargues et al., 1997) and 25 to 30 ˚C for 
M. brunneum (Ekesi et al., 1999). All experiments were carried out at 20˚C, which is 
close to the optimum for these species, although slightly low for M. brunneum. So the 
variation in EPF virulence could be due to the origin of the isolate and the climate to 
which it is adapted. Alternatively, the reason for C. militaris 11703 virulence being 
lower than other EPF may be its lifestyle. In nature it predominantly infects 
Lepidoptera pupae (Kryukov et al., 2011) and pupation generally lasts longer than 
each larval instar in Lepidoptera (Briere and Pracros, 1998; Liu et al., 2002; Mironidis 
and Savopoulou-Soultani, 2014). This gives C. militaris a longer period of time for 
infection, as moulting between larval stages sheds EPF conidia on the cuticle, 
therefore C. militaris may not have evolved to colonise the host rapidly. In contrast, 
M. brunneum and B. bassiana are generalists (Li, 1988; Roberts and St Leger, 2004; 
Wraight et al., 2010), due to the higher abundance of potential hosts they may have 
evolved to be more virulent to permit infection of a higher number of insects. 
 
  72 
Bioassays were successfully developed to quantify the effect of cordycepin on G. 
mellonella survival. Concentrations of cordycepin greater than 6 mg ml-1 (180 µg per 
larva) caused mortality of larvae, however this was variable between replicates. 
Variability in mortality and dark brown G. mellonella cadavers suggest that 
cordycepin was not directly responsible for mortality. The dark brown/ black cadavers 
with liquefied interiors suggested that mortality was caused by bacterial infection 
(Tanada and Kaya, 2012). Similar symptoms were observed by Kim et al., (2002), 
who found that P. xylostella fed on cordycepin became dark brown and lysed. 
However, these authors linked these symptoms to a direct effect to cordycepin and did 
not suggest a mode of action.  
 
In support of the hypothesis that cordycepin was facilitating bacterial infection, 
bacteria were isolated from the haemolymph of cadavers, but not of control larvae. 
The bacteria isolated from the haemolymph were identified as belonging to the phyla 
Proteobacter and Firmicutes. The 16S rRNA sequences of all bacteria isolated showed 
a high similarity to isolates in the NCBI database, with sequence differences between 
1-7%. This could indicate that new strains were isolated in this project, however 
further studies would be needed to confirm strain/species differences (Fox et al., 
1992). This is consistent with the hypothesis that cordycepin facilitates opportunistic 
infection of G. mellonella by gut-resident bacteria which are common in insects. Yun 
et al. (2014) isolated bacteria from the gut of 305 insects (218 species) and identified 
the following proportions of phyla: 62.1% Proteobacteria, 20.7% Firmicutes, 6.4% 
Bacteroidetes, 4.8% Actinobacteria, 1.9% Tenericutes and 3% unclassified. They also 
found that the range of bacteria present in the insect gut is dependent on the species of 
the host, host habitat, diet and developmental stage. Bucher and Williams, (1967) 
identified commonly occurring bacteria in G. mellonella including: Alcaligenes 
faecalis, Bacillus spp., Staphylococcus aureus, Micrococcus spp., Enterobacter spp., 
Pseudomonas spp., Lactobacillus sp. These are consistent with at least 9 of the 12 
bacteria (Enterobacter spp. and Bacillus spp.) isolated from G. mellonella cadavers in 
this project.  
 
The presence of gut-resident bacteria in the haemolymph may be due to disruption of 
the insect gut by cordycepin, or inhibition of the insect immune system. Both of these 
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hypotheses would explain how the opportunistic bacteria were able to leave the gut 
and colonise the haemolymph. In mammalian systems it has been found that 
cordycepin reduces the expression of inflammatory genes (Kim et al., 2006a; Lee et 
al., 2010) through inhibition of the NFKB pathway. Therefore, it is possible that 
cordycepin inhibits a homolog of NFKB in the insect immune system, which stops the 
immune system from being able to prevent colonisation by gut bacteria. This will be 
expanded on in later chapters.  
 
2.5 Conclusions 
 
Injection and spraying bioassays were developed in G. mellonella that were reliable 
and reproducible with minimal control mortality and could be readily adapted for 
different application methods of EPF or other pathogens. Characterisation of the 
virulence of EPF and cordycepin in G. mellonella showed that the response to EPF 
was dose-dependent, regardless of the fungal species, but the impact of cordycepin 
was more complex. Cordycepin may facilitate colonisation of G. mellonella by gut-
resident bacteria, which could be due to the inhibition of the immune system by 
cordycepin, as has been previously described in mammals. 
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Chapter 3- Determining the effect of 
entomopathogenic fungi on the expression of genes 
associated with immune reactions in Galleria 
mellonella  
 
3.1 Background 
 
3.1.1 The G. mellonella humoral immune response  
 
Galleria mellonella is increasingly used as a model organism to investigate the insect 
immune response to infection (Mylonakis et al., 2005; Bergin et al., 2006; Ramarao 
et al., 2012; Cook and McArthur, 2013; Harding et al., 2013), particularly the humoral 
response which has a critical role in the insect immune system by regulating the 
production of anti-microbial peptides (AMPs) and other effectors in response to 
infection (Leclerc and Reichhart, 2004). AMPs are peptides that kill microorganisms 
(Rolff and Schmid-Hempel, 2016), although they can have additional functions. They 
have been observed to have roles as immunomodulators, regulating inflammatory 
pathways, particularly in vertebrates (Mansour et al., 2014). In addition, they have 
been found to have an important role in mediating interactions between the host and 
commensal bacteria in invertebrates (Rolff and Schmid-Hempel, 2016). For example, 
the expression of the AMP attacin is thought to reduce the survival of trypanosomes 
in the gut of Glossina spp. (Tsetse flies; Hu and Aksoy, 2006). Six AMPs have been 
identified from G. mellonella to date (Schuhmann et al., 2003; Lee et al., 2004; Wedde 
et al., 1998; as described in Section 1.7.2.4) and have been used in studies of its 
response to infection (Mowlds et al., 2008; Mowlds and Kavanagh, 2008; Wojda et 
al., 2009). However, little is known about whether insect pathogens utilise counter 
measures against AMPs and other insect immune defence molecules. Since 
cordycepin is known to have anti-inflammatory effects in mammalian systems 
(Kondrashov et al., 2012) this raises the question about whether it functions as an 
immune inhibitor during infection by C. militaris.  
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Two AMPs (gallerimycin and galiomicin) and two other insect defence molecules 
(IMPI and lysozyme) were selected in the present study to characterise the humoral 
response of G. mellonella to infection, as they have been used previously to quantify 
the immune response of this insect (Altincicek and Vilcinskas, 2006; Wojda et al., 
2009). Schuhmann et al. (2003) first cloned the AMP gallerimycin from G. mellonella 
and found it to have anti-fungal properties; it inhibited the growth of M. anisopliae 
s.l., but not S. cerevisiae. It was later classified as a defensin, a class of AMPs present 
in both plants and animals (Langen et al., 2006) which have a conserved structure, 
although their targets and modes of action differ (Aerts et al., 2008; Yi et al., 2014). 
Some defensins such as defensin A and B in northern blowfly (Phormia terranovae) 
target gram-positive bacteria (Lambert et al., 1989) while others such as the defensin 
in the European bumblebee (Bombus pascuorum) inhibit growth of gram-positive 
bacteria, gram-negative bacteria and fungi (Rees et al., 1997). Galiomicin is another 
antifungal defensin from G. mellonella (Mak and Zdybicka-barabas, 2010), it has been 
found to kill filamentous fungi such as Fusarium oxysporum and yeasts including 
Candida albicans (Lee et al., 2004). Its expression also increases following challenge 
with the bacteria Escherichia coli and Bacillus subtillis, although it does not inhibit 
their growth (Lee et al., 2004).    
 
Metalloproteases are reported to play an important role as virulence factors in insect 
pathogens (Vallet-Gely et al., 2008). For example, the bacteria Bacillus thuringiensis 
and Pseudomonas entomophila both produce metalloproteases to facilitate infection 
of insects. It is hypothesised that they either degrade AMPs or destroy tissues to 
facilitate the spread of the pathogen in the insect (Vallet-Gely et al., 2008). 
Metalloproteases are also produced by EPF such as Metarhizium anisopliae s.l., where 
they have been conjectured to have a role in degradation of the insect cuticle or defence 
molecules (Qazi and Khachatourians, 2007; Mukherjee and Vilcinskas, 2018). G. 
mellonella produces an insect metalloprotease inhibitor (IMPI); this is the only 
metalloprotease inhibitor discovered so far in insects and plays a role in the innate 
immune response (Wedde et al., 2007). Its expression is stimulated by bacterial and 
fungal elicitors and it may confer resistance to metalloproteases (Wedde et al., 1998).  
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Another key component of the insect immune system is lysozyme (Section 1.7.3), 
which cleaves the b-1,4-glycosidic bonds in the peptidoglycan cell wall of bacteria 
(Jollès and Jollès, 1984). In Lepidoptera, including G. mellonella, it has been found to 
have activity against both gram-negative bacteria and gram-positive bacteria (Yu et 
al., 2002). Its production can also be activated by fungal elicitors such as zymosan, a 
polysaccharide fungal cell wall component, and by living yeast cells, suggesting that 
it may also have activity against fungi (Vilcinskas and Matha, 1997). The mechanism 
of lysozyme activity against fungi is not well understood, but is thought to promote 
apoptosis of fungal cells (Sowa-Jasiłek et al., 2016). 
 
3.1.2 The immune response of G. mellonella to fungal infection  
 
The immune response of G. mellonella to fungal infection has been characterised 
using EPF and non-pathogenic fungi, primarily through monitoring the expression of 
immune-related genes. Following infection of G. mellonella with C. albicans, an 
opportunistic human pathogen, the expression of galiomicin, IMPI and gallerimycin 
was observed to increase, peaking at 24 h after infection (Mowlds and Kavanagh, 
2008). However, as no sham injection control was included it is not possible to draw 
reliable conclusions from this work. This was subsequently addressed by Rossoni et 
al. (2017) who used appropriate controls and confirmed that the expression of 
gallerimycin and galiomicin increased following C. albicans treatment. 
 
Similarly, expression of IMPI, galiomicin and gallerimycin was significantly 
upregulated between 48 h and 72 h after either topical application or injection of B. 
bassiana conidia into G. mellonella (Wojda et al., 2009; Vertyporokh and Wojda 
2017). However, these experiments only measured expression in the fat body and, 
although this is the primary site of AMP production (Hoffmann and Reichhart, 2002), 
other cells may also contribute to the immune response (Ryu et al., 2006). In addition, 
these experiments used a limited number of insects, so may not be statistically robust. 
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3.1.3 Monitoring the progression on EPF infection 
 
As described previously, the EPF infection process is complex, but understanding it is 
important for evaluating and improving the efficacy of biopesticides. A number of 
classical approaches have been employed to quantify fungal biomass following 
treatment of insects with EPF as fungal infection progresses (Lacey, 2012). Dilution 
plating can be used to quantify the number of CFUs (colony forming units) from either 
the surface of insects or from macerated insects (Lacey, 2012). A disadvantage of this 
technique is that it cannot differentiate whether a colony grew from a conidia or 
mycelial fragment (Bell et al., 2009). The number of blastospores in insect 
haemolymph can also be determined microscopically (Ouedraogo et al., 2003), but 
this does not distinguish between viable and non-viable cells. 
 
More recently, qPCR has been used to monitor the progression of EPF infection in 
insects. One of the first studies to do this was in the mosquito Anopheles stephensi 
(Bell et al., 2009). A qPCR bioassay was designed with species-specific fluorescent 
probes to quantify the number of conidial genomes within each mosquito for seven 
days following B. bassiana treatment. A gradual increase in the number of conidial 
genomes was observed until 3-5 days after treatment (depending on dose), after which 
there was a rapid increase (10-fold change) in the number of conidial genomes. This 
increase in conidial units correlated with an increase in insect mortality. 
 
A similar increase in the number of fungal genomes following infection was observed 
for M. brunneum (Ríos-Moreno et al., 2017). The authors topically infected G. 
mellonella with this EPF and used a SYBR Green-based qPCR assay to quantify the 
number of M. brunneum genomes in the larvae, while also monitoring the amount of 
destruxin A produced using HPLC. The increase in the number of fungal genomes 
varied between two M. brunneum isolates. One increased until day four after treatment 
then reduced until the end of the experiment, while the other showed an initial increase 
in the number of fungal genomes up to day two, followed by a decrease until day four, 
then another increase until the end of the experiment. There was also a large variation 
in destruxin production between isolates. In the studies by both Bell et al. (2009) and 
Ríos-Moreno et al. (2017) insects were treated with high concentrations of conidia, 
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which would not be representative of natural infection. These experiments would 
therefore be informative for studies of biopesticide application, but would need to be 
adapted to investigate the natural progression of infection. 
 
3.1.4 Aims and objectives 
 
The overall aim of the research described in this chapter was to characterise the 
immune response of G. mellonella to EPF in order to develop a system that could be 
used later to quantify the impact of cordycepin on the expression of these genes. This 
was achieved through two objectives, firstly the expression of immune-related genes 
was quantified and secondly the progression of EPF infection was monitored. 
 
The expression of four immune-related genes (gallerimycin, galiomicin, IMPI and 
lysozyme) was monitored as they had been previously reported to respond to EPF 
infection (Wojda et al., 2009; Vertyporokh and Wojda, 2017). The expression levels 
of these immune-related effector genes are directly related to the activity of the G. 
mellonella immune system in response to fungal infection. The response to a non-
pathogenic fungus was also included to allow comparison to EPF. In addition, the 
progression of EPF infection was quantified with the objective of relating this to 
immune-related gene expression.  
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3.2 Materials and methods 
 
3.2.1 Insect material 
 
All experiments used final instar G. mellonella larvae, which were purchased and 
maintained as described in Section 2.2.1. 
 
3.2.2 Fungal material  
 
Two isolates of EPF were used for these experiments, B. bassiana 433.99 and C. 
militaris 11703 (Table 2.1). These isolates showed different levels of virulence in G. 
mellonella bioassays (Chapter 2) and B. bassiana 433.99 (GHA strain) has been 
widely investigated as a biopesticide (Wraight et al., 2000; Liu and Bauer, 2006; 
Castrillo et al., 2010). The maintenance, sub culturing and preparation of conidial 
suspensions was carried out as in Section 2.2.2. Aliquots (10 ml) of conidia were 
initially prepared at a concentration of 1x107 conidia ml-1 and diluted as required for 
each experiment. 
 
3.2.3 Timecourse experiments 
 
3.2.3.1 Treatment of G. mellonella with S. cerevisiae 
 
The expression of immune-related genes in G. mellonella was monitored following 
treatment with the non-pathogenic fungus Saccharomyces cerevisiae, to establish their 
activity during a successful immune response. A suspension of S. cerevisiae (Type II, 
Sigma Aldrich) was prepared by dilution in sterile distilled water and the cell density 
determined using an improved Neubauer haemocytometer. This suspension was 
further diluted with sterile distilled water to give a final density of approximately 3333 
cells ml-1. G. mellonella larvae were injected with 30 µl of this cell suspension as 
described in Section 2.2.5, to give an estimated dose of 100 cells per larva. Five larvae 
were treated for each treatment at each timepoint and two replicates were performed. 
Larvae were placed in 9 cm Petri dishes lined with filter paper (Whatman, GE 
Healthcare, U.K), and were maintained at 20 ˚C in a 16:8 h light:dark cycle throughout 
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the experiment. Larvae were sampled at 8, 48 and 72 h after treatment by snap freezing 
in liquid nitrogen. These times were chosen based on published immune-gene 
responses to B. bassiana injection (Wojda et al., 2009). RNA extraction and RT-qPCR 
were performed as described in Section 3.2.3.3.  
 
3.2.3.2 Treatment of G. mellonella with B. bassiana 433.99 conidia 
 
G. mellonella larvae were either sprayed or injected with B. bassiana 433.99 conidia 
as described in Sections 2.2.5 and 2.2.6. Final instar larvae were injected with 
approximately 100 conidia per larva using a 0.3 ml MicroFine insulin syringe (BD, 
U.K) or 4 ml of 1x106 conidia ml-1 was applied topically using a Potter tower air 
atomising sprayer at 34.5 KPa. These concentrations were selected as levels of 
mortality were similar between treatments. Within each replicate, larvae were kept on 
filter paper (damp filter paper following spray application) in a group with all other 
individuals to be sampled at the same timepoint. The dishes were sealed with Parafilm 
‘M’ ® (Bemis, USA) and maintained at 20 ˚C and 16:8 h light:dark cycle throughout 
the experiment. For all experiments larvae were sampled by snap freezing in liquid 
nitrogen and stored at -80 ˚C until RNA extraction. RNA extraction, cDNA synthesis 
and qPCR are described in Section 3.2.3.3.  
 
Two timecourse experiments were set up to elucidate the impact of injection of B. 
bassiana 433.99 conidia on G. mellonella immune-related gene expression. In the first 
timecourse larvae were injected with B. bassiana 433.99 conidia or 0.01% Triton X-
100, then sampled at 15 min, 2, 4, 8, 16, 24, 48 and 72 h after treatment. Five larvae 
were sampled for each treatment at each timepoint in two independent replicates. An 
additional timecourse was also performed where larvae were injected with B. bassiana 
433.99, 0.01% Triton X-100 or remained untreated, then sampled at 24, 48 and 72 h 
after treatment. This was repeated on three occasions and within each replicate five 
larvae were sampled for each treatment at each timepoint.  
 
A third timecourse experiment was performed to assess the impact of topical 
application of B. bassiana 433.99 conidia on immune-related gene expression in G. 
mellonella. Larvae were sampled at 24, 48, 72 and 96 h after treatment. The 
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experiment was replicated on two occasions, with five larvae being sampled for each 
treatment on each timepoint in each replicate.  
 
3.2.3.3 RNA extraction from G. mellonella  
 
Previously published experiments have extracted RNA from either just the G. 
mellonella fat body (Wojda et al., 2009) or the whole larvae (Vogel et al., 2011), so 
pilot experiments were done to determine the most effective means of extracting RNA 
for this work. RNA was extracted from three different types of larval tissue: fat body, 
haemolymph and whole larvae. Haemolymph was extracted from larvae that had been 
chilled on ice for 5 min by piercing the front right proleg, applying pressure to the 
abdomen and collecting liquid in a chilled 1.5 ml Eppendorf tube. The maximum 
volume of haemolymph obtained by this method was approximately 10 µl. To extract 
the fat body, larvae were chilled on ice for 5 min and incised ventrally along the 
abdomen. Pressure was applied until the fat body was forced out of the larvae and 
haemolymph was removed by absorption with tissue. The fat body was excised and 
placed in a chilled 1.5 ml Eppendorf tube. All tissues were frozen in liquid nitrogen 
and ground using an autoclaved mortar and pestle (9 cm diameter). Following these 
experiments, the whole insect extraction method was selected. 
 
The phenol: chloroform method, as described in the Sigma-Aldrich (USA) Tri-reagent 
product information, was used for RNA extraction from tissues. Briefly, 1 ml of Tri-
reagent (Sigma-Aldrich, USA) was added to the ground tissue, mixed by pipetting and 
centrifuged at 4 ˚C and 12,000 g for 10 min. Following this, the supernatant was 
removed and incubated for 5 min at room temperature, after which 200 µl of 
chloroform was added and the mixture shaken for 15 s by hand. This was centrifuged 
at 4 ˚C, 12,000 g for 15 min and the colourless, upper aqueous phase containing RNA 
was removed. Following this, 500 µl of isopropanol (Scientific Laboratory Supplies 
Ltd., U.K) was added, mixed and centrifuged for 10 min at 12,000 g at 4 ˚C. The 
resulting RNA pellet was washed in 70% ethanol and re-suspended in 50 µl DEPC-
treated water (Fisher Scientific, USA). To remove any DNA contamination, the RNA 
was treated with DNase I (ThermoFisher Scientific, USA) following the 
manufacturer’s instructions. The concentration of RNA was determined using a 
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NanoDrop ® ND-100 spectrophotometer (ThermoFisher Scientific, USA) and stored 
at -80 ˚C until use.  
3.2.3.4 cDNA preparation 
 
RNA (5 µg) was reverse transcribed using Superscript II (ThermoFisher Scientific, 
USA) according to the manufacturer’s guidelines (ThermoFisher Scientific, USA). 
The cDNA was diluted 1 in 5 in DEPC-treated water (ThermoFisher Scientific, USA) 
and stored at -20˚C.  
3.2.3.5 Quantitative PCR 
 
Expression of gallerimycin, galiomicin, IMPI and lysozyme was analysed using qPCR 
and normalised to the expression of the ribosomal protein S7e (a housekeeping gene). 
Primers for all genes are detailed in Table 3.1. 
Table 3.1- Primers used for qPCR. A list of published primers used for RT-qPCR analysis of Galleria 
mellonella immunity-related genes. 
 
 
Gene Primer sequence (5'-3') Reference 
gallerimycin 
TATCATTGGCCTTCTTGGCTG 
Wojda and Jakubowicz, 2007 
GCACTCGTAAAATACACATCCGG 
galiomicin 
 
TCGTATCGTCACCGCAAAATG Wojda et al., 2009 
GCCGCAATGACCACCTTTATA 
lysozyme 
 
TCCCAACTCTTGACCGACGA Altincicek and Vilcinskas, 2006 
AGTGGTTGCGCCATCCATAC 
Insect 
metalloprotease 
inhibitor (IMPI) 
 
AGATGGCTATGCAAGGGATG Altincicek and Vilcinskas, 2006 
AGGACCTGTGCAGCATTTCT 
S7e 
 
ATGTGCCAATGCCCAAGTTG Wojda and Jakubowicz, 2007 
GTGGCTAGGCTTGGGAAGAAT 
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QPCR was performed using a Lightcycler 480 (Roche Holding AG, Switzerland). 
Each reaction was composed of the following: 5 µl SensiFAST SYBR No-ROX 
(Bioline, USA), 2 µl DEPC-treated water, 1 µl forward primer (10 µM), 1 µl reverse 
primer (10 µM) (Table 3.1) and 1 µl cDNA prepared in Section 3.2.3.4. The PCR 
conditions were adapted from Wojda and Jakubowicz, (2007): initial denaturation at 
95 ˚C for 2 min, followed by 40 cycles of 95 ˚C for 5 s, 60 ˚C for 10 s and 72 ˚C for 
20 s. The Ct (cycle threshold) values were normalised against the housekeeping gene 
S7e, then the expression on day zero to give the DDCt values, 2-DDCt values (Livak and 
Schmittgen, 2001) were analysed using a Kruskal-Wallis test in SPSS Statistics 
(Version 24, IBM).   
3.2.4 Quantification of B. bassiana 433.99 conidia on the surface of G. mellonella 
following topical application 
 
The number of conidia adhering to the surface of G. mellonella larvae was quantified 
following topical application of 4 ml of 1x106 conidia ml-1 B. bassiana 433.99 conidia 
using a Potter tower air atomising sprayer (Section 2.2.6). This concentration was 
selected as it was used during the timecourse experiment described in Section 3.2.3 
due to mortality being similar to that following inoculation with 100 B. bassiana 
433.99 conidia. It was desirable to determine the number of conidia on the surface of 
the G. mellonella larvae to allow further comparison between inoculation and spraying 
treatments. Groups of ten larvae were either sprayed with 4 ml of 1x106 conidia ml-1 
B. bassiana 433.99 conidia or 0.01% Triton X-100 and allowed to air dry. They were 
then placed individually into a 1.5 ml Eppendorf tubes containing 1 ml of 0.01% Triton 
X-100 and vortexed for 1 min. Larvae were removed and 100 µl of the suspension was 
spread onto each of two 9 cm Petri dishes containing SDA with 0.06% (v/v) dodine, a 
semi-selective medium to select for B. bassiana (adapted from Inglis et al., 2012). The 
plates were incubated for approximately five days at 23 ˚C in darkness (LMS 
Incubator, U.K). When colonies became visible they were counted. This experiment 
was replicated on three occasions and the mean number of conidia per larva calculated. 
 
 
  84 
3.2.5 Development of primers for the quantification of B. bassiana 433.99 and C. 
militaris 11703 conidia from infected G. mellonella 
 
In order to relate the progression of fungal infection to the immune response, a 
bioassay was carried out in which G. mellonella larvae were injected or sprayed with 
B. bassiana 433.99 or C. militaris 11703 conidia and the progression of infection 
monitored. Injection and spraying were carried out as described in Sections 2.2.5 and 
2.2.6 at 100 conidia per larva for injection and 1x106 conidia ml-1 for spraying. Three 
larvae were snap frozen in liquid nitrogen every 24 h for seven days and stored at -80 
˚C. Larvae were then individually weighed and freeze-dried using a Modulyo ® freeze 
drier (Edwards, U.K). Larvae were individually weighed again and ground in liquid 
nitrogen using a mortar and pestle. DNA was extracted from 50 mg of tissue using a 
Qiagen DNeasy plant mini kit following the manufacturer’s instructions.  
In addition, DNA was extracted from a known concentration (5x107) of both B. 
bassiana 433.99 and C. militaris 11703 conidia for use as a standard in qPCR analysis. 
A conidial suspension was prepared for both EPF from 10-day old plates as described 
previously and the concentration adjusted to 1x107 conidia ml-1. Aliquots (5 ml) were 
centrifuged at 12,000 g for 2 min and supernatant discarded. Ten glass beads and 0.5 
g of silica beads were added to the tube and this was shaken in a FastPrep-24 (MP 
Biomedicals, USA) for three cycles of 20 s at a speed setting at 4.5. DNA was 
extracted using a Qiagen DNeasy plant mini kit (Qiagen, The Netherlands) following 
the manufacturer’s guidelines. 
Primers were designed for the genes in Table 3.2 and checked for specificity using the 
NCBI primer designing tool (Ye et al., 2012). Initially they were used to amplify EPF 
DNA in a conventional PCR, either extracted from G. mellonella during infection or 
from pure conidia, using the method described in Section 2.2.4. The PCR products 
were visualised by electrophoresis using a 2% agarose gel and GelRed (Section 2.2.4). 
Primers that resulted in good amplification were selected for qPCR. 
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Table 3.2 - Primers designed for biomass assessment of entomopathogenic fungi. A list of primers 
developed in this project to quantify the number of Beauveria bassiana 433.99 and Cordyceps militaris 
11703 genomes in insects.  
Fungus Gene Primer name Primer sequence (5'-3') 
B. bassiana 
433.99 
Actin 
BACT.F CTCGACTCTGGTGATGGTGT 
BACT.R CACGCTCAGCAAGGATCTTC 
Elongation Factor 1-
alpha 
BEF.F CTCGAACCAGCAATCTTCCG 
BEF.R GCAAGCGATCAAGGTCCATT 
Beta-tubulin 
BET.F CCATTGCTCTTGTTGACCCC 
BET.R CCTCGGACCCATTTCAGACT 
28S 
B28.F AAAGCCAACACTACCAAGAG 
B28.R TCGCAGAACCCACTACCATT 
C. militaris 
11703 
Actin 
CACT.F TGCAAAAGGAGTTGACTGGC 
CACT.R GCCAGCCTCATCATACTCCT 
Elongation Factor 1-
alpha 
CEF.F CCGTGTCGAGACTGGTATCA 
CEF.R CACGACGGATTTCCTTGACG 
Beta-tubulin 
CET.F CATGTCCAACACTACCAAGAG 
CET.R ACGAGCTGATGTACGGAGAG 
28S 
C28.F CATTTCAACCCTCGACGTCC 
C28.R TGATCCGAGGTCAACGTTCA 
    
 
3.2.6 Quantification of C. militaris 11703 and B. bassiana 433.99 conidia from 
infected G. mellonella 
 
The 28S primers (Table 3.2) were selected from Section 3.2.5 to quantify C. militaris 
11703 and B. bassiana 433.99 DNA from infected G. mellonella (Section 3.2.5). DNA 
was quantified using SensiFast No-ROX SYBR Green (Bioline, USA) and the 
conditions described in Section 3.2.3.5. The efficacy of amplification was assessed by 
observing the melt curve produced during heating to 97 ˚C and cooling. Due to the 
high copy number of this gene it is likely that differences in pipetting could introduce 
a high level of variation at low concentrations of DNA, therefore the detectable limit 
for the number of genomes was set at 1000 (Bell et al., 2009). 
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3.3 Results 
 
3.3.1 RNA extraction from G. mellonella larvae 
 
The concentration of RNA obtained from G. mellonella haemolymph was too low to 
be detected using the NanoDrop ® ND-100, so this technique was not used in later 
experiments. On the other hand, it was possible to extract a high concentration of RNA 
from the G. mellonella fat body and whole larvae, both gave successful amplification 
during qPCR. However, extraction of RNA from the fat body was found to be 
laborious and time consuming, so all extractions for gene expression analysis were 
from whole larvae, enabling a greater number of larvae to be processed at any one 
occasion.  
 
3.3.2 The response of G. mellonella immune-related genes to S. cerevisiae 
treatment 
 
RT-qPCR was used to monitor the expression of immune-related genes to injection 
with S. cerevisiae cells, to quantify a successful immune response. In some cases, RT-
qPCR was unsuccessful (there was low/no amplification), which may have been due 
to error in RNA extraction or cDNA synthesis. These samples were discarded, leaving 
9-10 samples per timepoint. The expression of the immune-related genes gallerimycin, 
galiomicin, IMPI and lysozyme were monitored following treatment with S. cerevisiae. 
There were no significant differences in expression of gallerimycin or galiomicin 
between larvae that were uninjected, injected with water or injected with S. cerevisiae 
(Figure 3.1). There was a significant increase (~4.5-fold) in lysozyme expression in 
larvae injected with water compared to the uninjected control at 48 h (p=0.012). There 
was also a significant increase in lysozyme expression 72 h after treatment in yeast-
injected larvae compared to uninjected larvae (p=0.018), with expression of treated 
larvae being ~3.5-fold greater than the uninjected control. However, in both of these 
cases there was no significant difference between the larvae injected with yeast or 
water. 
 
Similarly, there was a significant increase in IMPI expression in larvae injected with 
water or yeast 48 h after treatment, with expression of both being ~3.5 times greater 
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than the control (p=0.002). At 72 h there was a significant difference between 
expression in the uninjected control compared to the larvae injected with yeast 
(p=0.018), but neither of them was significantly different to the control injected with 
water.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1- Expression of immune-related genes in Galleria mellonella following injection of Saccharomyces 
cerevisiae. Change in expression of A) gallerimycin, B) galiomicin, C) lysozyme and D) IMPI in G. mellonella (n=10 
per treatment) following injection with 100 S. cerevisiae cells (pale grey), injection with water (mid grey) and no 
injection (dark grey). Expression was normalised against S7e expression and expression at day 0. A Kruskall-Wallis 
test was carried out at each time point to identify significant differences in expression, different letters indicate 
significant differences (p<0.05). Error bars show ±SEM. 
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3.3.3 The response of G. mellonella immune-related genes to injection with B. 
bassiana 433.99 
 
RT-qPCR was employed to monitor the expression of immune-related genes in G. 
mellonella in response to injection with B. bassiana 433.99 conidia. In some cases, 
qRT-PCR was unsuccessful (there was low/no amplification), which may have been 
due to error in RNA extraction or cDNA synthesis. These samples were discarded, 
leaving 8-10 samples per timepoint for the first injection timecourse and 13-15 for the 
second. 
 
Immune-related gene expression was initially monitored at: 0.25, 2, 4, 8, 16, 24, 48 
and 72 h after treatment with B. bassiana 433.99 conidia. Larvae injected with Triton 
X-100 were compared to those injected with conidia (Figure 3.2). There was a 
significant increase (~2.5-fold) in the expression of gallerimycin in larvae treated with 
B. bassiana 433.99 compared to sham-injected larvae at 72 h after treatment 
(p=0.007). There was also an ~2-fold increase in galiomicin expression in larvae 
treated with B. bassiana 433.99 compared to sham-injected larvae at 4 h (p=0.003) 
and ~3.5-fold increase 8 h after treatment (p=0.004). There was a significant increase 
in IMPI expression in larvae treated with B. bassiana 433.99 relative to the sham-
injected control at 2, 4 and 72 h after treatment of ~2-fold (p=0.028), ~2.5-fold 
(p=0.004), ~4-fold (p=0.011), respectively.  
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Following the experiment in Figure 3.2, it became clear that an uninjected control was 
necessary at all time points due to the wounding response caused by Triton X-100 
injection. Therefore, immune-related gene expression was monitored again at 24, 48 
Figure 3.2- Expression of immune related genes following injection with Beauveria bassiana 433.99 
conidia. Change in expression of A) gallerimycin, B) galiomicin, C) lysozyme and D) IMPI in G. mellonella 
(n=10 per treatment) following injection with 100 B. bassiana 433.99 conidia (mid-grey) and injection with 
Triton X-100 (dark grey). Expression was normalised against S7e expression and expression at day 0. A 
Kruskall-Wallis test was carried out at each time point to identify significant differences in expression, * 
indicates significant differences (p<0.05). Error bars show ±SEM. 
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and 72 h post-injection (Figure 3.3). Gallerimycin showed ~2-fold greater expression 
in infected larvae relative to the uninjected control at 48 h after treatment (p=0.013), 
but the increase was not significantly different from the injected control. At the same 
timepoint, galiomicin expression increased ~2.5-fold in infected larvae compared to 
the uninjected control (p=0.001), but again this was not significantly different from 
the injected control. 
 
At 72 h after treatment the expression of galiomicin was ~2-fold higher in infected 
larvae than either the uninjected (p=0.016) or the sham-injected control larvae 
(p=0.021). The expression of IMPI at 72 h in infected larvae was ~2-fold greater than 
uninjected controls (p=0.048), but not significantly different from the injected 
controls. At 24 h after treatment lysozyme expression in infected larvae was ~9-fold 
higher than in uninjected larvae and at 72 h it was ~5-fold higher (at 24 h p<0.001, at 
72 h p=0.01). However, expression was not significantly different from the injected 
control. At 48 h after treatment, the expression of lysozyme in larvae injected with only 
Triton X-100 was significantly higher than the uninjected control (p=0.001), but not 
significantly different from infected larvae. The expression of immune-related genes 
appeared greater following the sham injection than the uninjected control for most 
treatments, although this was mostly not statistically significant. This suggests that 
there is a wounding response following injection. 
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3.3.4 The response of the G. mellonella immune system to topical application of 
B. bassiana 433.99 
 
In order to circumvent the issues of the immune response being triggered by wounding 
(injection), B. bassiana 433.99 conidia were applied topically then the response of 
immune-related genes monitored using RT-qPCR. In some cases, qRT-PCR was 
Figure 3.3-Expression of immune-related genes in Galleria mellonella following injection with 
Beauveria bassiana 433.99 conidia. Change in expression of A) gallerimycin, B) galiomicin, C) 
lysozyme and D) IMPI in G. mellonella (n=12-15 per treatment) following injection with 100 B. 
bassiana conidia (pale grey), injection with Triton X-100 (mid grey) and no injection (dark grey). 
Expression was normalised against S7e expression and expression at day 0. A Kruskall-Wallis test 
was carried out at each time point to identify significant differences in expression, different letters 
indicate significant differences (p<0.05). Error bars show ±SEM. 
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unsuccessful (there was low/no amplification), which may have been due to error in 
RNA extraction or cDNA synthesis. These samples were discarded, leaving 8-10 
samples per timepoint. When B. bassiana 433.99 was applied topically to final instar 
G. mellonella no change in gene expression was observed until 72 h, except for 
expression of lysozyme (Figure 3.4, Table 3.3). Expression of gallerimycin was ~2.5-
fold higher than the control at 72 h and over 15-fold greater than the control at 96 h. 
Expression of galiomicin was ~1.5-fold higher than the control at 72 h and 2.5-fold 
higher at 96 h. At 72 h after treatment expression of IMPI was ~2.5-fold higher than 
the control, then at 96 h expression was ~6-fold higher than the control. Finally, 
expression of lysozyme showed the greatest response to infection, with expression in 
infected larvae at 72 h being ~9.5-fold higher than the control and at 96 h it was over 
80-fold higher than the control. Although the expression of lysozyme was found to be 
significantly less in infected larvae than in the control larvae at 24 h following 
spraying, this result is probably not meaningful as the difference only amounts to a 
very small relative change. There was no change in expression of any genes other than 
lysozyme in controls sprayed with Triton X-100 throughout the experiment. 
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Figure 3.4-Experssion of immune-related genes in Galleria mellonella following spraying with 
Beauveria bassiana 433.99 conidia. Change in expression of A) gallerimycin, B) galiomicin, C) 
lysozyme and D) insect metalloprotease inhibitor (IMPI) in G. mellonella larvae (n=8-10 per 
treatment) following spraying with 4 ml of 1x106 B. bassiana 433.99 conidia ml-1 (mid-grey) and 
spraying with Triton X-100 (dark-grey). Expression was normalised against S7e expression and 
expression at day 0. A Kruskall-Wallis test was carried out at each time point to identify significant 
differences in expression, asterisks indicate significant differences (p<0.05). 
*
*
*
*
*
*
*
*
*
Sprayed with Triton X-100  
 
Sprayed with B. bassiana 
 
*
*
*
*
*
*
*
*
*
A B 
C D 
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Table 3.3- Significance of differences 1 in immune related gene expression following spraying of 
Galleria mellonella with Beauveria bassiana 433.99 conidia in comparison to Triton X-100.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 A Kruskall-Wallis test was carried out at each time point to identify significant differences in 
expression, asterisks indicate significant differences (p>0.05). 
 
3.3.5 Quantification of B. bassiana 433.99 conidia on the G. mellonella surface 
following topical application 
 
In order to quantify the number of B. bassiana 433.99 conidia on the surface of G. 
mellonella larvae following topical application, conidia were washed off larvae, 
cultured on selective media and the number of colonies counted. The mean number of 
viable conidia recovered from larvae was 437 (± 50.7), 1 (± 0.48) and 4 (± 2.10) for 
larvae topically treated with either B. bassiana 433.99, Triton X-100 or left untreated, 
respectively (Table 3.4). The recovery of conidia on the control larvae could indicate 
the existence of low levels of B. bassiana conidia in the environment. However, it is 
also possible that the Potter tower sprayer was contaminated despite efforts to 
Gene Time (h) p-value 
Gallerimycin 24 0.529 
48 0.353 
72 <0.001* 
96 0.001* 
Galiomicin 24 0.796 
48 0.739 
72 0.035* 
96 0.009* 
Lysozyme 24 0.029* 
48 0.853 
72 <0.001* 
96 0.003* 
Insect 
metalloprotease 
inhibitor 
24 0.853 
48 0.529 
72 0.002* 
96 <0.001* 
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decontaminate it after each use, or the conidia of other species were able to germinate 
on this selective media, although the observed colonies were morphologically 
identical to B. bassiana 433.99.  
 
Table 3.4- The number of conidia on Galleria mellonella following topical application 1. 
 
 
 
 
 
 
1The mean number of conidia on the surface of each G. mellonella larva sprayed with 4 ml of Beauveria 
bassiana 433.99 conidia (1x106 conidia ml-1) or Triton X-100 using a Potter tower. 
 
3.3.6 Development of primers for the quantification of B. bassiana 433.99 and C. 
militaris 11703 conidia from infected G. mellonella 
 
Primers were designed to amplify DNA from both C. militaris 11703 and B. bassiana 
433.99, to be used in later qPCR experiments quantifying EPF biomass during 
infection. The quality of primers was initially assessed by amplification of fungal 
DNA by PCR, followed by visualisation of the PCR products by agarose gel 
electrophoresis. Figure 3.5 illustrates these gels for a selection of primers, and shows 
that B28 and C28 gave the best amplification with minimal primer dimers and so were 
selected for further analysis.  
 
 
 
 
 
 
 
 
 
 
Treatment 
Mean number of 
conidia ± SEM 
B. bassiana 433.99 436.8 ± 50.7 
Triton X-100 1.33 ± 0.48 
Unsprayed 4.00 ± 2.10 
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3.3.7 Quantification of C. militaris 11703 and B. bassiana 433.99 conidia from 
infected G. mellonella 
 
Preliminary qPCR tests showed that at low concentrations of fungal DNA, B28 
primers exhibited non-specific binding. The melt curve produced at the end of the 
qPCR run showed multiple peaks inconsistent with the positive control (Figure 3.6). 
Non-specific binding was not seen in the negative control but was seen in control 
larvae that had not been treated with EPF, indicating that the primers had bound to G. 
mellonella DNA to give some low-level amplification that was not detected in a 
conventional PCR. However, the 28S primers for C. militaris 11703 successfully 
amplified DNA extracted from G. mellonella (Figure 3.6). A standard curve was 
constructed using DNA from a known concentration of C. militaris 11703 conidia 
(5x107-5x101 conidia). It was assumed that this would be equivalent to the number of 
genomes present in the sample i.e. DNA from 1000 conidia is equivalent to 1000 
genomes. 
Figure 3.5- Agarose gel showing amplification of Beauveria 
bassiana 433.99 or Cordyceps militaris 11703 DNA using 
primers developed in this project. Agarose gel showing the 
products of PCR following amplification with primers targeting 
actin (ACT), elongation factor 1-alpha (EF), beta-tubulin (ET) 
and 28S (28). Positive controls amplified DNA from either B. 
bassiana (B prefix) or C. militaris conidia (C prefix) and 
negative controls, containing no DNA, were included. 
+      - +      - +      - +      - +      - +      -
BET BEF CACT CEF BACT CET
+       - +       -
B28 C28
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When C. militaris 11703 conidia were introduced by injection, their presence was first 
detected on day four, but then fell back below detectable levels on days five and six. 
However, by day seven there was a very large increase in the number of C. militaris 
genomes from <1000 genomes per larva to 5.36 x104 genomes per larva, which was 
more than a 500-fold increase on initially injected dose of conidia. On day seven there 
was a detectable amount of DNA in some untreated control larvae, which may be due 
contamination during the injection process or during qPCR (Figure 3.7).  
 
When G. mellonella larvae were sprayed with C. militaris 11703 conidia an increase 
in the number of fungal genomes was first detected two days after treatment and rose 
to approximately 2.00 x 107 genomes per larva on day seven. The largest increase in 
the number of C. militaris genomes was between days six and seven, where the 
number of genomes detected increased approximately 400-fold. There was a low level 
of C. militaris DNA detected on days one and seven after treatment in the control. The 
number of C. militaris genomes detected was higher in larvae that had been sprayed 
with C. militaris 11703 than those injected, but both had a similar pattern of fungal 
genome accumulation and the rate of mortality was similar. The number of conidia 
applied during each treatment was also comparable, 100 conidia were delivered by 
injection and approximately 400 by topical application. There was a slow increase in 
the number of C. militaris genomes between days one to six which was below 
Figure 3.6-Melt curves produced following amplification of fungal DNA with primers designed 
in this project. Melt curves produced by Lightcycler 480 (Roche) from heating PCR products to 97˚C 
and then cooling. Curves A and C are examples curves produced using B28 primers and Beauveria 
bassiana DNA extracted from infected G. mellonella, curve B is produced using C28 primers from 
Cordyceps militaris 11703 DNA from infected larvae.  
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detectable levels when this fungus was injected, followed by a rapid increase in the 
number of fungal genomes between days six and seven.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7- The mean number of Cordyceps militaris genomes present in Galleria mellonella following 
infection by either spraying or injection with C. militaris 11703 conidia. The mean number of C. 
militaris genomes detected using qPCR per G. mellonella larvae when injected with 100 conidia per larva 
(A) or sprayed with 4 ml of 1x106 conidia (B). The cut off for detection was 1000 genomes per larva (red 
line).   
A
B
Control 
C. militaris  
Treatment  
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3.4 Discussion 
 
Insects respond to infection through the activation of immune pathways, however, 
EPF evade or overcome these immune responses to successfully colonise a host. The 
aim of the work in this chapter was to develop an RT-qPCR system for quantifying 
the expression of immune-associated genes of G. mellonella in response to EPF 
infection. Initial experiments focused on quantifying the immune response of G. 
mellonella to injection of B. bassiana 433.99 conidia over time to determine which 
timepoints should be investigated in more detail. The response to EPF was compared 
to a control treatment of larvae injected with Triton X-100. Three of the immune genes 
tested (galiomicin, gallerimycin and IMPI) showed an increase in expression on at 
least one time point throughout the experiment relative to the control, illustrating that 
B. bassiana 433.99 conidia are detected by the G. mellonella immune system which 
responds by production of these immune effector proteins. However, a key finding 
was that sham injection also stimulated an immune response, which made 
interpretation of immune-related gene expression more difficult. This response to 
wounding was also observed when G. mellonella were injected with water in Section 
3.3.2. A general response to wounding has been characterised in other insects (Section 
1.7.4), although only a small number of studies have been done to date. Upregulation 
of AMPs has been observed in Bombus terrestris in response to wounding (Erler et 
al., 2011). It was thought that this response may have evolved to prime the immune 
system for infection as most wounds in nature result in infection. An experiment by 
Bidla et al., (2009) found that the D. melanogaster phenoloxidase response is also 
induced by wounding, leading to melanisation localised around the injection site. 
Another factor that may have contributed to the response to wounding identified in 
this chapter could be the presence of pyrogens in the sterile, distilled water used to 
prepare Triton X-100 for sham injections. Future experiments could be performed 
using pyrogen free water to quantify the response of immune-related gene expression 
to wounding in G. mellonella.  
 
S. cerevisiae is reported to be non-pathogenic to G. mellonella larvae and is a 
commonly used negative control when assessing the impact of pathogenic yeasts on 
this insect (Vilcinskas and Matha, 1997; Brennan et al., 2002; Reeves et al., 2004). 
The expression of the selected G. mellonella immune-related genes to challenge by S. 
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cerevisiae therefore demonstrates what to expect for a successful immune response. 
In the present study no significant difference was observed in the expression of 
gallerimycin and galiomicin between treated and control larvae, suggesting that 
infection with S. cerevisiae is not cleared through production of anti-fungal AMPs. 
The expression of these AMPs is likely to be driven primarily by the Toll pathway 
(Lemaitre and Hoffmann, 2007), which is activated by yeasts such as C. albicans and 
S. cerevisiae in G. mellonella (Bergin et al., 2006). It is possible that the Toll pathway 
was only activated weakly by the low numbers of S. cerevisiae used in this study, so 
was undetectable through RT-qPCR. Alternatively, an early immune response may 
clear the S. cerevisiae infection, so any upregulation in gallerimycin or galiomicin 
could have occurred prior to 8 h after treatment (when sampling in this experiment 
began), or it may be cleared by the cellular immune response. In particular, 
melanisation and associated reactions are an immediate response to infection 
(Lemaitre and Hoffmann, 2007) and may clear S. cerevisiae rapidly through 
encapsulation and the production of toxins (Section 1.7.1).  
 
Expression of lysozyme was upregulated in larvae treated with S. cerevisiae relative to 
the uninjected control, but was not significantly different from the injected control. 
Therefore, it is not possible to conclude whether the increase in expression of lysozyme 
was due to challenge with S. cerevisiae. IMPI expression was also upregulated in 
response to both wounding and treatment with S. cerevisiae. In particular at 48 h after 
treatment, larvae injected with water or S. cerevisiae had significantly higher 
expression of IMPI than the uninjected control. It has previously been reported that 
IMPI activity increases in G. mellonella upon injection with bacterial (LPS) and fungal 
(zymosan) elicitors up to 48 h after treatment (Wedde et al., 1998). However, the 
authors did not quantify the expression of IMPI in response to sham injection, so it is 
not clear whether the response was caused by the elicitors or wounding. IMPI is 
thought to be active against bacterial metalloproteases and endogenous matrix 
metalloproteases, which may be involved in the degradation of AMPs or insect tissues 
(Wedde et al., 2007; Vallet-Gely et al., 2008). IMPI is thought to aid in the innate 
immune response and possibly play a role in metamorphosis. It may have evolved 
through host-parasite coevolution, driven by the evolution of metalloproteases in M. 
anisopliae s.l. (Joop and Vilcinskas, 2016). The experiments in this chapter suggest 
  101 
that IMPI plays a role in immunity, although in injection experiments it can be difficult 
to resolve the response to fungi from the wounding response.   
 
When an untreated control was included, injection of G. mellonella larvae with B. 
bassiana 433.99 conidia increased expression of all four of the immune-related genes 
tested (gallerimycin, galiomicin, IMPI and lysozyme) relative to the uninjected control 
at 48 and 72 h post-injection. However, only galiomicin expression was significantly 
higher than in the sham injected larvae, confirming that expression of this gene is 
significantly upregulated in response to B. bassiana 433.99 infection. This contrasts 
with the response to S. cerevisiae, where any increase in immune-related expression 
could not be separated from the sham-injection control. This indicates that B. bassiana 
433.99 induced a stronger immune response in G. mellonella than S. cerevisiae at the 
timepoints studied here, which could be due to activation of the Toll pathway by a 
different mechanism. The Toll pathway is reported to detect yeasts through the 
GNBP3 receptor, whereas B. bassiana is reported to activate the Toll response through 
the recognition of virulence factors, such as proteases which may give responses of 
different magnitudes (Gottar et al., 2006; Issa et al., 2018). Alternatively, B. bassiana 
could elicit a stronger immune response by growing within the larvae, unlike S. 
cerevisiae, making it more likely to be detected by the immune system. Although, the 
results from Section 3.3.7 suggest that significant B. bassiana proliferation does not 
occur until late in the infection process, there may be slow growth of B. bassiana 
during early infection leading to an increased immune response. The response of 
lysozyme expression to B. bassiana 433.99 injection seen in this chapter contrasts with 
the findings of Vilcinskas and Matha, (1997a), who observed that treatment of G. 
mellonella with B. bassiana reduced the activity of lysozyme in comparison to 
treatment with yeast. This could be due to differences between B. bassiana strains or 
EPF affecting lysozyme activity post-transcription.  
 
A recent study by Vertyporokh and Wojda (2017) characterised the response of G. 
mellonella to B. bassiana by injecting G. mellonella larvae with 1000 B. bassiana 
conidia and monitoring gene expression using RT-qPCR. The authors identified peaks 
in expression for all genes tested (gallerimycin, galiomicin and IMPI) at 48 h post 
injection, which was significantly higher than the uninjected controls. However, they 
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did not compare this expression to injected controls for all time points, only at 24 h 
post-injection. These results are similar to the experiments described here, where high 
expression was identified at 48 h post-injection for gallerimycin and galiomicin. In 
addition, this project found that the expression of galiomicin increased at 72 h post-
injection which is different to the findings of Vertyporokh and Wojda (2017). The 
difference may be because Vertyporokh and Wojda (2017) monitored expression in 
the fat body, which is the main site of AMP production, or there was variability in 
gene expression between individual larva.   
 
In order to better elucidate the response of G. mellonella to B. bassiana 433.99, conidia 
were topically applied to larvae to permit natural infection. This eliminated the 
wounding response, allowing only the response to the fungi to be characterised. There 
was a strong induction of immune-related gene expression, beginning at 72 h post- 
spraying and becoming highest at 96 h. All genes tested (galiomicin, gallerimycin, 
IMPI and lysozyme) had significantly increased expression relative to the control. 
Galiomicin and gallerimycin are anti-fungal AMPs (Schuhmann et al., 2003; Mak and 
Zdybicka-barabas, 2010), therefore their expression would be expected to be 
upregulated in response to B. bassiana. Both IMPI and lysozyme are thought to be 
anti-microbial, so their increased expression in response to infection would also be 
expected (Vilcinskas and Matha, 1997; Wedde et al., 2007). It was determined that 
the number of conidia on the surface of each G. mellonella larvae following topical 
application of B. bassiana 433.99 conidia was a mean of 400, which is comparable 
with the number of conidia (100 per larvae) applied during injection gene expression 
studies. Expression levels of immune-related genes following either topical 
application or injection of conidia were similar 72 h after treatment. However, 
identification of significant results was facilitated by topical application of conidia as 
sham injection triggered an immune reaction that could not always be separated from 
the response to B. bassiana 433.99 conidia. 
  
Vertyporokh and Wojda (2017) also characterised expression of gallerimycin, 
galiomicin and IMPI over 96 h following topical application of B. bassiana conidia. 
As in this project, they found that gallerimycin expression increased over 96 h 
following topical application. However, they found that galiomicin expression 
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reduced after 48 h, whereas in this experiment expression continued to increase up to 
96 h. This may be due to changes being detected more rapidly when analysing only 
the fat body which is the main site of AMP production, B. bassiana strain differences, 
different doses of conidia or because they analysed five insects per timepoint so 
variation between individuals could have a bigger impact on the average value 
reported. The expression pattern of IMPI was also different between these studies. 
Vertyporokh and Wojda (2017) only saw a significant increase in IMPI expression 
after 48 h, in contrast, the results here show an approximately 5-fold increase in 
expression relative to the control after 96 h. IMPI is a protein unique to G. mellonella, 
homologs have not been identified in other insects so little is known about its 
production. These results could suggest that cells outside the fat body, such as free 
haemocytes in the haemolymph, are also responsible for IMPI expression. This is 
supported by a study by Dubovskiy et al., (2013) who found that IMPI is expressed 
by cells in both the fat body and integument. 
 
In summary these results indicate that B. bassiana is detected by the G. mellonella 
immune system during infection and this triggers the expression of immune-related 
genes. This may be through the recognition of virulence factors, such as degradative 
enzymes (Gottar et al., 2006; Issa et al., 2018). The immune-related genes monitored 
in this experiment are likely to be induced by different immune pathways, which 
illustrates that different aspects of the G. mellonella immune system work in concert 
against infection. Expression of galiomicin and gallerimycin are likely to be controlled 
by the Toll pathway, as these are antifungal AMPs (Schuhmann et al., 2003; Lee et 
al., 2004). Gallerimycin and galiomicin are both defensins (Schuhmann et al., 2003; 
Bergin et al., 2006) and the expression of defensins are controlled by the Toll pathway 
in D. melanogaster (Meng et al., 1999). On the other hand, lysozyme is constitutively 
expressed but is upregulated in response to fungi and the method of IMPI induction is 
not known at this time. Therefore, multiple pathways are integrated in the immune 
response to B. bassiana to drive the expression of immune-related genes. 
 
In order to better understand the progression of EPF infection and relate it to the 
expression of immune-related genes, experiments were done to quantify EPF growth 
during infection. The most promising primers amplified the 28S rRNA gene from C. 
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militaris 11703 and B. bassiana 433.99. There are likely to be multiple copies of this 
gene in B. bassiana 433.99 and C. militaris 11703 because multiple copies of rRNA 
genes have been observed in other filamentous fungi (Black et al., 2013). The qPCR 
assay based on 28S rRNA primers for C. militaris 11703 allowed detection above 
approximately 1000 genomes per sample. This cannot be assumed to be equivalent to 
approximately 1000 fungal cells per sample, because although C. militaris has not 
been reported to produce multinucleated mycelia this is common in other filamentous 
fungi (Roper et al., 2011). When 28S primers for B. bassiana 433.99 were used for 
qPCR there appeared to be primer dimers and non-specific primer binding, which may 
have been due to binding to insect DNA or other fungi present.   
 
Low concentrations of C. militaris DNA were detected in three negative controls. This 
may be due to contamination of G. mellonella larvae during injection and spraying or 
contamination of DNA during the DNA extraction process. The number of C. militaris 
11703 genomes increased throughout the experiment gradually until day seven, where 
there was a large increase in the number of C. militaris genomes per larva. This may 
be similar to the progression of B. bassiana 433.99 infection, but this could not be 
established during this project due to the non-specific binding of B. bassiana primers. 
This builds on the findings of Ríos-Moreno et al. (2017) and Bell et al. (2009), who 
quantified B. bassiana and M. brunneum DNA from insects. In particular these 
findings are similar to those of Bell et al. (2009), who observed a gradual increase in 
the number of B. bassiana genomes until days 3-5 after treatment followed by a rapid 
increase in the number of conidial genomes. Bell et al. (2009) identified an increase 
in the number of fungal genomes shortly before larval death, which is similar to the 
experiment described in this chapter. The concentrations of C. militaris 11703 used in 
this experiment cause mortality after approximately days 6-7 for topical application 
and later than day 7 when injected (Chapter 2), the rapid increase in the number of C. 
militaris genomes was observed shortly prior to this. The large increase in the number 
of fungal genomes late in the infection process shown in this and previous studies 
supports the hypothesis that EPF must first overcome the insect immune response 
before they are able to proliferate rapidly. It also suggests that the interactions between 
an EPF and its host constitutes a major part of the infection process, which has 
implications for selection of EPF biopesticides and strain improvement. In particular 
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strains that are virulent and kill the insect more rapidly would be desirable, so it is 
important to identify strains that are able to overcome this insect immune system more 
rapidly. It also raises a question about how EPF are able to overcome the insect 
immune system prior to their rapid growth within the host, in particular whether EPF 
produce chemicals that inhibit host immunity. For example, destruxin A is thought to 
play a role in suppression of the insect immune response during Metarhzium 
anisopliae s.l. infection (Pal et al., 2007). 
 
3.5 Conclusions 
 
This study has developed methodologies to monitor the expression of immune-related 
genes in G. mellonella, which will permit the effect of cordycepin on the insect 
immune system to be measured. The experiments in this chapter have demonstrated 
that there is an increase in the expression of immune-related genes (galiomicin, 
gallerimycin, IMPI and lysozyme) in G. mellonella following B. bassiana 433.99 
topical infection. However, the immune response to injection of B. bassiana 433.99 
conidia was difficult to separate from the wounding response, therefore topical 
application of conidia allowed a better understanding of the immune response to 
infection. Although an attempt was made to link the increase in the number of B. 
bassiana 433.99 genomes to the immune response of larvae, it was unsuccessful. The 
increase in the number of C. militaris 11703 genomes suggested that the growth of 
EPF is initially impaired by the insect immune response, but at later stages of infection 
the number of fungal genomes increases rapidly.  
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Chapter 4- Determining the effect of cordycepin on 
Galleria mellonella survival and the expression of 
immune-related genes 
 
4.1 Background 
 
4.1.1 The impact of fungal secondary metabolites on the insect immune system 
 
The infection process by hypocrealean EPF results in the death of the host and the 
production of a large number of conidia on the host cadaver. To achieve this, most of 
the host soft tissue is converted to fungal biomass (Duan et al., 2017). Research 
presented in the previous chapter and performed by Bell et al. (2009), with C. militaris 
and B. bassiana, showed that fungal growth remains at low levels within the insect for 
a large duration of the pre-mortality period. The number of fungal genomes then 
increases rapidly shortly before host death, one explanation for this is that in order to 
successfully colonise a host insect in this way, EPF need to subvert or overcome the 
host immune response. Secondary metabolites are thought to play a role in this process 
(Section 1.8; Pal et al., 2007; Xu et al., 2008; Xu et al., 2009), although little is known 
about their exact function and mode of action. There are two approaches used to 
research the natural function of EPF secondary metabolites (Section 1.8.2): artificially 
introducing the metabolite into an insect and observing the response, or creating 
mutant EPF strains that lack genes to produce the metabolite and testing their 
virulence. In this chapter the first approach is employed to characterise the impact of 
cordycepin on G. mellonella, which was intended to provide baseline data that would 
act as a foundation for gene knockouts in the future. With the long-term aim of 
developing both a fundamental understanding of the mode of action of cordycepin 
during C. militaris infection and its potential as a biopesticide. Similar studies have 
previously been done to research the action of destruxins (Figure 1.7), a group of 
secondary metabolites produced by Metarhizium spp. (Vilcinskas et al., 1997c). 
Destruxins A and E inhibit the phagocytic activity of G. mellonella plasmatocytes in 
vitro and at high doses cause paralysis and death of larvae (Vilcinskas et al., 1997c). 
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Subsequently this group of toxins were seen to inhibit attachment and spreading of G. 
mellonella plasmatocytes (Vilcinskas et al., 1997b). Furthermore, Pal et al. (2007) 
found that destruxin A inhibits the IMD immune pathway in D. melanogaster. The 
authors challenged D. melanogaster with E. coli and/or destruxin A, then used RT-
qPCR to measure AMP expression and a microarray to monitor expression of over 
400 other immune-related genes. They found that genes involved in the IMD pathway, 
which is known to regulate the anti-bacterial humoral response in insects (Lemaitre 
and Hoffmann, 2007), were downregulated by destruxin A following bacterial 
immune challenge. The success of these experiments illustrates the ability of bioassays 
and RT-qPCR to assess the function of secondary metabolites.  
  
4.1.2 Understanding the effects of different biopesticides applied together as part 
of an IPM strategy   
 
EPF metabolites that act as virulence factors could have potential for use as 
biopesticides, most probably to be applied together with other pest control agents as 
part of an IPM strategy. IPM is the coordinated use of pest management strategies to 
minimise negative impacts on society and the environment, whilst providing 
maximum benefit to the producers (Kogan, 1998). In order to optimise this strategy, 
it is critical to assess the interactions between IPM components (Section 1.2), to 
understand if different crop protection agents interact when used together, and the 
types of interactions that occur. Understanding the type of interaction is also important 
for ecotoxicological assessments as there is concern that combined applications of 
pesticides may result in synergistic effects on non-target organisms (Cedergreen et al., 
2014) and the same might be true for biopesticides. 
  
There have been a limited number of studies looking at the effects of combining EPF 
with conventional pesticides (Appendix B.1), with the aim of achieving enhanced 
levels of pest control and reduced pesticide inputs. No studies have been published to 
date about using EPF metabolites as novel biopesticides in conjunction with EPF. An 
example of combining EPF with insecticides is the use of B. bassiana and M. 
anisopliae s.l. to treat citrus root weevil (Diaprepes abbreviatus) larvae in conjunction 
with a sub-lethal dose of the insecticide imidacloprid which found a synergistic 
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interaction leading to an increase in larval mortality (Quintela and McCoy, 1998). This 
type of study has been replicated with these EPF and a range of low dose insecticide 
applications in different pest species (Appendix B.1) (Hiromori and Nishigaki, 2001; 
Purwar and Sachan, 2006; Farenhorst et al., 2010), with most studies having been 
based around measuring the effects of applying a fixed dose of each agent. Whether 
the effect of co-application of EPF and insecticide is synergistic, additive or 
antagonistic depends on the mode of action of the insecticide and the characteristic of 
the EPF (Purwar and Sachan, 2006). 
 
The effect of co-application of two different agents has been more thoroughly 
characterised in the field of pharmacology because it is important to know if drugs 
interact within the body to cause side effects. In this field, four main ways of 
identifying the outcome of a combination treatment are used (Williamson, 2001): 
1. Identify whether the effect (E) of a combination of fixed doses of two 
compounds (A and B) is greater than the sum of their individual effects, i.e. 
EA+B > EA + EB.  
2. Measure the effect of a fixed dose of one compound on the dose response of 
the other. 
3. Identify whether the effect (E) of the combination of treatments (A and B) is 
greater than the effect of each treatment individually, i.e. EA+B > EA and EA+B 
> EB. 
4. Determine the effect of a range of different doses of one compound on a range 
of doses of another (Figure 4.1). This is known as the isobole method.  
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In pharmacology the isobole method is regarded as the most reliable for identifying 
interactions between drugs (Williamson, 2001). However, there does not appear to be 
a consensus reached in terms of the best way to investigate the effects of application 
of two different agents in pest control techniques (Appendix B.1). In some cases, 
approach 3 (see the above list) is used, where low concentrations of the pesticide and 
biopesticide are applied and the combined effect is compared to their effects 
individually using an ANOVA (Hiromori and Nishigaki, 2001; Sun et al., 2011; 
Seyed-Talebi et al., 2014). Other studies have used approach 2, where the effect of a 
fixed dose of insecticide is measured in conjunction with multiple doses of a 
biopesticide (Furlong and Groden, 2001). Chi-squared tests are also used to assess 
whether combinations of treatments interact synergistically (Purwar and Sachan, 
2006; Mohan et al., 2007), this will be discussed further in Chapter 6. 
 
A review by Cedergreen et al. (2014) that assessed environmental toxicity of 
chemicals characterised synergy of independently acting chemicals as:  "#$% = "' + ") − "'"). Where "#$%  is the probability of dying from the chemical 
mixture, "' is the probability of dying from the first chemical and ")  is the probability 
of dying from the second chemical. The predominant criticism of the use of this 
equation to determine synergy is that chemicals rarely act independently- even if their 
modes of action differ, there may be more subtle interactions that have not been 
discovered (Williamson, 2001). Additionally, this method does not account for the 
shape of the dose effect curve for each agent used in combination.   
Figure 4.1- An example of an 
isobologram. The responses to doses of 
chemical A are plotted against responses to 
chemical B. The red line illustrates a typical 
antagonistic response, green a synergistic 
response and the dashed blue line shows no 
interaction. (Adapted from Williamson 
2001). 
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4.1.3 Aims and objectives 
 
The first aim of this chapter was to identify the impact of cordycepin on the expression 
of immune-related genes in G. mellonella to better understand its natural function. The 
second aim was to identify whether EPF and cordycepin would be compatible for use 
as biopesticides in IPM. These aims were achieved through the following objectives: 
1. Identify whether cordycepin inhibits EPF germination. 
2. Determine the type of outcome (synergistic, additive or antagonistic) of the 
combined application of cordycepin and EPF in G. mellonella. 
3. Use RT-qPCR to monitor expression of immune-related genes in response 
to cordycepin treatment in G. mellonella. 
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4.2 Materials and Methods 
 
4.2.1 Insect material   
 
Final instar G. mellonella larvae were purchased and maintained as described in 
Section 2.2.1. 
 
4.2.2 Fungal material  
 
B. bassiana 433.99, C. militaris 11703 and M. brunneum 275.86 were used for 
experiments (Table 2.2.2). They were selected as B. bassiana and M. brunneum are 
commercially available biopesticides and C. militaris produces cordycepin. The 
maintenance, subculturing and preparation of conidia suspensions was carried out as 
described in Section 2.2.3. Aliquots (10 ml) of conidia were prepared at a 
concentration of 1x107 conidia ml-1 and were diluted to the required concentration for 
each experiment. 
 
4.2.3 The impact of cordycepin on germination of EPF conidia 
 
The impact of cordycepin on fungal germination was determined through incubation 
of B. bassiana 433.99, C. militaris 11703 and M. brunneum 275.86 conidia with two 
different concentrations of cordycepin (Sigma-Aldrich, USA), 6 mg ml-1 and 3 mg  
ml-1. These concentrations were selected as 3 mg ml-1 was found to be sub-lethal when 
applied to G. mellonella larvae, whereas 6 mg ml-1  caused mortality of these larvae 
(Chapter 2). Cordycepin was prepared by diluting a 100 mg ml-1 stock solution in 
DMSO (Fisher Scientific, USA) with 0.01% Triton X-100. The aim of this was to 
establish whether it would be appropriate to coapply EPF and cordycepin in later 
experiments.  
 
A preparation was made containing 100 µl conidial suspension (1x107 conidia ml-1), 
0, 30, 60 µl of cordycepin (100 mg ml-1), 2.7 µl pentostatin (2’-deoxycoformycin; 
Sigma-Aldrich, USA; 0.1 mg ml-1) and made up to 1 ml using Sabouraud’s Dextrose 
Broth (Sigma-Aldrich, USA). This gave final concentrations of: 1x106 conidia ml-1, 
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30, 60 mg ml-1 (12 mM and 24 mM respectively) cordycepin and 1 µM pentostatin. 
The purpose of adding pentostatin was to inhibit adenosine deaminase (Johnston, 
2011) to reduce the breakdown of cordycepin. 
 
This mixture was incubated in darkness for 24 h at 23 ˚ C and the number of germinated 
and ungerminated conidia was counted. Briefly, the mixture was vortexed for 
approximately 2 min and 20 µl pipetted onto an improved Neubauer haemocytometer 
and visualised using an Olympus BH-2 microscope (Olympus U.K & Ireland, U.K). 
The germination of approximately 100 conidia was recorded, a conidium was 
considered germinated if the germ tube was longer than the length of the conidium. 
Percentage germination was calculated and the experiment was performed on three 
separate occasions. Percentage germination was transformed using the LOGIT 
transformation (Warton and Hui, 2011) and analysed using a one-way ANOVA in 
SPSS (Version 24, IBM). A post-hoc Bonferroni test was used to identify pairwise 
significant differences between the percentage germination of EPF at different 
concentrations of cordycepin. During the LOGIT transformation process, a constant 
(1%) was subtracted from germination values so that 100% germination could be 
included in the analysis.   
 
4.2.4 Identifying the influence of co-administration of cordycepin and EPF on G. 
mellonella survival 
 
The interactions between cordycepin and EPF (B. bassiana 433.99, M. brunneum 
275.86 and C. militaris 11703) were assessed using G. mellonella bioassays. Conidial 
suspensions were prepared as described in Section 2.2.2 and diluted in 0.01% Triton 
X-100 to give concentrations of approximately 666 and 6666 conidia ml-1. A stock 
solution of cordycepin was diluted with DEPC-treated water (Fisher Scientific, USA) 
to 6 mg ml-1. Mixtures for injection were prepared by adding equal volumes of conidial 
suspension to cordycepin solution, giving final concentrations of approximately 333 
or 3333 conidia ml-1, 3 mg ml-1  cordycepin and 3% DMSO. The cordycepin solution 
also contained pentostatin at a final concentration of 1 µM. The dose of cordycepin 
used (3 mg ml-1) had been found during preliminary experiments to be sub-lethal to 
G. mellonella. 
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Three independent replicates of ten larvae per treatment were injected with 30 µl of 
each mixture into the right front proleg using a 0.3 ml microfine insulin syringe (BD, 
USA) or 30 µl of a 0.01% Triton X-100/DMSO mixture as a control (Section 2.2.5). 
This gave a final dose of approximately 10 or 100 conidia and 90 µg of cordycepin 
per larva. Larvae were maintained in 9 cm petri dishes lined with filter paper at 20 ˚C 
and 16:8 h light:dark cycle and survival was monitored for eight days. A Kaplan-Meier 
estimator was carried out in SPSS (Version 24, IBM) and the significance of 
differences in survival were assessed using a log-rank test. 
 
4.2.5 Assessing the impact of cordycepin on immune-related gene expression in 
G. mellonella using RT-qPCR 
 
To quantify the effect of cordycepin on the G. mellonella humoral response, larvae 
were injected with B. bassiana 433.99 or C. militaris 11703 conidia (100 conidia per 
larva) and cordycepin (90 µg per larva), as described in Section 2.2.5. Injection was 
selected to administer EPF and cordycepin as cordycepin does not have activity when 
applied topically (Kim et al., 2002) and final instar G. mellonella do not feed. Also, 
B. bassiana 433.99 was chosen as it has been used previously to characterise the G. 
mellonella immune response and C. militaris 11703 was used as it produces 
cordycepin. Larvae were snap frozen in liquid nitrogen at 48 and 72 h after injection 
and stored at -80 ˚C until use. Fifteen larvae were sampled for each treatment at each 
time point from three independent experiments. 
 
RNA was extracted from whole larvae using the phenol:chloroform method as 
described in Section 3.2.3.3 and reverse transcribed using SuperScript II 
(ThermoFisher Scientific, USA) to give cDNA (Section 3.2.3.4). The expression of 
galiomicin, gallerimycin, lysozyme and IMPI was measured with a Lightcycler 480 
(Roche Holding AG, Switzerland) using primers and conditions described in Section 
3.2.3.5. To determine whether cordycepin had an impact on S7e expression, a Mann-
Whitney test was performed to compare the Ct (cycle threshold) values between G. 
mellonella that were not treated with cordycepin (n=105) and those that were (n=60). 
To assess the impact of cordycepin on immune-related gene expression Ct values were 
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normalised against the housekeeping gene S7e, then the expression on day zero to give 
DDCt values and 2-DDCt values (Livak and Schmittgen, 2001) were analysed using a 
Kruskal-Wallis test in SPSS Statistics (Version 24, IBM).   
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4.3 Results 
 
4.3.1 The impact of cordycepin on fungal germination 
 
EPF conidia were incubated with cordycepin to determine the impact of this 
metabolite on germination. B. bassiana 433.99 and M. brunneum 275.86 germination 
was significantly reduced (back-transformed data in Figure 4.2) to 57.6% and 25.4% 
(back-transformed means), respectively when treated with 6 mg ml-1 cordycepin 
compared to 79.3% and 72.5% at 3 mg ml-1 (p=0.001 for both), and 74.7% and 81.2% 
at 0 mg ml-1 (p=0.004 for B. bassiana and p<0.001 M. brunneum). Differences in 
germination of C. militaris 11703 conidia between cordycepin treatments were found 
to be significant using an ANOVA (p=0.038), but pairwise differences were not found 
to be significant in a Bonferroni post-hoc test. Germination at 0, 3 and 6 mg ml-1 
cordycepin was 81.5%, 79.4% and 63.2%, respectively (back-transformed means).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 - The impact of cordycepin on EPF germination. Mean (back-transformed) percentage 
germination of Beauveria bassiana 433.99, Cordyceps militaris 11703, and Metarhizium brunneum 
275.86 conidia ±SE following incubation for 24 h with 0 (dark grey), 3 (mid grey) and 6 (pale grey) 
mg ml-1 of cordycepin. Different letters represent significant differences (p<0.05) between cordycepin 
treatments within each EPF species determined by ANOVA and Bonferroni post-hoc test.  
a
a
b
a a
a
a
a
b
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4.3.2 Determining the influence of co-administration of cordycepin and EPF on 
G. mellonella survival 
 
In order to characterise the effect of co-application of EPF and cordycepin, G. 
mellonella larvae were injected with a sub-lethal dose of cordycepin and EPF and their 
survival monitored. Survival of larvae injected with only cordycepin was not 
significantly different from those injected with DMSO only (p=0.178; Figure 4.3.D). 
For each of B. bassiana 433.99, C. militaris 11703 and M. brunneum 275.86 there was 
a significant difference between survival of G. mellonella when cordycepin was 
applied with EPF (Figure 4.3) compared to EPF alone. When treated with 100 B. 
bassiana 433.99 conidia, cordycepin reduced the time to mortality by approximately 
1 day (p=0.001). When treated with 10 B. bassiana 433.99 conidia, cordycepin 
reduced the time to mortality by 2-3 days (p<0.001). Mortality caused by C. militaris 
11703 appeared to be the most affected by cordycepin treatment, with the time to 
mortality reducing by at least 2 days following treatment with 10 (p<0.001) or 100 
(p<0.001) conidia. Mortality caused by treatment with M. brunneum 275.86 conidia 
appeared to be the least affected by treatment with cordycepin. At 100 conidia per 
larva the time to mortality appeared to only differ by 12 h following cordycepin 
treatment (p=0.011), at 10 conidia per larva cordycepin reduced the time to mortality 
by 1-2 days (p<0.001). This suggests that cordycepin reduced the time to mortality 
when co-injected with EPF and this effect was more apparent when a lower dose of 
EPF was applied. 
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Figure 4.3 - The survival of Galleria mellonella 
treated with cordycepin and EPF. Kaplan-Meier 
analysis of G. mellonella larvae injected with 30 µl 
cordycepin (3 mg ml -1) and 100 or 10 A) Beauveria 
bassiana 433.99 conidia B) Cordyceps militaris 11703 
conidia C) Metarhizium brunneum 275.86 conidia or 
D) Triton X-100 and DMSO control. Pentostatin (1 
µM) was included in all solutions. The blue line shows 
survival with conidia only and the green line shows 
conidia with cordycepin. N=30 per treatment.  
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4.3.3 Assessing the impact of cordycepin on the expression of immune-related 
genes in G. mellonella larvae using RT-qPCR 
 
To confirm whether cordycepin impacts the expression of immune-related genes, G. 
mellonella larvae were injected with cordycepin and B. bassiana 433.99 conidia, then 
immune-related gene expression monitored using RT-qPCR. RNA extraction and 
cDNA synthesis were successful for 14 of the 15 larvae sampled. The Ct values for 
S7e expression in G. mellonella injected with cordycepin were compared to controls 
using a Mann-Whitney test. There was found to be no significant difference between 
them (p=0.581), which shows that cordycepin did not alter expression of this 
housekeeping gene. Therefore, it was appropriate to normalise expression of the genes 
of interest (galiomicin, gallerimycin, IMPI and lysozyme) against S7e.  
 
Figure 4.4 shows the expression of galiomicin, gallerimycin, IMPI and lysozyme 48 h 
and 72 h after treatment with 100 B. bassiana 433.99 conidia with and without 
cordycepin and the response to a sham injection (Triton X-100). In all cases the 
expression of these genes increased following treatment with B. bassiana 433.99 or a 
sham injection. It appeared that injection with B. bassiana 433.99 resulted in a larger 
increase in expression than sham-injection, however they were not significantly 
different (Appendices B.2-B.9). At 48 h after injection cordycepin appeared to reduce 
the expression of all immune-related genes, whether their expression was induced by 
wounding or B. bassiana 433.99 injection. The p-values from a Kruskal-Wallis test 
followed by Bonferroni correction are in Appendices B.2-B.9. When the immune 
response was stimulated with B. bassiana 433.99, cordycepin significantly reduced 
the expression of all immune-related genes. Expression of galiomicin was reduced by 
~3.5 times (p=0.004) following cordycepin treatment in conjunction with B. bassiana 
433.99 treatment, gallerimycin by ~3 times (p=0.044), IMPI by ~7.5 times (p<0.001) 
and lysozyme by ~6.5 times (p<0.001). The expression of immune-related genes was 
similar 72 h after treatment, although the response to wounding (sham injection) 
appeared to be lower than at 48 h. Like at 48 h, the expression of all genes (galiomicin, 
gallerimycin, IMPI and lysozyme) in response to B. bassiana 433.99 infection was 
significantly reduced by co-application of cordycepin. Expression of galiomicin was 
reduced by ~3 times (p=0.006) following cordycepin treatment in addition to B. 
bassiana 433.99, gallerimycin by ~3 times (p=0.012), IMPI by ~5 times (p<0.001) 
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and lysozyme by ~3.5 times (p<0001). The expression of these genes following sham 
injection was also significantly reduced by treatment with cordycepin, particularly at 
48 h after treatment (Appendices B.2-B.9). 
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Figure 4.4 - Expression of 
immune-related genes in 
response to cordycepin and 
Beauveria bassiana 48 h and 
72 h after treatment. The 
expression of galiomicin, 
gallerimycin, insect 
metalloprotease inhibitor 
(IMPI) and lysozyme in 
response to stimulation by B. 
bassiana injection and sham 
(Triton X-100) injection 48 h 
(A-D) and 72 h (E-H). 
Expression is normalized 
against S7e expression and 
expression of each gene prior 
to injection. Stimulation 
without cordycepin is shown 
by dark grey bars and with 
cordycepin by light grey bars, 
expression in uninjected 
insects is also included. 
N=13-15 per treatment. 
Asterisks indicate significant 
differences (p<0.05) between 
treatments with and without 
cordycepin, other p-values are 
in Appendices B.2-B.9. 
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G. mellonella were also treated with 100 C. militaris 11703 conidia and cordycepin or 
conidia alone (Figure 4.5), a sham injection (Triton X-100) was also included. A 
similar pattern of expression was seen to that when insects were injected with B. 
bassiana 433.99 and cordycepin. The expression of immune-related genes increased 
following treatment with C. militaris 11703 or sham injection. In most cases it 
appeared that injection with C. militaris 11703 resulted in a larger increase in 
expression than sham-injection, however they were not significantly different 
(Appendices B.10-B.17). At both timepoints immune-related gene (galiomicin, 
gallerimycin, IMPI and lysozyme) expression when treated with C. militaris 11703 
alone was significantly higher than when it was co-administered with cordycepin (p-
values in Appendices B.10-B.17). At 48 h after treatment expression of galiomicin 
was reduced by ~5 times (p<0.001) following cordycepin treatment in addition to C. 
militaris 11703, gallerimycin by ~ 2 times (p=0.005), IMPI by ~4 times (p=0.005) and 
lysozyme by ~6.5 times (p=0.002). At 72 h after treatment, expression of galiomicin 
was reduced by ~4.5 times (p<0.001) following cordycepin treatment in addition to C. 
militaris 11703, gallerimycin by ~2 times (p=0.007), IMPI by ~6 times (p<0.001) and 
lysozyme by ~4 times (p<0.001). The expression of immune-related genes in response 
to C. militaris 11703 appeared to be lower than the response to B. bassiana 433.99, 
however these cannot be directly compared as they were separate experiments.  
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Figure 4.5- Expression of 
immune-related genes in 
response to cordycepin and 
Cordyceps militaris 48 h and 72 h 
after treatment. The expression of 
galiomicin, gallerimycin, insect 
metalloprotease inhibitor (IMPI) 
and lysozyme in response to 
stimulation by C. militaris 
injection and sham (Triton X-100) 
injection 48 h (A-D) and 72 h (E-
H). Expression is normalized 
against S7e expression and 
expression of each gene prior to 
injection. Stimulation without 
cordycepin is shown by dark grey 
bars and with cordycepin by light 
grey bars, expression in uninjected 
insects is also included. N=13-15 
per treatment. Asterisks indicate 
significant differences (p<0.05) 
between treatments with and 
without cordycepin, other p-values 
are in Appendices B.10-B.17. 
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4.4 Discussion 
 
An aim of this chapter was to identify whether EPF and cordycepin would be 
compatible for IPM, by assessing the effect of cordycepin on EPF germination. A 
concentration of cordycepin of 6 mg ml-1 was found to inhibit germination of M. 
brunneum 275.86 and B. bassiana 433.99 relative to conidia treated with DMSO and 
Triton X-100, whereas a lower concentration (3 mg ml-1) did not. The mode of action 
of this inhibition is not known, however one hypothesis is that it could be due to 
cordycepin preventing mRNA processing of genes critical to germination and 
survival, in particular it has been seen to reduce the expression of rapidly expressed 
genes such as those involved in the anti-inflammatory response (Kim et al., 2006). 
The switch of fungal conidia from a resting state to a germinating state likely requires 
a large, rapid upregulation of genes, as has been documented in Fusarium 
graminearum (Seong et al., 2008). A GeneChip was used to monitor expression levels 
in F. graminearum and it was found that less than two hours after initiation of 
germination, 1805 genes were upregulated including those involved with metabolism, 
protein synthesis, the cell cycle, nucleotide metabolism and amino acid metabolism. 
A similar switch in expression likely occurs in EPF so cordycepin may inhibit the 
expression of these rapidly upregulated genes and prevent germination. 
 
C. militaris 11703 conidia were the least affected by cordycepin treatment, possibly 
because C. militaris produces cordycepin and has evolved to tolerate high 
concentrations. This tolerance could be due to a putative cordycepin transporter that 
has been identified in C. militaris and is thought to be responsible for the transport of 
cordycepin out of cells (Xia et al., 2017). M. brunneum 275.86 seemed to be more 
affected by cordycepin then B. bassiana 433.99, despite neither of them being known 
to produce cordycepin. Using LC-MS analysis Xia et al. (2017) showed that 
cordycepin cannot be detected from B. bassiana or Metarhizium robertsii (closely 
related to M. brunneum). Beauveria spp. are more closely related to Cordyceps spp. 
than Metarhizium spp. (Section 1.4) as they are in the same family, so B. bassiana 
may share genes with C. militaris that confer some resistance to cordycepin. 
Alternatively, there may be a structural feature of M. brunneum conidia that makes 
them more susceptible to cordycepin. This suggests that if cordycepin and EPF were 
  123 
used in combination for IPM, it would be important to select a concentration of 
cordycepin that does not inhibit EPF germination. Furthermore, it appears that B. 
bassiana 433.99 would be more appropriate for use with cordycepin as germination 
was less affected than M. brunneum 275.86.  
 
As 3 mg ml-1 cordycepin did not inhibit EPF germination, this concentration was 
selected to be co-administered to G. mellonella with EPF. Although this dose was not 
lethal to G. mellonella larvae if administered alone, it did reduce the time to mortality 
of larvae when co-injected with either 10 or 100 conidia of all three of the EPF tested. 
The hypothesis developed from this research is that cordycepin inhibits the immune 
response of larvae thus enabling the EPF to colonise the larvae more rapidly. This is 
supported by the finding in Chapter 2, where it was speculated that cordycepin 
facilitated opportunistic infection by bacteria through inhibition of the insect immune 
system. Alternatively, this may be due to cordycepin preventing mRNA processing or 
halting the cell cycle (Wu et al., 2007; Jung et al., 2012; Kondrashov et al., 2012) in 
larval cells, resulting in stress that increases the susceptibility of the insect to infection 
(Adamo and Parsons, 2006). The impact of cordycepin on the progress of mortality 
during EPF infection appeared more pronounced at 10 conidia per larva than at 100 
conidia per larva, as a higher number of conidia would presumably overwhelm the 
humoral and cellular immune responses more rapidly and make the impact of 
cordycepin less noticeable. The effect of cordycepin was greatest for C. militaris 
11703, but least for M. brunneum 275.86. C. militaris 11703 is less susceptible to the 
toxic effects of cordycepin than M. brunneum 275.86 (Section 4.3.1) and this could 
account for the differences in their interactions within G. mellonella. 
 
The experiments in Section 4.3.2 used a sub-lethal dose of cordycepin to characterise 
its interactions with EPF. A sub-lethal dose simplifies the calculation used to 
characterise interactions between chemicals, where EA would be the effect of EPF 
application and EB the effect of cordycepin application (Section 4.1.4), as EB and EAEB 
would both be equal to zero and any increase in mortality above EA would be due to 
potentiation by cordycepin. Therefore, the results in Section 4.3.2 indicate that 
cordycepin acts to enhance the effect of EPF to increase the rate of G. mellonella 
mortality. However, a condition for the use of the equation in Section 4.1.4 is that the 
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chemicals being tested act independently which may not be true for EPF and 
cordycepin. EPF interact with the insect immune response at different levels, including 
the cellular and humoral responses, in order to successfully infect an insect (Hajek and 
St. Leger, 1994). For example, plasmatocytes isolated from G. mellonella treated with 
EPF proteases have reduced phagocytic activity (Griesch and Vilcinskas, 1998), 
suggesting that in vivo these proteases inhibit the cellular immune response. B. 
bassiana infection triggers the expression of AMPs in G. mellonella (Vertyporokh and 
Wojda, 2017), which illustrates that EPF also interact with the humoral response. 
Cordycepin may also impact these immune pathways, which is supported by the 
results in Sections 4.3.3 and 2.2.6. Consequently, cordycepin and EPF may act upon 
the same immune pathways and identification of potentiation using "#$% = "' +") − "'")  may not be reliable, although it does not negate the possibility that 
cordycepin potentiates the effect of EPF. A more reliable means of assessing 
interactions between chemicals would be to use the isobole method (Williamson, 
2001). This would require a range of doses of cordycepin to be administered to G. 
mellonella with a range of doses of EPF and mortality monitored. This has not been 
commonly used for assessment of pesticide interactions, probably because it would 
require a high number of bioassays, which would increase the cost and time taken for 
the experiments. However, in the future it would be beneficial to use the isobole 
approach to investigate the effect of the dose of cordycepin on interactions with EPF, 
in particular at concentrations of this metabolite that would be realistic in the field if 
it were developed as a biopesticide.  
 
In order to test how cordycepin affects the G. mellonella immune system when co-
injected with EPF, the expression of the four immune-related genes gallerimycin, 
galiomicin, IMPI and lysozyme were monitored using RT-qPCR. When B. bassiana 
433.99 conidia were injected into larvae with cordycepin, expression of gallerimycin, 
galiomicin, lysozyme and IMPI was reduced at 48 and 72 h post-injection. In all cases, 
levels were reduced to that of uninjected larvae which suggests that cordycepin could 
be associated with effects on the insect immune system, particularly reducing the 
expression of immune-related genes. Similar results were seen when the immune 
response of G. mellonella was stimulated through injection of C. militaris 11703 
conidia (Figure 4.5). This was unexpected as C. militaris 11703 produces cordycepin 
(Huang et al., 2003), which might be anticipated to inhibit the immune response of 
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larvae irrespective of additional cordycepin. However, it is possible that the dose of 
cordycepin introduced during this experiment was higher than that produced during 
the early stages of natural infection. The amount of cordycepin found to be produced 
by C. militaris mycelia varies depending on cultivation method, strain and extraction 
method, but is between 750-16500 µg g-1 (Huang et al., 2003; Li et al., 2004; Yang 
and Li, 2008). The amount injected in Section 4.2.5 was 90 µg per insect, which based 
on the above estimates would be produced by 5.5 mg-120 mg of C. militaris. This 
level of biomass would likely not accumulate until the late stages of the G. mellonella 
infection. To quantify the concentration of cordycepin produced by C. militaris early 
in infection LC/MS or HPLC (Huang et al., 2003; Li et al., 2004) could be used, 
however analysis of these low concentrations would likely be complicated by the 
structural similarity of cordycepin to adenosine (Figure 1.8). As discussed in Chapter 
3, sham injection increases expression of galiomicin, gallerimycin, IMPI and 
lysozyme. Cordycepin significantly reduced the expression of these genes at either 48 
or 72 h after treatment, despite their expression being induced by wounding rather than 
infection, illustrating that cordycepin reduces immune-related gene expression 
regardless of how expression was stimulated.   
 
There has been limited previous research into the effect of EPF secondary metabolites 
on the insect immune system and the majority has focused on their impact on the 
activity or structure of haemocytes (Vilcinskas and Matha, 1997a; Vilcinskas et al., 
1997b; Vilcinskas et al., 1997c). There has been one previous study in which immune-
related gene expression has been monitored following treatment with an EPF 
metabolite. In D. melanogaster destruxin A was found using microarray data to cause 
significant down regulation of humoral response genes in comparison to other genes 
(Pal et al., 2007). The same study also found that destruxin reduced AMP expression, 
specifically AMPs controlled by the IMD pathway (Pal et al., 2007). This is an 
antibacterial response, which contrasts with the effect on the Toll response observed 
in this chapter. However, Pal et al., (2007) did not carry out experiments suitable to 
identify a specific response to the Toll pathway as they used bacteria to stimulate the 
IMD pathway. In the current study, the Toll response was focused on as it would be 
more relevant to natural infection by EPF. In the future, other immune pathways could 
be investigated which would be facilitated by the whole genome sequence of G. 
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mellonella recently becoming available (Lange et al., 2018). In G. mellonella 
beauverolides (a metabolite of Beauveria spp.) also have an effect on the immune 
system (Vilcinskas et al., 1999), but the response is less clear. When administered at 
sub-lethal concentrations beauverolides increased nodulation and melanisation but 
inhibited phagocytic activity. This could indicate that the response to cordycepin, like 
destruxins and beauverolides, is part of a larger more complex response that needs 
further characterisation.  
 
There is a large amount of cross talk between immune response pathways (Han and 
Ip, 1999; De Gregorio et al., 2002; Hedengren-Olcott et al., 2004), so cordycepin may 
be affecting multiple immune pathways individually or a single process impacting 
multiple pathways. Although the genes investigated during this project are all 
immune-related, their transcription is not likely to be controlled by the same immune-
response pathway, which supports the hypothesis that cordycepin acts on multiple 
immune pathways. Gallerimycin is reported to be antifungal (Schuhmann et al., 2003) 
and galiomicin is reported to be anti-bacterial and anti-fungal (Lee et al., 2004). It is 
likely that their expression is controlled, at least in part, by the Toll pathway as this 
pathway predominantly responds to fungi. Expression of lysozyme and IMPI is likely 
to be controlled by separate pathways, but there may be feedback from the Toll 
pathway as their expression increases following exposure to fungi (Chapter 3). 
Cordycepin has been reported to particularly reduce the expression of inflammatory 
genes through the inhibition of polyadenylation (Kondrashov et al., 2012), although it 
has also been reported to reduce the polyadenylation of other genes. For example, it 
reduces the mRNA levels of genes involved in the cell cycle including c-myc (White; 
Ioannidis et al., 1999) and met (Chen et al., 2008). Therefore, through inhibition of 
polyadenylation, cordycepin may impact multiple pathways within insects, including 
immune pathways. 
 
4.5 Conclusions 
 
Cordycepin appears to facilitate infection of G. mellonella by multiple EPF (B. 
bassiana 433.99, C. militaris 11703 and M. brunneum 275.86), although it could not 
be conclusively determined whether this was an additive or synergistic effect because 
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the way in which both treatments interact with larvae is not known. However, taken 
together with the results from Chapter 2, where cordycepin permitted opportunistic 
bacterial infection, the data presented indicates that cordycepin inhibits the G. 
mellonella immune system. In order to elucidate the mechanism behind cordycepin’s 
impact on the G. mellonella immune response, immune-related gene expression was 
monitored. It was found that cordycepin reduced expression of galiomicin, 
gallerimycin, IMPI and lysozyme whether their expression was stimulated by the 
wounding or treatment with EPF. This suggests that the natural function of cordycepin 
is to inhibit the insect immune response thereby facilitating the infection and 
colonisation by C. militaris.   
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Chapter 5- Investigating the effect of cordycepin on 
the expression of immune-related genes in Drosophila 
melanogaster S2r+ cells  
 
5.1 Background 
 
5.1.1 Immunity of D. melanogaster 
 
The D. melanogaster immune system is one of the best characterised in insects 
(Section 1.7; Rolff and Reynolds, 2009). In particular, it has been used to elucidate 
the Toll and IMD pathways of the humoral response (Lemaitre et al., 1995; O’Neill, 
2006) which are activated by detection of PAMPs, virulence factors and stress signals. 
Upon activation they upregulate the transcription of immune-related genes (Gottar et 
al., 2006; Erler et al., 2011). Additionally, the Toll pathway is involved in dorsal-
ventral patterning during the development of the D. melanogaster embryo (Belvin and 
Anderson, 1996).  
 
There are seven groups of AMPs (Section 1.7.2.4) in D. melanogaster (Table 1.4; 
Section 1.7) and four were selected for the present study: Attacin, Diptericin, 
Drosomycin and Metchnikowin. Attacin is identified in the literature as having 
antibacterial activity, although its expression also increases following B. bassiana 
infection despite it not being known to have antifungal activity (Lemaitre et al., 1997). 
Similarly, Diptericin is reported to have activity against gram-negative bacteria 
(Lemaitre and Hoffmann, 2007) and its expression also increases in response to B. 
bassiana infection, although it too has not been found to have antifungal activity 
(Lemaitre et al., 1997). Metchnikowin is reported to have activity against gram-
positive bacteria and fungi, inhibiting the growth of both Micrococcus luteus and 
Neurospora crassa (Levashina et al., 1995). Whereas Drosomycin is reported to be 
primarily active against fungi, inhibiting the growth of N. crassa, Botrytis cinerea and 
Fusarium oxysporum, but has no activity against bacteria (Fehlbaum et al., 1994). 
Two additional proteins, Relish and DIF are transcription factors in the NFkB family 
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that control AMP transcription in the IMD and Toll pathways, respectively. They have 
a key role in activating transcription of immune-related genes in these pathways (Rolff 
and Reynolds, 2009; Ganesan et al., 2010). 
 
Cellular immunity (Section 1.7.1) is another important aspect of the D. melanogaster 
immune response. Circulating haemocytes can phagocytose or encapsulate invading 
microorganisms, but also have key roles in wound healing and the melanisation 
response (Williams, 2007). Additionally, there is evidence that haemocytes are 
involved in activating the humoral immune response. Mutant D. melanogaster larvae 
that do not produce haemocytes cannot synthesise AMPs in response to bacterial 
infection (Basset et al., 2000). It was hypothesised that this is due to the need for 
haemocytes to produce a second signal following detection of pathogens to trigger 
AMP production (Basset et al., 2000). A second signal has been identified as being 
necessary for the Toll pathway, as haemocytes produce the cytokine Spätzle following 
detection of infection to trigger this pathway (Shia et al., 2009). 
 
The impact of a selection of fungal secondary metabolites on the survival and immune 
response of insects has been previously investigated using D. melanogaster (Paterson 
et al., 1987; Pal et al., 2007). For instance, metabolites derived from Penicillium spp. 
were fed to D. melanogaster larvae and their effect on mortality and feeding quantified 
to evaluate their potential for use as biopesticides (Paterson et al., 1987). Additionally, 
Pal et al. (2007) carried out a series of experiments to further understand the activity 
of destruxin A in D. melanogaster. RT-qPCR was used to show that this metabolite 
inhibits the expression of the AMPs diptericin, attacin and metchnikowin (Pal et al., 
2007). This is the only study to specifically investigate the impact of an EPF secondary 
metabolite on immune-related gene expression in insects, but its success suggests that 
similar techniques may be applied to determine whether cordycepin can also affect the 
D. melanogaster immune system. 
 
5.1.2 Drosophila melanogaster cell lines 
 
D. melanogaster is the primary model organism for studying genetics (Jennings, 2011; 
Gramates et al., 2017), as well as researching innate immune pathways and improving 
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understanding of the innate immune system in humans (Buchon et al., 2014). There 
are a range of D. melanogaster cell lines available including S2 and Kc, which can be 
transformed using plasmid expression vectors (Cherbas et al., 1994) or RNAi and have 
been used to study signalling pathways (Clemens et al., 2000). This is potentially of 
use for future work into understanding the natural function of cordycepin as it will 
permit use of techniques including gene knockouts and reporter gene assays. 
 
The S2 cell line was developed by Schneider (1972) from late embryonic stage D. 
melanogaster cells and it has since been found to have macrophage-like 
characteristics, such as the ability to phagocytose bacteria (Rämet et al., 2001). This 
has led to it being used as a tool to characterise the D. melanogaster immune response 
(Georgel et al., 2001; Cheng and Portnoy, 2003; Kallio et al., 2005; Wang et al., 
2006), especially monitoring gene expression in response to immune stimulation 
(Tauszig et al., 2000; Kallio et al., 2005). The present study uses the D. melanogaster 
S2r+ cell line, a line derived from S2 cells, which differs from the S2 line in its ability 
to respond to Wingless signalling (Yanagawa et al., 1998). The Wingless pathway is 
important in the regulation of tissue development (Swarup and Verheyen, 2012).  
 
5.1.3 Mammalian innate immunity vs invertebrate immunity  
 
The innate immune response is an early response to pathogens found in many 
multicellular organisms (Kimbrell and Beutler, 2001). There are extensive homologies 
between the innate immune response in vertebrates and the humoral response in 
invertebrates. These homologies extend to immune receptors, immune effectors and 
signalling pathway components (Kimbrell and Beutler, 2001). Comparing human and 
invertebrate responses can be particularly informative when elucidating immune 
pathways or for determining the effect of chemicals on the functioning of the immune 
system. Most of the research published to date on cordycepin has focused on its impact 
on the human inflammatory response. However, because of the conservation of the 
innate immune response between vertebrates and invertebrates, this can inform 
research into its function during infection by C. militaris. The Toll-like receptor (TLR) 
pathway (Figure 5.1) in mammals shows homology with the Toll and IMD pathways 
of invertebrates (Kimbrell and Beutler, 2001). It controls the release of inflammatory 
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cytokines (Takeda and Akira, 2004) and can be initiated by recognition of fungi 
(Bourgeois and Kuchler, 2012), bacteria and viruses (Medzhitov, 2001). The 
recognition of a PAMP by a TLR triggers a signalling cascade (Figure 5.1), involving 
Myd88 and IRAK, which are homologous to Myd88 and Pelle, respectively, in the D. 
melanogaster Toll pathway (Kimbrell and Beutler, 2001).  
 
NFkB is a key transcription factor in the mammalian TLR pathway that is homologous 
to DIF and Relish in the insect Toll and IMD pathways, respectively and its activation 
occurs via a similar mechanism to these insect transcription factors. NFkB is held in 
an inactive form in the cytoplasm by association with the inhibitory protein IkB (Tak 
and Firestein, 2001). Upon activation, the TLR signalling cascade activates IkB kinase 
(IKK) which phosphorylates IkB triggering its degradation (Figure 5.1). This frees 
NFkB to dimerise and enter the nucleus (Tak and Firestein, 2001), where it binds to 
the promoters of immune responsive genes and activates their expression. In insects, 
DIF remains in the cytoplasm due to association with Cactus, a homologue of IkB 
(Karin, 1999). Following activation of the Toll pathway Cactus is phosphorylated 
which triggers its degradation, although the precise mechanism is not known. DIF then 
dimerises and enters the nucleus to drive transcription of target genes (Valanne et al., 
2011). Activation of Relish is slightly different to that of DIF and NFkB as it contains 
an IkB-like module that holds it in the cytoplasm. The IMD signalling cascade 
activates a kinase in the IKK family that phosphorylates the IkB-like module of Relish 
causing it to be cleaved, freeing Relish to dimerise and enter the nucleus (Valanne et 
al., 2011). The similarities between the insect and mammalian NFkB pathways show 
that they have been evolutionarily conserved and understanding the pathway in one 
organism can improve understanding of that in other organisms.  
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Figure 5.1 - The Toll and IMD pathways in Drosophila melanogaster cells (left) and the Toll-like receptor (TLR) 
pathway in mammalian cells (right). A diagram comparing the Toll and IMD pathways in D. melanogaster cells to the 
TLR pathway in mammalian cells, homologous proteins have the same shape and colour. The TLR pathway responds to 
bacteria, viruses and fungi to trigger an inflammatory immune response. A family of TLR receptors bind to PAMPs, which 
triggers a signalling a cascade within the cell that includes the proteins Myd88 and IRAK (which are homologous to Myd88 
and Pelle in the Toll pathway, respectively). Following the cascade, a kinase in the IKK family phosphorylates IkB 
(homologous to Cactus), which leads to its degradation. NFkB (homologous to DIF and Relish) is then free to dimerise and 
enter the nucleus. Fungi and gram-positive bacteria are detected by the Toll pathway. Fungal PAMPS are detected by β-
GRPs and gram positive bacteria by PGRP-SAs. These then bind to the Toll receptor via the protein Spatzle. This activates 
a protein cascade in the cytoplasm that ends in DIF being released from the inhibitory protein cactus. DIF then diffuses into 
the nucleus where it acts as a transcription factor activating AMPs. Gram negative bacteria are detected by the PGRP-LC 
receptor, which triggers a protein cascade in the cytoplasm that ends in the activation of the transcription factor Relish. 
Relish then diffuses into the nucleus and activates transcription of AMPs. Adapted from Lemaitre and Hoffmann, (2007), 
Takeda and Akira, (2004) and Myllymäki and Rämet, (2014).  
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5.1.4 Aims  
 
The overall aim of this chapter was to identify the impact of cordycepin on the 
expression of immune-related genes in D. melanogaster S2r+ cells to improve 
understanding of the natural function of cordycepin. This builds on the findings from 
Chapter 4, where cordycepin was seen to reduce immune-related gene expression in 
G. mellonella. For this chapter, a cell line was used to circumvent the problems seen 
previously with the wounding response that occurred when G. mellonella were 
injected with EPF and cordycepin, which complicated the analysis of immune-related 
gene expression. Furthermore, because the D. melanogaster immune response has 
been well characterised the results obtained should produce new fundamental 
information of the mechanism of action of cordycepin.  
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5.2 Materials and Methods 
 
5.2.1 Maintenance of Drosophila melanogaster S2r+ cell culture 
 
D. melanogaster S2r+ cells (Yanagawa et al., 1998) were provided by Dr Lopez de 
Quinto (Cardiff University, U.K). Cells were cultured in 15 ml cell culture flasks 
(VWR, USA) with 12 ml of Schneider’s Drosophila Insect Medium (ThermoFisher 
Scientific, USA) supplemented with 10% foetal bovine serum (FBS; Sigma-Aldrich, 
USA) and 10% penicillin-streptomycin (Sigma-Aldrich, USA). The cell cultures were 
maintained at 25 ˚C in an environmental test chamber (Sanyo, Japan) and were split 
into new 15 ml cell culture flasks when their density reached approximately 1x107 
cells ml-1. All cells used in experiments were between passages 5-15.  
Cells to be used in RT-qPCR experiments were seeded into 6-well plates (TPP, 
Switzerland) 24 h prior to experiments. In order to do this, the density of cells was 
determined following trypan blue staining and used to calculate the total number of 
cells present in each flask. Briefly, cells were loosened from the flask by aspirating 
with a serological pipette and 100 µl of cell suspension was mixed with 100 µl of 0.4% 
trypan blue. Living cells exclude this dye, whereas dead cells are stained blue, which 
allows their differentiation. Cells were visualized using an improved Neubauer 
Haemocytometer and the number of viable cells per ml calculated using the following 
equation:  +,-./	1,.		3$.4/5	65//7	$8	.	/.9:5	7;<.95=> 	?	10000	?	2. Cells were collected in a 
15 or 50 ml universal tube (Fisher Scientific, USA) by centrifugation at 1500 g for 5 
min at 4˚C. The media was removed and replaced with fresh Schneider’s Drosophila 
Insect Medium (ThermoFisher Scientific, USA) supplemented with 10% FBS (Sigma-
Aldrich, USA). This was aspirated to disrupt the pellet and 3 ml pipetted into each 
well of a 6-well plate (TPP, Switzerland) at a density of approximately 8x105 cells  
ml-1. Plates were incubated at 25 ˚C in an environmental test chamber (Sanyo, Japan). 
5.2.2 The effect of cordycepin on D. melanogaster S2r+ survival   
 
The density of S2r+ cells was determined by staining with 0.4% trypan blue solution 
(Sigma-Aldrich, USA) as described in Section 5.2.1. The total number of cells 
required for each experiment was calculated and the desired number were seeded into 
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new media. This was done by centrifuging the cell suspension for 5 min at 1500 g 
(Tabletop centrifuge, Fisher Scientific, USA) to pellet the cells and resuspending in 
Schneider’s Insect Medium (ThermoFisher Scientific, USA) supplemented with 10% 
FBS (Sigma-Aldrich, USA) to the volume required for the experiment.  
Cordycepin (Sigma-Aldrich, USA) was diluted in DMSO (Fisher Scientific, USA) to 
give the following concentrations: 50, 100, 200, 400, 800 and 1600 mM. Then 3 ml of 
cell suspension was pipetted into eight wells of two 6-well plates (TPP, Switzerland) 
and 3 µl of each cordycepin dilution was added to each well giving final cordycepin 
concentrations of 50, 100, 200, 400, 800 and 1600 µM. Two controls were included 
in the experiment, one remained untreated whilst the other contained 3 µl of DMSO. 
These plates were incubated at 25 ˚C in an environmental test chamber (Sanyo, Japan) 
for 48 h and the number of viable and non-viable cells were counted daily using trypan 
blue staining, as described previously. All cells within the larger 4x4 haemacytometer 
grid were counted, in each replicate three aliquots were counted from each treatment 
and the mean calculated. The experiment was repeated on three occasions. A model 
was fitted to the data using the DRC package (Ritz et al., 2015) in R (RStudio, 2017). 
Initially five models were fitted to the data; two, three and four parameter log-logistic 
models, Weibull-1 model and Weibull-2 model. These were compared using a lack-
of-fit test and the model with the highest p-value selected and used to calculate the 
LC50 (concentration that causes 50% mortality) for cordycepin after 24 and 48 h 
exposure to cordycepin.  
 
5.2.3 Development of a D. melanogaster S2r+ bioassay system 
 
A series of pilot experiments were performed to determine the optimum conditions for 
later RT-qPCR experiments. For all pilot experiments one biological replicate was 
performed. In order to determine the most appropriate time for sampling, cells were 
treated with sterile distilled water, LPS (Lipopolysaccharides from Escherichia coli 
O127:B8 purified by phenol extraction, Sigma-Aldrich, USA) or curdlan (Carbosynth 
Ltd, Newbury U.K) to a final concentration of 1 µg ml-1 24 h after seeding. LPS 
stimulates an anti-bacterial response as it is a bacterial cell wall component and 
curdlan stimulates an anti-fungal immune response as it is structurally similar to fungal 
cell wall polysaccharides, although it is produced by the bacteria Alcaligenes faecalis 
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(Harada et al., 1968). Cells were incubated at 25 ˚C for 1, 2 or 4 h. 
In order to identify conditions to achieve maximum expression of immune-related 
genes, varying concentrations of LPS or curdlan (10 or 20 µg ml-1) were applied 24 h 
after cell seeding. A control treated only with sterile RO water was also included. Cells 
were incubated at 25 ˚C for 4 h. Finally, to identify the optimum concentration of 
cordycepin to use in future experiments, S2r+ cells were treated with 20 µg ml-1 of 
stimulant (LPS or curdlan) and 20, 50 or 100 µM of cordycepin (Sigma-Aldrich, USA) 
dissolved in DMSO (Fisher Scientific, USA). Controls containing DMSO only were 
also included. Cells were then incubated at 25 ˚C for 4 h. In all experiments, following 
incubation of cells, RNA was extracted and used as a template for RT-qPCR of a 
selection of genes (diptericin, drosomycin, RP49 and attacin), which is described in 
detail in Section 5.2.4.  
5.2.4 Monitoring the impact of cordycepin on the expression of immune-related 
genes in D. melanogaster S2r+ cells  
 
At 24 h after seeding, S2r+ cells were stimulated with 20 µg ml-1 curdlan (Carbosynth 
Ltd, Newbury U.K), 20 µg ml-1 LPS (Sigma-Aldrich, USA) or sterile RO water. At the 
same time, they were treated with either 100 µM cordycepin or the same volume of 
DMSO. In all experiments, an untreated control was also included. The cells were 
incubated at 25 ˚C for 4 h, then placed on ice. The cell suspension was gently pipetted 
up and down to loosen cells adhering to the plate, then transferred to a 15 ml universal 
tube and centrifuged at 4 ˚C for 5 min at 1500 g to pellet cells. The medium was 
removed and the pellet washed with ice cold PBS and centrifuged as before. RNA was 
extracted using the ReliaPrepTM RNA Cell Miniprep system (Promega, USA) 
following the manufacturer’s instructions, the concentration measured using a 
NanoDrop ® ND-100 spectrophotometer (ThermoFisher Scientific, USA) and stored 
at -80˚C. Three independent biological replicates of this experiment were performed.  
SuperScript III (ThermoFisher Scientific, USA) was used to carry out reverse 
transcription reactions on 100 µg of RNA from each sample. The manufacturer’s 
instructions were followed, except 0.5 µl (100 units) of Superscript III was added to 
each reaction instead of the 1 µl (200 units) recommended. The cDNA produced from 
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this reaction was diluted 1 in 5 in DEPC-treated water. 
QPCR was performed using a Lightcycler 480 (Roche Holding AG, Switzerland) and 
SensiFAST SYBR No-ROX (Bioline, USA) as described in Section 3.2.3.5. The PCR 
primers used for gene amplification are listed in Table 5.1. Reactions and cycle 
conditions were the same as those described in Section 3.2.3.5. The raw Ct values for 
Rp49 (rRNA gene) expression with and without cordycepin were compared using a 2-
tailed t-test, to determine whether it was appropriate to normalise expression of genes 
of interest against this gene. Following this test, it was found that cordycepin did not 
affect RP49 expression, so Ct values were normalised against RP49 and the expression 
of untreated control using the 2-DDCt method (Livak and Schmittgen, 2001). These 2-
DDCt values were assessed for normality using a Shapiro-Wilk test and analysed in 
SPSS Statistics (Version 24, IBM) using either an independent 1-tailed t-test if they 
were normally distributed or a 1-tailed Mann-Whitney U test if they were not normally 
distributed. This was based on the hypothesis developed in Chapter 4 that treatment 
with cordycepin would result in lower levels of gene expression compared to those 
treated with an immune challenge only. 
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Table 5.1 -Primers used for analysis of immune-related gene expression in Drosophila 
melanogaster S2r+ cells.  
Gene Primer sequence (5'-3') Reference 
attacin A 
AGGTTCCTTAACCTCCAATC Jin et al., (2008) CATGACCAGCATTGTTGTAG 
RpL32 
 
AGTCGGATCGATATGCTAAGCTGT Jin et al., (2008) 
TAACCGATGTTGGGCATCAGATACT 
diptericin 
 
ATGCAGTTCACCATTGCCGTC Jin et al., (2008) 
TCCAGCTCGGTTCTGAGTTG 
drosomycin 
 
CTTGTTCGCCCTCTTCGCTGTC Jin et al., (2008) 
AGCACTTCAGACTGGGGCTGCA 
RP49 
 
GACGCTTCAAGGGACAGTATCTG Gobert et al., (2003) 
AAACGCGGTTCTGCATGAG 
relish 
 
GGCATCATACACACCGCCAAGAAG Petersen et al., (2013) 
GTAGCTGTTTGTGGGACAACTCGC 
dif 
 
CAGTTTGCTACGACCGGAGAGCTA Petersen et al., (2013) 
GAATATCCGCCAGTTGCAGAGTGC 
metchnikowin 
 
TCTTGGAGCGATTTTTCTGG Castillo et al., (2013) 
AATAAATTGGACCCGGTCTTG 
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5.3 Results 
 
5.3.1 The effect of cordycepin on D. melanogaster S2r+ cell survival  
 
D. melanogaster S2r+ cells were incubated with a range of cordycepin concentrations 
and survival was quantified at 24 and 48 h after treatment. To generate dose-response 
curves, the DRC package in R was used to fit models to survival. No model tested was 
found to give a good fit to the survival 24 h after treatment, as the p-values obtained 
from lack-of-fit tests were less than 0.05. This may be due to percentage mortality not 
exceeding 45%. The best fitting model was the W2.2 model (Weibull type 2 model 
with a lower limit of 0 and upper limit of 1; Figure 5.2), which gave a p-value of 0.012. 
The LL.2 model (2 parameter log-logistic model with EC50 as a parameter, upper limit 
of 1 and lower limit of 0) was found to best fit the data at 48 h after treatment using a 
lack-of-fit test (p=0.70). This model was used to estimate the LC50 for cordycepin 
treatment as being 383.55 µM. At both timepoints, the fitted models indicate that the 
mortality of S2r+ cells increased approximately linearly with log[concentration of 
cordycepin]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 - Survival of Drosophila melanogaster S2r+ cells in response to cordycepin treatment. Dose 
response curves produced in R showing the survival of D. melanogaster S2r+ cells in response to treatment with 
a range of cordycepin doses (50, 100, 200, 400, 800 and 1600 µM) after incubation for A) 24 h and B) 48 h. A 
W2.2 model is fitted to survival after 24 h and LL.2 model to survival after 48 h. Points are the mean of three 
replicates. 
Concentration (µM)
A B
Concentration (µM)
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5.3.2 Development of a D. melanogaster S2r+ bioassay system 
 
To determine a suitable timepoint for S2r+ cell sampling following treatment with 
LPS or curdlan, an expression timecourse was performed. The concentrations of LPS 
and curdlan used did not cause a large stimulation of AMP expression, but the highest 
increase in expression appeared 4 h after treatment (Figure 5.3). Therefore 4 h was 
selected as the sampling time for later experiments and it was determined that higher 
concentrations of LPS and curdlan would be necessary. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to establish the concentrations of stimulant necessary to give a large increase 
in expression of immune-related genes, S2r+ cells were treated with either 10 or 20 
µg ml-1 of LPS or curdlan and expression measured 4 h after treatment. Expression of 
all immune-related genes increased following LPS or curdlan treatment relative to 
unstimulated cells. As 20 µg ml-1 gave the greatest increase in expression (Figure 5.4) 
and was used for later experiments. LPS and curdlan did not appear to affect 
Figure 5.3- Expression of immune-related 
genes in Drosophila melanogaster S2r+ cells 1, 
2 and 4 h after curdlan or LPS stimulation. 
The expression of A) diptericin (Dpt), B) 
drosomycin (Drm) and C) attacin (Att) in a 
preliminary experiment, following stimulation 
with LPS or curdlan (1 mg ml-1).  Expression was 
normalized against the housekeeping gene RP49 
and the expression of unstimulated cells at each 
timepoint. A single biological replicate was 
performed. 
Curdlan
LPS
Treatment
R
el
at
iv
e 
ch
an
ge
 in
 e
xp
re
ss
io
n
R
el
at
iv
e 
ch
an
ge
 in
 e
xp
re
ss
io
n
R
el
at
iv
e 
ch
an
ge
 in
 e
xp
re
ss
io
n
A B 
C 
  141 
expression of RpL32, a housekeeping gene, hence this concentration was used in future 
experiments. Finally, an expression timecourse was performed to identify the 
concentration of cordycepin that affected immune-related gene expression in D. 
melanogaster S2r+ cells (data not presented). Treatment with 100 µM cordycepin 
gave the greatest reduction in AMP gene expression, without appearing to effect 
RpL32 expression, therefore this was selected for later experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4- Expression of AMP genes in Drosophila melanogaster S2r+ cells in response to LPS or 
curdlan stimulation. The expression of A) diptericin (Dpt), B) drosomycin (Drm), C) attacin (Att) and 
D) RpL32 in response to stimulation with 10 or 20 mg ml-1 of LPS or curdlan 4 h after treatment. The 
expression was normalized against the housekeeping gene RP49 and the expression in untreated cells. A 
single biological replicate and three technical replicates were performed. Error bars show ±SEM. 
 
Dpt Drm
Att RpL32
10 mg ml-1
20 mg ml-1
R
el
at
iv
e 
ch
an
ge
 in
 e
xp
re
ss
io
n
R
el
at
iv
e 
ch
an
ge
 in
 e
xp
re
ss
io
n
R
el
at
iv
e 
ch
an
ge
 in
 e
xp
re
ss
io
n
R
el
at
iv
e 
ch
an
ge
 in
 e
xp
re
ss
io
n
Concentration 
of stimulant
A B
C D
  142 
5.3.3 Determining the effect of cordycepin on the expression of immune-related 
effector genes in D. melanogaster S2r+ cells 
 
D. melanogaster S2r+ cells were incubated with 100 µM cordycepin and the 
expression of immune-related genes determined with RT-qPCR (Figures 5.5 and 5.6). 
Expression of diptericin and drosomycin appeared to increase slightly in response to 
curdlan treatment, but cordycepin had no significant effect on expression of these 
genes. Both genes also showed no response to LPS treatment. However, the expression 
of both attacin and metchnikowin increased following curdlan or LPS treatment, but 
this increase was prevented by the presence of cordycepin. The increases in expression 
of attacin and metchnikowin in response to curdlan were significantly reduced by the 
addition of cordycepin by ~3-fold and ~2.5-fold, respectively (p=0.025 and p=0.049 
respectively). This was determined using a one-tailed Mann-Whitney U test for attacin 
expression, which was not normally distributed and a one-tailed t test for 
metchnikowin which was normally distributed. 
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In order to investigate the humoral immune pathways of D. melanogaster in more 
detail and to determine the cause of the reduction in AMP expression by cordycepin, 
the response of the transcription factors dif and relish were compared to the 
housekeeping gene RpL32. The relative expression of RpL32 remained at 
approximately 1.0 throughout treatments, however this increased to 1.4 following 
Figure 5.5- Expression of AMPs in Drosophila melanogaster S2r+ cells in response to cordycepin 
treatment. S2r+ cells (three biological replicates and three technical replicates) were treated with 20 
µg ml-1 LPS or curdlan and treated with either DMSO or 100 µM cordycepin then sampled 4 h after 
treatment. Expression was normalized against RP49 and the expression of untreated cells. Relative 
change of expression of A) diptericin (Dpt), B) drosomycin (Drm), C) attacin (Att) and D) 
metchnikowin (Metch) is shown. Error bars show ± SEM and asterisks indicate significant differences 
(p<0.05) that were determined using either a one-tail t test (diptericin, drosomycin, and metchnikowin) 
or one-tailed Mann-Whitney test (attacin). 
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curdlan treatment. Furthermore, RpL32 expression was significantly reduced by the 
addition of cordycepin in both the control (p=0.025) and curdlan-treated cells 
(p=0.025). Dif and relish expression fluctuated slightly between treatments but 
relative expression levels remained close to 1.0. The large standard error of some 
treatments may indicate that there was variation in sample quality or there is natural 
variation in the expression of these genes. The significance of the impact of cordycepin 
treatment was assessed using an independent one tailed t test where 2-DDCt values were 
normally distributed (relish, dif) or one tailed Mann-Whitney U test where 2-DDCt 
values were not normally distributed (RpL32).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6-Expression of Drosophila melanogaster immune-related genes in response to cordycepin 
treatment. S2r+ cells (3 biological replicates and 3 technical replicates) treated with 20 µg ml-1 LPS or 
curdlan together with either DMSO or 100 µM cordycepin and sampled 4 h after treatment. Expression was 
normalized against RP49 expression and the expression of untreated cells. Expression of A) RpL32, B) 
relish (Rel) and C) Dif is shown. Error bars show ± SEM and asterisks indicate significant differences 
(p<0.05) that were determined using either a one-tailed t test (relish and dif) or one-tailed Mann-Whitney 
test (RpL32). 
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5.4 Discussion  
 
The aim of the research presented in this chapter was to improve understanding of the 
natural function of cordycepin, in particular its impact on the insect immune system, 
building on the findings from Chapter 4. Initial experiments observed the impact of 
cordycepin on D. melanogaster S2r+ cell survival to assess whether it would be 
appropriate to treat cells with this metabolite in future experiments. At 48 h after 
treatment, cordycepin (50-1600 µM) caused mortality in D. melanogaster S2r+ cells 
compared to the control, the mortality increased linearly with log[concentration of 
cordycepin]. A similar experiment has been performed in a human multiple myeloma 
cell line (MM.1S) by Chen et al. (2008), who found that cordycepin (>10 µM) 
inhibited cell growth significantly after 24 h and induced apoptosis of these cells. This 
was thought to be due to cordycepin reducing the expression of MET, a survival factor 
in multiple myeloma cells (Chen et al., 2008). MET is a receptor associated with 
tumours and is thought to be a key determinant of malignancy (Shinomiya et al., 
2004). MET mRNA has a very short half-life (Moghul et al., 1994) i.e. it is rapidly 
turned over within cells. Rapidly expressed genes e.g. inflammatory genes, are targets 
of cordycepin (Kondrashov et al., 2012), which may be the reason for reduction in 
MET expression (Chen et al., 2008). By extension, inhibition of genes that produce 
mRNA with a short half-life may be the cause of D. melanogaster cell death observed 
in this chapter. It may take longer for death to occur in S2r+ cells than cancerous cells 
as they divide at a slower rate and so may have a slower mRNA turnover.  
 
Further studies have found that cordycepin induces apoptosis in cell lines by other 
mechanisms, such as increasing the expression of pro-apoptotic molecules, causing 
cell cycle arrest, activating caspases and generating ROS (He et al., 2010; Choi et al., 
2011; Jeong et al., 2011). In a human oral cancer cell line, concentrations of 
cordycepin greater than 10 µM cause cell cycle arrest at the G2/M transition (Wu et 
al., 2007). In breast cancer cells cordycepin stimulates the production of Bax, a 
proapoptotic molecule that results in cell death (Choi et al., 2011). In human 
leukaemia cells cordycepin treatment causes the production of ROS to activate 
caspases that drive apoptosis (Jeong et al., 2011). This illustrates that the mechanisms 
of cordycepin-induced apoptosis vary between cell types. The concentrations of 
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cordycepin used in this chapter may have inhibited the cell cycle by one of these 
mechanisms and induced apoptosis in D. melanogaster S2r+ cells. It would be 
possible to test this hypothesis using flow cytometry, which can quantify the number 
of cells in each phase of the cell cycle following cordycepin treatment (Wu et al., 
2007; Chen et al., 2008), and this technique has been previously used for cell cycle 
analysis in D. melanogaster tissue culture cells (Tapon et al., 2001). 
 
In this chapter the expression of immune-related genes was monitored in S2r+ cells to 
determine the impact of cordycepin on the insect immune response, whilst eliminating 
the effect of wounding observed in Chapter 4. The expression of attacin and 
metchnikowin appeared to increase following treatment with curdlan and LPS, 
whereas drosomycin and diptericin expression did not, although the significance of 
these changes was not assessed. The attacin and metchnikowin genes are expressed by 
D. melanogaster in response to fungi, with attacin having been found to be expressed 
in response to B. bassiana and metchnikowin in response to Micrococcus luteus and 
Neurospora crassa (De Gregorio et al., 2002; Lemaitre and Hoffmann, 2007). 
Additionally, attacin has been found to be expressed at high levels in response to 
gram-negative bacteria (Lemaitre and Hoffmann, 2007). Therefore, the increase in 
attacin and metchnikowin expression in response to curdlan treatment observed in this 
chapter was expected, as well as an increase in attacin expression following LPS 
stimulation. Other studies have found that drosomycin and diptericin genes show an 
increased expression in response to immune challenges of adult D. melanogaster with 
fungi (Aspergillus luteus) or bacteria (Micrococcus luteus or Erwinia carotovora) 
respectively (Pili-Floury et al., 2004), but they were not upregulated in the 
experiments in this chapter. This may be due to differences in the experimental 
conditions between the two pieces of work. In a study by Pal et al. (2007), adult D. 
melanogaster were treated by injection with E. coli cells, which caused increased 
drosomycin expression 8 h after treatment and increased attacin and metchnikowin 
expression 4 h after treatment. This is concurrent with the findings of this chapter. 
However, Pal et al. (2007) also saw increased diptericin expression after 4 h which 
was not seen in this chapter, but may have been a response to wounding in their work. 
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There were significant differences between the expression of attacin and 
metchnikowin with and without cordycepin treatment, although there were no 
differences identified between diptericin and drosomycin expression following 
cordycepin treatment. Expression of attacin and metchnikowin was increased by 
stimulation with curdlan and significantly reduced by co-application with cordycepin, 
which supports the findings from Chapter 4 that suggested cordycepin reduces 
expression of insect immune-related genes. Cordycepin had little effect on drosomycin 
and diptericin expression. This is likely because drosomycin and diptericin expression 
was not stimulated by either curdlan or LPS treatment in this experiment, therefore 
any impact of cordycepin was not noticeable. There were significant differences in the 
expression of the housekeeping gene RpL32 following the co-application of 
cordycepin in both the control and curdlan treatments. There also appeared to be an 
increase in RpL32 expression following treatment with curdlan alone. The increased 
expression of this gene in response to curdlan could be due to a general increase in the 
metabolic rate of insect cell cultures in response to infection (Palomares et al., 2004), 
although if this were the case an increase in LPS expression may have also been 
expected. Therefore, it could also be an anomalous result and further replicates would 
need to be performed to determine this. Additionally, the reduction in RpL32 
expression caused by cordycepin could be due to a reduction in overall transcription 
because of the impact of cordycepin on polyadenylation (Ioannidis et al., 1999; Chen 
et al., 2008; Kondrashov et al., 2012). However, cordycepin has been reported to not 
have a large effect on polyadenylation of housekeeping genes (Kondrashov et al., 
2012) and this project did not see an impact of cordycepin on the expression of another 
rRNA gene, Rp49. In addition to this, the relative difference between the expression 
of RpL32 with and without cordycepin was less than 1-fold, hence further replicates 
would need to be performed to validate these results.  
 
In human cells, the impact of cordycepin on inflammatory gene expression is thought 
to be due to its interaction with the NFkB pathway (Kim et al., 2006b; Lee et al., 2010; 
Choi et al., 2014), in particular it has been observed to inhibit NFkB activation, by 
preventing its transport to the nucleus (Lee et al., 2009; Jeong et al., 2010; Ren et al., 
2012). In this chapter the expression of relish and dif (NFkB homologs) was monitored 
to determine whether cordycepin inhibits the Toll/IMD pathways by reducing the 
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transcription of these genes. Their expression was found to vary slightly between 
treatments, but changes were neither significant nor did they follow the pattern of 
expression seen for the AMPs attacin and metchnikowin. This suggests that 
cordycepin does not inhibit the expression of these transcription factors, so it is 
possibly interacting with them directly or affecting the expression or activity of other 
proteins upstream in the Toll pathway to inhibit Relish/Dif activity post-translation.  
 
The mechanism by which cordycepin reduces expression of attacin and metchnikowin 
has not been determined in the present study, but there are a range of possibilities 
based on evidence from studies with mammalian cells. In particular, studies using 
mammalian cells have found that cordycepin prevents the translocation of NFkB to 
the nucleus through the interaction with IkB and IKK (Jeong et al., 2010; Ren et al., 
2012). In unstimulated cells NFkB remains in the cytoplasm in complex with the 
inhibitory protein IkB (Baeuerle and Henkel, 1994). Activation of the TLR pathway 
causes IkB to be degraded following phosphorylation, freeing NFkB to form dimers 
and enter the nucleus to drive gene expression (Gilmore, 2006). Cordycepin has been 
found to prevent phosphorylation of IkB in human cells, possibly by reducing the 
activity of kinases that phosphorylate this protein through direct interactions with IKK 
as oppose to inhibition of IkB/IKK transcription, although the nature of these 
interactions is not known (Ren et al., 2012). Cactus is an IkB homolog found in D. 
melanogaster that inhibits the transport of DIF into the nucleus (Karin, 1999). 
Cordycepin may prevent degradation of Cactus in a similar way to IkB, which would 
prevent DIF from dimerising and entering the nucleus, reducing the expression of 
AMPs. Unlike DIF, Relish contains its own IkB-like domain that holds it in the 
cytoplasm. This domain is cleaved following IMD activation (Stöven et al., 2000), 
which requires kinase activity (Stöven et al., 2003). Cordycepin may interact with the 
kinases that phosphorylate the IkB-like domain by a similar mechanism that it does in 
human cells (Ren et al., 2012). The prevention of transport of DIF and Relish to the 
nucleus would account for the reduction of attacin and metchnikowin expression 
following cordycepin treatment. Alternatively, cordycepin could affect transcription 
of AMPs directly by inhibiting polyadenylation of their mRNA, through its 
incorporation into the poly(A) tail, reducing the stability of these transcripts 
(Kondrashov et al., 2012). 
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In order to better understand the mechanism behind the effect of cordycepin, future 
experiments could monitor the activity of Relish and DIF in more detail. Western 
blotting has been used to monitor the localisation of NFkB transcription factors in 
human airway smooth muscle cells (Kondrashov et al., 2012) and this could be applied 
to D. melanogaster cells. Additionally, luciferase reporter assays could be performed 
to monitor NFkB activity following treatment with cordycepin (Ren et al., 2012), the 
impact of knockouts introduced using RNAi, or the impact of cordycepin in cells 
overexpressing key proteins such as IKK (Ren et al., 2012). Western blots can also 
monitor degradation of proteins, therefore this technique could be used to follow the 
degradation of IkB-like proteins in D. melanogaster cells, using a similar method to 
that employed by Ren et al., (2012) to monitor the degradation of IkB in human 
embryonic kidney cells.  
 
5.5 Conclusions  
 
Cordycepin (50-1600 µM) was lethal to D. melanogaster S2r+ cells after 48 h. In 
human cell lines this lethality is due to it arresting the cell cycle and inducing 
apoptosis, so a similar response may occur in S2r+ cells. Cordycepin also caused a 
reduction in expression of the AMPs attacin and metchnikowin, which supports the 
findings from Chapter 4. However, the expression of the housekeeping gene RpL32 
was also reduced, which may be an anomalous result or indicate that cordycepin has 
a general impact on transcription. The impact of cordycepin on AMP expression may 
be due to it preventing Relish and DIF from entering the nucleus as similar effects 
have been observed in human cells, however further work needs to be done to 
elucidate this mechanism. 
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Chapter 6- Investigating the potential of cordycepin 
as a biopesticide against Plutella xylostella  
 
6.1 Background 
 
6.1.1 Diamondback moth (Plutella xylostella)  
 
Diamondback moth (P. xylostella) is a major lepidopteran pest of Brassica worldwide, 
costing the world economy US$ 4-5 billion annually in control methods and crop 
losses (Zalucki et al., 2012). Its larvae (Figure 6.1) feed on the foliage of important 
food crops (Figure 6.2) including: canola, cauliflower, cabbage, mustard and turnip 
(Sarfraz et al., 2005).  
 
 
 
 
 
 
 
 
 
 
P. xylostella has a wide temperature range (10 ˚C-32.5 ˚C) (Golizadeh et al., 2007; 
Marchioro and Foerster, 2011) and is thought to be the most widely distributed 
Lepidoptera pest (Shelton, 2004). Multiple generations of P. xylostella can occur in a 
year depending on climatic conditions and between 4 and 20 generations per year have 
been reported (Harcout, 1986; Feng et al., 2011). The larvae have four instars and the 
mean time taken to develop from egg to adult at 20 ˚C is 21.34 days on cauliflower 
and 23.56 days on cabbage (Golizadeh et al., 2007). 
 
P. xylostella has developed resistance to all major classes of conventional chemical 
insecticides (Furlong et al., 2013), which is likely due to its short life cycle. In 2018 
Figure 6.1- Fourth instar Plutella xylostella larva. 
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the Arthropod Pesticide Resistance Database had documented reports of resistance to 
95 pesticides in P. xylostella populations in the field (APRD, 2018), including 
resistance to B. thuringiensis (Ferré et al., 1991). There is little plant genetic resistance 
to this pest, so new non-chemical control methods are urgently needed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.1.2 Biological control of P. xylostella 
 
Due to the prevalence of insecticide resistance in P. xylostella, IPM techniques have 
been widely investigated for its control and the use of parasitoids in particular has been 
explored. Globally there are over 135 insect species that parasitize P. xylostella 
(Sarfraz et al., 2005) and some have been used successfully to control it as part of IPM 
programmes (Vos, 1953; Goodwin, 1979). For example, three species of parasitoid 
wasp (Diadegma cerophaga, Thyraeela collaris and Diadegma rapi) were released in 
Australia and their effect on P. xylostella population monitored over two years. These 
parasitoids became established and gave an average of 49% parasitism over the course 
of the study (Goodwin, 1979). IPM is important to minimise the use of chemical 
pesticides when parasitoids are being considered to control pest populations, as many 
pesticides can cause parasitoid mortality (Haseeb et al., 2004) and reduce the rate of 
parasitism (Haseeb et al., 2000).  
Figure 6.2- Damage to Brassica oleracea var. botrytis caused by 
Plutella xylostella. Characteristic ‘window pane’ damage to 
Brassica oleracea var. botrytis from a culture containing multiple 
developmental stages of P. xylostella larvae.  
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Inhibition of moulting is an activity of some pesticides and has been suggested for use 
in IPM. For example the chemical azadiractin is an extract from the plant Neem 
(Azadirachta indica) that disrupts moulting and growth (Khater, 2012). Additionally, 
microbial biopesticides have been investigated for the control of P. xylostella. As 
mentioned in Section 1.3, B. thuringiensis spores and the purified Bt ¶-endotoxin are 
widely used biopesticides and have been used to control P. xylostella. However, 
resistance has emerged in field populations (Ferré et al., 1991) which makes this 
control method less reliable and highlights the need for novel control methods. EPF 
have also been explored to control P. xylostella, in particular Beauveria bassiana and 
Metarhizium anisopliae s.l. The virulence of these EPF against P. xylostella has been 
studied in both laboratory experiments (Vandenberg et al., 1998b; Yoon et al., 1999; 
Godonou et al., 2009; Wraight et al., 2010; Batta, 2013) and field trials (Vandenberg 
et al., 1998a; Shi and Feng, 2006; Godonou et al., 2009).  
 
In laboratory experiments, B. bassiana has been found to significantly increase the 
mortality of P. xylostella larvae, particularly when applied at high concentrations 
(Vandenberg et al., 1998b; Yoon et al., 1999). A large variation in strain virulence has 
also been observed (Wraight et al., 2010), which would impact strain selection for use 
in biopesticides. Results from field and glasshouse trials have suggested that B. 
bassiana may be useful to control P. xylostella commercially. Vandenberg et al. 
(1998a) carried out short-term field and glasshouse experiments by introducing 
laboratory-reared P. xylostella to broccoli or cabbage and treating crops with B. 
bassiana conidia, a significantly increased larval mortality was identified in both 
trials. Godonou et al. (2009) carried out field trials over two years to assess the 
efficacy of B. bassiana treatment on cabbage and found that it was more effective at 
controlling P. xylostella than the traditional insecticide bifenthrin. However, both 
Godonou et al. (2009) and Vandenberg et al. (1998a) concluded that the use of EPF 
for pest control needed more research and development. A problem with using EPF in 
the field is that in general there is a lag between treatment and population reduction 
(Johnson and Goettel, 1993; Jaros-Su et al., 1999; Benjamin et al., 2002; Peng et al., 
2008). EPF also cause a lower level of mortality than most traditional chemical 
insecticides and are more sensitive to environmental conditions (discussed in Section 
1.4.1), which reduces their efficacy. The use of other biopesticides or novel 
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compounds, such as cordycepin, in conjunction with EPF may increase the rate of 
insect mortality and efficacy to EPF, allowing them to be more widely used in IPM. 
This would be a novel approach for using EPF within insect control programs. 
  
6.1.3 The impact of cordycepin on P. xylostella  
 
There has been one published study into the impact of cordycepin on P. xylostella 
larvae (Kim et al., 2002). In this work 3rd instar larvae were fed on leaf disks dipped 
in cordycepin solutions ranging in concentration from 25-500 mg ml-1 and survival 
monitored. Up to 100% mortality was observed when larvae were fed 500 mg l-1 of 
cordycepin, with lower mortality at 400, 300, 200, 100, 50 and 25 mg l-1. It was 
observed that prior to death, larvae became dark brown and then body lysis occurred. 
It was also found that topical application of cordycepin did not cause mortality and 
therefore it was hypothesised that cordycepin was acting on the larval gut (Kim et al., 
2002). 
 
6.1.4 Aims and objectives 
 
The overall aim of this chapter was to identify the potential of cordycepin as a 
biopesticide against P. xylostella. This was done by achieving the following 
objectives: 
• Assess the impact of feeding cordycepin on P. xylostella survival. 
• Identify synergistic/antagonistic/additive effects of combined applications of 
cordycepin and B. bassiana when applied to P. xylostella larvae to determine 
whether they would be compatible in an IPM strategy against this pest. 
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6.2 Materials and Methods 
 
6.2.1 Plant material 
 
All plants were grown in 7x7x8 cm plant pots (Desch Plantpak, The Netherlands) in 
Levington F2 +S compost (Levington Horticulture Ltd., U.K) and maintained at 20 ˚C 
at 16:8 h light:dark cycle in a controlled environment room. 
 
6.2.2 Insect material  
 
P. xylostella used in this project were taken from a culture maintained at Warwick 
Crop Centre (The University of Warwick, Wellesbourne, U.K) originally collected in 
1995 at Wellesbourne, Warwickshire, U.K. Adult P. xylostella were kept in a 30 x 30 
x 30 cm BugDorm cage (Watkins and Doncaster Ltd, Herefordshire, U.K) with a 
single Brussels sprout cv. Doric plant (Brassica oleracea var. gemmifera) and allowed 
to oviposit. After 24-48 h these plants were removed and placed in a 47.5x 47.5 x 47.5 
cm BugDorm cage (Watkins and Doncaster Ltd, Herefordshire, U.K) with cauliflower 
cv. Skywalker plants (Brassica oleracea var. botrytis). After larvae had emerged, new 
plants (10-20 weeks old) were added and old plants removed as necessary. Adult P. 
xylostella were transferred between cages using a mechanical pooter (Watkins and 
Doncaster Ltd., Herefordshire, U.K). All cages were maintained at 18 ˚C with 16:8 h 
light:dark cycle in a controlled environment room.  
 
Second instar P. xylostella larvae were collected for use in experiments by production 
of a fixed age culture. One Brussels sprout plant was placed in a 30 x 30 x 30 cm 
BugDorm cage with adult P. xylostella to allow oviposition for 24 h. This plant was 
then refrigerated at 4 ˚C while the process was repeated with another plant. The 
following day, both plants were placed in a 47.5x 47.5 x 47.5 cm BugDorm cage with 
a cauliflower plant (<10 weeks old). Early second instar larvae (approximately six 
days after oviposition) were used for experiments and starved for 3 h prior to use.  
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6.2.3 Fungal material 
 
B. bassiana 433.99 (Table 2.1) was used for these experiments because it is 
commercially available as a biopesticide and it is effective in laboratory studies for 
the control of P. xylostella (Vandenberg et al., 1998b; Yoon et al., 1999). The 
maintenance, subculturing and preparation of conidial suspensions was carried out as 
in Section 2.2.3. Aliquots (10 ml) of conidia were prepared at a concentration of 1x107 
conidia ml-1 and this was diluted to the concentration desired in each experiment.   
 
6.2.4 Response of P. xylostella larvae to cordycepin treatment 
 
Two experiments were carried out to determine the impact of cordycepin on survival 
of P. xylostella larvae (Figure 6.3). In the first, cordycepin was applied as a one-off 
treatment and in the other it was administered continuously.  
 
 
 
 
 
 
 
 
 
 
 
 
6.2.4.1 Response of P. xylostella larvae to short-term cordycepin treatment 
 
Leaf discs were cut from cauliflower leaves using a size 16 cork borer (23.75 mm 
diameter). Dilutions of cordycepin at 6, 3, 1.5, 0.75 and 0.375 mg ml-1 were prepared 
by diluting a 100 mg ml-1 cordycepin stock solution (prepared in DMSO) in sterile 
0.01% Triton X-100 (Merck, Germany). These solutions contained either pentostatin 
at a final concentration of 1 µM or the same volume of DMSO. Then 100 µl aliquots 
Figure 6.3- Short term and long term cordycepin feeding experiments in Chapter 6. Time taken for each section 
of short-term exposure to cordycepin experiments (experiment 1; Section 6.2.4.1) and prolonged exposure to cordycepin 
experiments (experiment 2; Section 6.2.4.2).  
Experiment 1
Short-term 
cordycepin 
feeding
Experiment 2
Continuous 
cordycepin  
feeding 
Starvation
3 h 
Feed leaf discs treated 
with cordycepin
Feed leaf discs treated with 
cordycepin (and pentostatin)
Feed leaf discs treated with cordycepin (and pentostatin)
Feed untreated leaf discs
Feed untreated leaf discs
Day 1 Days 2-7
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of the solution were spread onto the underside of each leaf disc with an ‘L’ shaped 
spreader (Greiner bio-one, Austria). Two controls were incorporated that contained 
DMSO in 0.01% Triton X-100, or DMSO in 0.01% Triton X-100 with 1 µM 
pentostatin. The leaf discs were dried for at least 2 h in a laminar flow hood before use 
in experiments.  
A single leaf disc was placed in the centre of a 9 cm Petri dish (SARSTEDT, Germany) 
(Figure 6.4) containing 1.2% water agar (Agar Technical No. 3, Oxoid, USA). To 
allow air flow into the Petri dish and minimise condensation, the lid contained holes 
covered with perforated plastic (micro-perforated polypropylene bag, Cryovac ®). Up 
to 12 second instar P. xylostella larvae were placed on the leaf disc and the Petri dish 
was sealed with Parafilm ‘M’ ® (Bemis, USA). The dishes were maintained at 20 ˚C 
(16:8 h light:dark) in an environmental test chamber (Sanyo, Japan). Every 24 h for 
seven days surviving larvae were transferred to an untreated size 16 (23.75 mm 
diameter) leaf disc and the old leaf disc was photographed. The experiment was 
replicated on three separate occasions. The area of leaf disc eaten was determined 
using ImageJ (Schneider et al., 2012). Regression models (linear, second degree 
polynomial or third degree polynomial) were fitted to mortality on day seven in R 
(RStudio, 2017) and the fit of the models was compared using an ANOVA to 
determine whether they gave significant improvement over a linear regression model. 
Where no significant improvement was seen, a linear regression was used and models 
were visualised using the ggplot2 package in R (Wickham, 2016). This was also done 
to visualise the mean percentage of leaf disc eaten per individual larva throughout the 
experiment. 
 
The significance of the effect of co-administering pentostatin was determined using a 
chi-squared test. The expected mortality was calculated using the following equation: CD = CE + CF(1 − HI=JJ) , where MP is the percentage mortality caused by pentostatin 
alone and MC is the percentage mortality caused by cordycepin alone. Chi-squared 
values were calculated using the following equation: LM = (CN − CD)M/CD, where 
MO is the observed percentage mortality for combined treatments. These values were 
compared to the chi-squared value for 1 degree of freedom at 0.05 significance level 
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(3.841). Any chi-squared value greater than this indicated synergy (or antagonism) 
and anything lower suggested an additive effect.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.2.4.2 Response of P. xylostella to prolonged exposure to cordycepin 
 
Leaf discs were cut from cauliflower leaves using a size 16 cork borer (23.75 mm 
diameter). The following dilutions of cordycepin (Sigma-Aldrich, USA) were made 
from a 100 µM stock solution (in DMSO) using Triton X-100: 1.5, 0.75, 0.375, 0.185 
and 0.093 mg ml-1. These solutions also contained pentostatin at a final concentration 
of 1 µM. A control was included that contained DMSO in 0.01% Triton and 1 µM 
pentostatin. Aliquots (100 µl) were spread onto each leaf disc as described in Section 
6.2.4.  
A single leaf disc was placed in the centre of a 9 cm Petri dish (Figure 6.4) containing 
water agar (Agar Technical No. 3, Oxoid, USA), as described in Section 6.2.4.1. Up 
to 12 second instar P. xylostella larvae were placed on the leaf disc and the Petri dish 
was sealed with Parafilm ‘M’ ® (Bemis, USA). Dishes were maintained at 20 ˚C (16:8 
h light:dark) in an environmental test chamber (Sanyo, Japan). After 24 h, surviving 
Figure 6.4- Plutella xylostella larvae in a leaf disc feeding bioassay. Size 16 leaf disc 
(Brassica oleracea var. botrytis) in the centre of a 9 cm Petri dish containing water agar with 
P. xylostella larvae that had been sprayed with Beauveria bassiana 433.99 conidia (1x105 
conidia ml-1). Holes were made in the Petri dish lid and covered in perforated plastic (left) to 
prevent condensation.  
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larvae were counted and transferred to another freshly treated leaf disc and the old leaf 
disc was photographed. This was repeated every 24 h for seven days and the 
experiment was repeated on three occasions. The area of leaf disc eaten was 
determined using ImageJ (Schneider et al., 2012). Regression models (linear, second 
degree polynomial or third degree polynomial) were fitted to mortality at day seven in 
R (RStudio, 2017) and the fit of the models was compared using an ANOVA to 
determine whether they gave significant improvement over a linear regression model. 
Where no significant improvement was seen, a linear regression was used and models 
were visualised using the ggplot2 package in R (Wickham, 2016). This was also done 
to visualise the mean percentage of leaf disc eaten per individual larva throughout the 
experiment. 
 
6.2.5 Effect of combined applications of cordycepin and B. bassiana 433.99 on the 
mortality of P. xylostella  
 
Two experiments were carried out to quantify the effect of combined application of B. 
bassiana 433.99 conidia and cordycepin. In the first, cordycepin was given as one 
short-term dose for 24 h (1.5 mg ml-1) and in the other a low concentration (0.1 mg 
ml-1) was administered continuously. These concentrations were selected as 0.1 mg 
ml-1 was found to be sub-lethal and 1.5 mg ml-1 to cause a high level of mortality (but 
less than 80% mortality) and reduce feeding activity in previous experiments. 
Cordycepin was applied to cauliflower leaf discs as described in Section 6.2.4. In the 
first experiment larvae were fed 1.5 mg ml-1 cordycepin for 24 h following B. bassiana 
433.99 application, then fed untreated leaf discs for the remainder of the experiment. 
In the second experiment, larvae were fed leaf discs treated with 0.1 mg ml-1 of 
cordycepin following B. bassiana 433.99 application, which were replaced with fresh 
cordycepin-treated leaf discs daily.  
 
Conidial suspensions of B. bassiana 433.99 were prepared at the concentrations: 
1x107, 1x106, 1x105, 1x104 and 1x103 conidia ml-1 (Section 2.2.3) and 0.01% Triton 
X-100 was used as a control. Groups of ten larvae, which had been cooled on ice for 
five minutes, were placed onto filter paper (Whatman, GE healthcare, U.K) within a 
9 cm Petri dish lid. Larvae were treated with 4 ml of a conidial suspension using a 
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Potter tower air atomising sprayer (Potter, 1952) at 34.5 KPa. Larvae were allowed to 
recover at room temperature for 30 min and surviving larvae were transferred onto a 
cordycepin-treated leaf disc or a control leaf disc (treated with DMSO in 0.01% Triton 
X-100) in a 9 cm Petri dish containing 1.2% water agar (Agar Technical No. 3, Oxoid, 
USA) (similar to Figure 6.4). Dishes were maintained at 20 ˚C 16:8 h light:dark cycle 
in an environmental test chamber (Sanyo, Japan) and treated or untreated leaf discs 
were replaced daily. Survival was monitored daily for seven days, larvae that died 
immediately following topical application (due to handling) were not included in the 
overall mortality. This experiment was replicated on three occasions for each dose of 
cordycepin (0.1 mg ml-1 or 1.5 mg ml-1). 
 
The mortality of P. xylostella on days five, six and seven were used to perform a chi-
squared test to compare observed mortality and expected mortality at different 
concentrations of B. bassiana 433.99. This method has been used previously to 
identify synergy between EPF and other compounds (Koppenhöfer and Fuzy, 2003; 
Morales-Rodriguez and Peck, 2009). The expected mortality was calculated using the 
following equation: CD = CF + C)(1 − HP=JJ), where MC is the percentage mortality 
caused by cordycepin alone and MB is the percentage mortality caused by B. bassiana 
433.99 alone. Chi-squared values were calculated using the following equation: LM =(CN − CD)M/CD, where MO is the observed percentage mortality for combined 
treatments. These values were compared to the chi-squared value for 1 degree of 
freedom at 0.05 significance level (3.841). Any chi-squared value greater than this 
indicated synergy (or antagonism) and anything lower suggested an additive effect.  
 
6.2.6 Choice experiments to determine the antifeedant effect of cordycepin  
 
Choice experiments were carried out to identify whether cordycepin has an anti-
feedant effect. The doses chosen were 0.1 or 1.5 mg ml-1, because they were used in 
Section 6.2.5 and caused low mortality after 48 h of feeding. Cauliflower leaf discs 
(0.5 cm diameter) were treated with either 0, 0.1 or 1.5 mg ml-1 of cordycepin solution 
(with 1 µM pentostatin) as described in Section 6.2.4. Two treated leaf discs were 
placed on a 9 cm Petri dish containing water agar (Section 6.2.4.1) in the following 
combinations: 0 mg ml-1 /0 mg ml-1, 0 mg ml-1/0.1 mg ml-1, and 0 mg ml-1/1.5 mg ml-
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1 (Figure 6.5). A single second instar P. xylostella larva was placed equidistant 
between them and the Petri dish was sealed with Parafilm ‘M’ ® (Bemis, USA). On 
each occasion there were ten individuals per treatment combination and the 
experiment was replicated three times. Dishes were maintained at 20 ˚C and 16:8 h 
light:dark in an experimental test chamber (Sanyo, Japan).  
 
After 24 and 48 h leaf discs were photographed and ImageJ (Schneider et al., 2012) 
was used to calculate the area of leaf disc eaten. If a larva had died or had not 
consumed any leaf disc, it was excluded from analysis. The anti-feedant index (AI) 
was calculated using the following equation described by Ortego et al., (1995): 
AI=FQ+FR+ ?100. Where C is the area of the untreated leaf disc consumed and T is the 
area of the treated leaf disc consumed. The mean AI was determined for three 
replicates and analysed in SPSS Statistics (Version 24, IBM). Firstly, normality was 
assessed using a Shapiro-Wilk test, then a one-sample Wilcoxon signed rank test was 
performed, with a hypothesis that the median was equal to 0.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5- Plutella xylostella choice experiment after 24 h. A 
second instar P. xylostella larva given the choice between two 
leaf discs (0.5 mm diameter), both  treated with a control solution 
(DMSO, Triton X-100 and pentostatin).  
1 cm
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6.3 Results 
 
6.3.1 Response of P. xylostella larvae to cordycepin treatment 
 
6.3.1.1 Response of P. xylostella to short-term cordycepin treatment 
 
Cordycepin (without pentostatin) reduced the survival of P. xylostella larvae when it 
was administered by feeding for 24 h at the beginning of the experiment (Figure 6.6). 
Often, cadavers appeared to be dark grey or black (Figure 6.7) following cordycepin 
feeding, which may be a symptom of bacterial infection. At day seven after treatment 
there appeared to be a dose response, with 1.5-3 mg ml-1 causing the highest mortality 
in all three replicates and mortality decreasing at higher concentrations (Figure 6.6). 
At 1.5 mg ml-1 and 3 mg ml-1 of cordycepin the mean mortality was 51.2% and 62.3%, 
respectively on day seven and the mean mortality of control larvae was 6%. A second 
order polynomial regression was found to best fit the data (adjusted R-squared= 
0.5031) and the regression analysis showed that the correlation between concentration 
of cordycepin and mortality was significant (p=0.002; Appendix C.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6- Mortality of Plutella xylostella larvae following 24 h of cordycepin feeding. 
The percentage mortality on day seven of P. xylostella larvae (n=10 for each dose in each 
replicate) following 24 h of feeding with cordycepin at: 0, 0.375, 0.75, 1.5, 3 and 6 mg ml-1. A 
second order polynomial regression was fitted in R (R Studio 2017), which gave an adjusted 
R-squared value of 0.5031. Shaded area represents the standard error of the model. 
Concentration of cordycepin (mg ml-1)
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When larvae were treated with a mixture of cordycepin and pentostatin, there also 
appeared to be a dose response after seven days, however it was variable between 
replicates (Figure 6.8). Treatment with 1.5 mg ml-1 and 3 mg ml-1 of cordycepin 
appeared to cause the highest mortality on day seven (71.6 % and 71.5 % mean 
mortality, respectively) and the mean percentage mortality of the control was 21.9 %. 
The high mortality at 0.375 mg ml-1 may be an anomaly as it is higher than survival 
at 0.75 mg ml-1 and does not fit the dose response pattern. A second order polynomial 
regression was found to best fit the data (adjusted R-squared=0.2741) and the 
regression analysis showed that there was a significant correlation between 
concentration of cordycepin and mortality (p=0.03; Appendix C.1). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7-Plutella xylostella larvae cadavers following treatment with cordycepin. Examples 
of P. xylostella cadavers following feeding with 0.375 mg ml-1 cordycepin (left) or 3 mg ml-1 
cordycepin (right). Cadavers are circled in red. 
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A chi-squared test illustrated that co-application of pentostatin with cordycepin had 
either an additive or synergistic effect on day six after treatment, depending on the 
concentration of cordycepin (Table 6.1). Similar results were obtained on day five and 
day seven after treatment (Appendix C.1). However, these results may not be reliable 
due to the variation between replicates. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8- Mortality of Plutella xylostella larvae following 24 h of cordycepin (with 
pentostatin) feeding. The percentage mortality on day seven of P. xylostella larvae (n=10 
for each dose in each replicate) following 24 h of feeding with cordycepin (and 1 µM 
pentostatin) at: 0, 0.375, 0.75, 1.5, 3 and 6 mg ml-1. A second order polynomial regression 
was fitted in R (R Studio 2017) and gave the adjusted R-squared value of 0.2741. Shaded 
area represents the standard error of the model.  
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Table 6.1- Effect of co-application of a range of cordycepin concentrations and pentostatin on 
Plutella xylostella survival. Mortality of P. xylostella larvae on day six after treatment following 
feeding of cordycepin with or without pentostatin (1 µM) for 24 h. Interactions between treatments 
were identified as additive or synergistic using a chi-squared test, chi-squared values are also presented. 
Concentration 
of cordycepin 
(mg ml-1) 
Measurement 
Percentage 
Mortality 
(+-SEM) 
Chi-
squared Effect 
0.375 Observed 62.42 7.08 Synergistic 
Expected 44.64 
0.75 Observed 40.91 0.31 Additive 
Expected 44.64 
1.5 Observed 68.56 2.88 Additive 
Expected 55.88 
3 Observed 68.18 0.02 Additive 
Expected 69.20 
6 Observed 48.48 0.00 Additive 
Expected 48.77 
 
Feeding was monitored throughout the experiments, the anti-feedant effect could not 
be calculated as mortality occurred at all concentrations of cordycepin. Whether 
cordycepin was fed alone or with pentostatin it appeared to cause a reduction of 
feeding (Figures 6.9 and 6.10), the effect appeared greatest at 3 mg ml-1 and 6 mg ml-
1, although there was a large variation between replicates. This is illustrated by low 
adjusted R-squared values and high p-values obtained during regression analyses 
(Appendices C.2 and C.3). 
 
The mean percentage of leaf disc eaten per individual P. xylostella larva when fed 
only cordycepin is shown in Figure 6.9. Feeding activity was low on days one to four, 
which prevented regressions being fitted to the data, hence only days five to seven are 
presented. The mean percentage of control leaf disc eaten per individual on day seven 
when fed only cordycepin was 10.4%. This was reduced by the addition of cordycepin 
to 3.7% and 1.8% when treated with 3 mg ml-1 and 6 mg ml-1, respectively. Linear 
regression analysis best described the data on days five to seven (Figure 6.9; adjusted 
R-squared values in Appendix C.2), indicating that feeding reduced as the 
concentration of cordycepin increased. However, in all cases the regression analysis 
did not show that this relationship was significant (p>0.05; Appendix C.2), which 
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could be due to variance between replicates. Larvae in replicate one appeared to 
consume a greater area following cordycepin treatment than the other two replicates, 
possibly due to biological variation between individuals or differences in the amount 
of cordycepin ingested on day one. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When pentostatin was co-applied with cordycepin the mean percentage of leaf disc 
eaten per individual was 10.5% for controls on day seven. It was reduced to 2.4% and 
1.6% for by the addition of 3 mg ml-1 or 6 mg ml-1 of cordycepin, respectively. The 
best fitting regression models were linear for days five to seven (Figure 6.10; adjusted 
R-squared values in Appendix C.3), however regression analyses only identified a 
significant relationship between feeding and concentration of cordycepin on day seven 
after treatment (p=0.0303; Appendix C.3). The lack of significance may be due to 
variation between replicates. There was not an effect of pentostatin alone on the 
feeding activity of larvae, the mean percentage eaten per individual without 
pentostatin was 10.4% on day seven and with pentostatin was 10.5%.   
 
Concentration of cordycepin (mg ml-1) Concentration of cordycepin (mg ml-1)
Concentration of cordycepin (mg ml-1)
A B 
C Figure 6.9- Feeding activity of Plutella xylostella larvae 
following cordycepin feeding for 24 h. The mean 
percentage of leaf disc eaten by individual P. xylostella 
larva on days A) five, B) six and C) seven following 24 h of 
cordycepin feeding (0, 0.375, 0.75, 1.5, 3 and 6 mg ml-1). 
Untreated leaf discs were replaced following the initial 24 h 
of treatment. Linear regressions (R Studio 2017) were fitted 
to the data and the adjusted R-squared values are presented.  
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6.3.1.2 Response of P. xylostella to prolonged exposure to cordycepin 
 
P. xylostella larvae were continuously fed on leaf discs treated with a range of low 
concentrations of cordycepin. The percentage mortality increased linearly as the 
concentration of cordycepin increased (Figure 6.11; adjusted R-squared value in 
Appendix C.1) and regression analysis illustrated that this relationship was significant 
(p<0.001). On day seven the two concentrations of cordycepin that caused the highest 
mortality were 0.75 mg ml-1 and 1.5 mg ml-1, giving a mean mortality of 56.7% and 
70%, respectively, with control larvae having a mean mortality of 13.7%. 
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Figure 6.10- Feeding activity of Plutella xylostella 
larvae following feeding on cordycepin and pentostatin 
for 24 h. The mean percentage of leaf disc eaten by 
individual P. xylostella larva on days A) five, B) six and 
C) seven following 24 h of cordycepin feeding (0, 0.375, 
0.75, 1.5, 3 and 6 mg ml-1) with pentostatin (1 µM). 
Untreated leaf discs were replaced following the initial 24 
h of treatment. Linear regression models (R Studio 2017) 
were fitted to the data and the adjusted R-squared values 
are presented.  
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The percentage of leaf disc eaten per individual when cordycepin was fed continuously 
is shown in Figure 6.12. Cordycepin reduced feeding of P. xylostella larvae, 
particularly at 0.75 mg ml-1 and 1.5 mg ml-1 and regression analyses (adjusted R-
squared values in Appendix C.4) identified a significant relationship between the 
concentration of cordycepin and percentage of leaf disc eaten per individual larva 
(p<0.001 for days five and six, p=0.001 for day seven). On day seven the mean 
percentage of leaf disc eaten by control larvae was 7.1%, for larvae treated with 0.75 
mg ml-1 of cordycepin was 0.1% and for those treated with 1.5 mg ml-1 of cordycepin 
was 0.2%. 
 
 
 
 
 
Figure 6.11- Mortality of Plutella xylostella larvae continuously fed cordycepin. 
The percentage mortality on day seven of P. xylostella larvae (n=10 for each dose in 
each replicate) while being fed cordycepin (and 1 µM pentostatin) at: 0, 0.093, 
0.1875, 0.375, 0.75 and 1.5 mg ml-1. A linear regression model was fitted in gglot2 
(R Studio 2017) and the adjusted R-squared value is presented. Shaded area 
represents the standard error of the model.  
 
Concentration of cordycepin (mg ml-1)
R^2=0.5607
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6.3.2 Effect of combined applications of cordycepin and B. bassiana 433.99 on the 
mortality of P. xylostella 
 
P. xylostella larvae were fed cordycepin after being sprayed with B. bassiana 433.99 
conidia and insect survival was monitored over seven days (Figure 6.13). Initially 
larvae were fed 1.5 mg ml-1 of cordycepin for 24 h and then fed untreated leaf discs 
for the remainder of the experiment. This treatment was selected as in the previous 
experiments it had been shown to cause mortality and reduce feeding of P. xylostella 
larvae. When larvae were fed 1.5 mg ml-1 of cordycepin and treated with less than 
1x106 B. bassiana 433.99 conidia ml-1, the percentage mortality of larvae ranged from 
32.1% to 59.1% on day seven (1x103-1x106 conidia ml-1 , respectively; Table 6.2). 
These were not found to vary from expected values suggesting co-application of ≤ 
1x106 B. bassiana 433.99 conidia ml-1 and cordycepin had an additive effect. At a 
Concentration of cordycepin (mg ml-1) Concentration of cordycepin (mg ml-1)
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Figure 6.12- Feeding of Plutella xylostella larvae 
continuously fed cordycepin. The mean percentage of 
leaf disc eaten on days A) five, B) six and C) seven by P. 
xylostella larvae (n=10 for each concentration in each 
replicate) while being fed cordycepin (and 1 µM 
pentostatin) at: 0, 0.093, 0.1875, 0.375, 0.75 and 1.5 mg 
ml-1. Treated leaf discs were replaced daily throughout the 
experiment. Second order polynomial and linear 
regression models (R Studio 2017) were fitted to the data 
and the adjusted R-squared values are presented.  
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higher concentration of B. bassiana 433.99 (1x107 conidia ml-1) the observed 
mortality of larvae on day seven was 100%, this was higher than the expected 
mortality of 77% (Appendix C.5), which suggests that the interactions were 
synergistic (chi-squared=6.85). This is supported by the results on days five and six 
(Appendices C.6 and C.7), where additive effects were observed at 1x103-1x106 
conidia ml-1 of B. bassiana 433.99 and interactions were synergistic at 1x107 conidia 
ml-1 (chi-squared values of 24.79 and 11.19 for days five and six respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.13- Beauveria bassiana 433.99 growing from 
Plutella xylostella cadaver following infection by this 
EPF. 
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Table 6.2- Effects of co-application of a range of Beauveria bassiana 433.99 concentrations and 
short-term cordycepin treatment. Mortality of Plutella xylostella larvae on day seven after treatment 
following spraying with B. bassiana 433.99 conidia and feeding 1.5 mg ml-1 cordycepin (with 1 µM 
pentostatin) for 24 h. Chi-squared values are presented and the effects of treatments identified as 
additive or synergistic using a chi-squared test.  
Concentration of 
B. bassiana 
(conidia ml-1) 
Measurement 
Percentage 
mortality 
(±SEM) Chi-squared Effect 
1.00E+03 Observed 32.1 ± 17.5 1.17 Additive Expected 38.9 
1.00E+04 Observed 39.4 ± 10.6 0.30 Additive Expected 36.1 
1.00E+05 Observed 53.9 ±13.3 1.96 Additive Expected 44.6 
1.00E+06 Observed 59.1 ±21.5 0.04 Additive Expected 57.7 
1.00E+07 Observed 100 ±0 6.85 Synergistic Expected 77 
 
Following the short-term treatment of P. xylostella larvae with cordycepin and B. 
bassiana 433.99, cordycepin (0.1 mg ml-1) was fed continuously to P. xylostella larvae 
following topical application of B. bassiana 433.99 conidia. This concentration of 
cordycepin was selected as it was found to be sub lethal. On day seven the percentage 
mortality ranged from 25.2% to 70% (1x105 conidia ml-1 and 1x107 conidia ml-1, 
respectively; Table 6.3; Appendix C.8). The effect of co-application was additive at 
1x103, 1x106 and 1x107 conidia ml-1, but antagonistic at 1x104 and 1x105 conidia ml-1 
(chi-squared values of 4.79 and 12.06 respectively). The effect varied between days 
five and six (Appendices C.9 and C.10), with synergistic, additive and antagonistic 
effects being identified.  
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Table 6.3- Effects of co-application of a range of Beauveria bassiana concentrations and 
prolonged cordycepin treatment. Mortality of Plutella xylostella larvae on day seven after treatment 
following spraying with B. bassiana 433.99 conidia and feeding 0.1 mg ml-1 cordycepin (with 1 µM 
pentostatin) throughout the experiment. Chi-squared values are presented and the effects of treatments 
identified as additive or synergistic using a chi-squared test.  
Concentration of 
B. bassiana 
(conidia ml-1) 
Measurement 
Percentage 
mortality  
(±SEM) Chi-squared Effect 
1.00E+03 Observed 31.7 ±10.8 0.11 Additive Expected 33.6 
1.00E+04 Observed 27.8 ±7.9 4.79 Antagonistic Expected 42 
1.00E+05 Observed 25.2 ±5.1 12.06 Antagonistic Expected 49.7 
1.00E+06 Observed 44 ± 15.6 0.21 Additive Expected 41 
1.00E+07 Observed 70 ± 21.9 0.51 Additive Expected 64.3 
 
6.3.3 P. xylostella choice experiment 
 
In order to determine the mechanism behind cordycepin causing mortality in P. 
xylostella, a choice experiment was carried out (Figure 6.14). The mean (± SEM) area 
of leaf disc eaten on day one for control treatments was 1.67 (±0.51): 2.26 (±0.44) 
mm2 (0 mg ml-1: 0 mg ml-1cordycepin), for treatment with the lowest concentration of 
cordycepin was 2.27 (±0.44) : 1.36 (±0.38) mm2 (0 mg ml-1: 0.1 mg ml-1 cordycepin) 
and for treatment with the highest concentration of cordycepin was 1.00 (±0.42) : 2.30 
(±0.40) mm2 (0 mg ml-1: 1.5 mg ml-1 cordycepin). On day two the mean area of leaf 
disc eaten for control treatments was 2.57 (±0.73) : 4.08 (±0.85) mm2 (0 mg ml-1: 0 
mg ml-1 cordycepin), for treatment with the lowest concentration of cordycepin was 
3.55 (±0.89) : 4.08 (±0.81) mm2 (0 mg ml-1: 0.1 mg ml-1 cordycepin) and for treatment 
with the highest concentration of cordycepin was 1.98 (±0.72) : 4.81 (±0.69) mm2 (0 
mg ml-1: 1.5 mg ml-1 cordycepin). This suggests that cordycepin (1.5 mg ml-1) 
promotes feeding by P. xylostella larvae, although there was a large variation in the 
total area consumed by each larva.   
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The anti-feedant index, AI=FQ+FR+ ?100, was calculated to determine the significance of 
variation in feeding caused by cordycepin treatment (Table 6.4). No significant effect 
on feeding was seen with leaves treated with 0.1 mg ml-1 of cordycepin, but treatment 
with 1.5 mg ml-1 significantly promoted feeding after 24 h (p=0.034) and 48 h 
(p=0.005) of feeding. 
 
Figure 6.14- The area of leaf discs consumed by Plutella xylostella during choice 
experiments. The mean area of leaf disc consumed after (A) 24 h and (B) 48 h by P. 
xylostella larvae during choice experiments, where larvae were given a choice between: 
two untreated leaf discs (0v0), an untreated leaf disc (dark grey) v a leaf disc treated with 
0.1 mg ml-1 of cordycepin (light grey; 0v0.1) and an untreated leaf disc (dark grey) v a leaf 
disc treated with 1.5 mg ml-1 of cordycepin (light grey; 0v1.5). Asterisks indicate 
significant differences (p<0.05) identified using the anti-feedant index analysis displayed 
in Table 6.4. 
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Table 6.4- Choice experiment to determine anti-feedant effect of cordycepin on Plutella xylostella. 
Mean antifeedant index ± SEM of second instar larvae fed with leaf discs treated with combinations of 
0.1 mg ml-1, 1.5 mg ml -1 or 0 mg ml-1 of cordycepin. Asterisks show significant differences from a 
median of 0, determined by a Wilcoxon signed-rank test. 
 
 
 
 
 
 
 
 
 
 
 
 
Cordycepin (mg ml-1) Time (h) Anti-feedant index (%) (±SEM) 
0 24 -21 ± 19 
0.1 24 -23± 19 
1.5 24 -42 ± 19 * 
0 48 -19 ± 20 
0.1 48 -18 ± 19 
1.5 48 -55 ± 15 * 
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6.4 Discussion 
 
The aim of this chapter was to identify the potential of cordycepin as a novel 
biopesticide by assessing its effect on P. xylostella survival and feeding. Cordycepin 
caused mortality of second instar P. xylostella larvae when administered for a short 
period (24 h of feeding) or when administered continuously (every day for seven 
days). This is consistent with the findings of Kim et al. (2002) who established that 
cordycepin caused significant mortality of third instar P. xylostella larvae when it was 
fed continuously. They suggested that cordycepin was gut-acting and this hypothesis 
is supported by the findings in this chapter. Mortality was induced by 24 h of feeding 
on cordycepin (>0.75 mg ml-1), which suggests that cordycepin is toxic and mortality 
is not due to an anti-feedant effect.  
 
Intermediate concentrations of cordycepin (1.5-3 mg ml-1) caused the highest 
mortality, within the range of concentrations tested, when administered as a one-off 
treatment (i.e. a single application by feeding cordycepin-treated leaf discs for 24 h). 
Feeding larvae on leaf discs coated in 1.5 mg ml-1 and 3 mg ml-1 of cordycepin caused 
the highest mortality, with 6 mg ml-1 causing a lower mortality. The curves that best 
fit this response were second order polynomial curves, which suggests the dose 
response to cordycepin is not a classic sigmoidal curve commonly seen in response to 
pesticides (Nauen et al., 2003) or EPF (Yoon et al., 1999; Ansari et al., 2004). In a 
sigmoidal dose response, mortality increases as dose increases until maximum 
mortality occurs (Figure 6.15). In contrast, cordycepin appeared to give a bell-shaped 
dose response curve in which mortality increased with the concentration of cordycepin 
initially, then decreased at higher concentrations (Figure 6.15). This might be due to 
high concentrations of cordycepin having an antifeedant effect, which would result in 
larvae fed an intermediate concentration receiving a higher overall dose as they ate 
more. However, in choice experiments 1.5 mg ml-1 cordycepin appeared to 
significantly promote feeding of larvae. This was unexpected, as when the amount of 
leaf disc consumed was monitored over seven days (Section 6.3.1), there was a 
negative relationship between increasing concentrations of cordycepin and amount of 
leaf disc consumed. This suggests that at 1.5 mg ml-1 cordycepin initially promotes 
feeding, but the toxicity of the compound then reduces feeding over time. Future 
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experiments could build on this research and use higher concentrations of cordycepin 
in feeding choice experiments. Other studies have also found that the deterrent 
properties of compounds depend on dose (Fischer et al., 1990; Isman et al., 1990). For 
example, neem oil was found to deter feeding by Peridroma saucia (cutworm) larvae 
in a choice bioassay (Isman et al., 1990). Like the choice bioassays developed during 
this project, neem oil was applied to leaf discs and larvae were given a choice between 
treated or untreated leaf discs. In this case, the larvae were found to prefer untreated 
leaf discs, but the response varied depending on the concentration of the active 
chemical (azadirachtin) in the neem oil. Furthermore, if larvae only had access to 
treated diet, they consumed less and their weight reduced (Isman et al., 1990). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When administered continuously (i.e. insects were fed with a new cordycepin-treated 
leaf disc everyday), cordycepin appeared to cause a similar level of mortality to when 
it was administered as a one-off treatment. However, responses were less variable 
between replicates when cordycepin was administered continuously and there was a 
linear dose response relationship between concentration of cordycepin applied and 
mortality. This linear relationship is likely due to lower cordycepin concentrations 
being used for this experiment than when cordycepin was only fed to larvae for 24 h. 
In particular, a comparison can be made between treatment with 0.375, 0.75 and 1.5 
mg ml-1 of cordycepin as these doses were applied in both experiments. The mean 
mortality of larvae treated with cordycepin and pentostatin for 24 h on day seven was 
Figure 6.15 - Typical dose response curves. A 
classic sigmoidal dose response curve (green) and a 
bell-shaped dose response curve (red). 
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68.8%, 43.9% and 71.6% for 0.375, 0.75 and 1.5 mg ml-1 cordycepin, respectively. 
The mean mortality of larvae treated continuously with cordycepin on day seven was 
20.8%, 55.0% and 72.5% for 0.375, 0.75 and 1.5 mg ml-1, respectively. The survival 
of larvae treated with 0.75 and 1.5 mg ml-1 of cordycepin was similar between 
experiments, however survival after treatment with 0.375 mg ml-1 was different 
between the two experiments (Figures 6.6 and 6.8). Therefore, mortality following 
short-term cordycepin (plus pentostatin) treatment at 0.375 mg ml-1 may be 
anomalous. This could be due to a degradation of cordycepin on the leaf disc (Johns 
and Adamson, 1976) or differences between batches of P. xylostella larvae. In Chapter 
2 it was postulated that cordycepin promotes colonisation of larvae by opportunistic 
gut bacteria and P. xylostella cadavers exhibited a similar morphology to the G. 
mellonella cadavers observed in Chapter 2. Different batches of P. xylostella could 
have different bacterial loads or contain species of bacteria that are more/less 
pathogenic. Microbial diversity in the midgut of P. xylostella has been characterised 
by sequencing (Xia et al., 2013). Differences were seen between the number of 
operational taxonomic units (OTUs; closely related bacteria) identified from different 
P. xylostella strains, but samples were pooled so differences between individuals were 
not determined. Another reason for the differences between replicates may be that 
larvae in one replicate consumed less cordycepin during the 24 h of exposure by 
chance, so were less affected by toxicity. 
 
Not only did cordycepin appear to cause mortality of P. xylostella larvae, it also 
reduced their feeding activity. When fed cordycepin for 24 h and then fed untreated 
leaf discs for the remainder of the experiment, increasing the concentration of 
cordycepin appeared to reduce feeding activity of P. xylostella larvae. However, this 
relationship was not significant, which was likely to due to the variation between 
replicates. Similarly, when larvae were fed cordycepin daily, feeding activity 
decreased as the concentration of cordycepin increased, but in this case the 
relationship was statistically significant. However, as this project found that 
cordycepin initially promotes feeding, a hypothesis can be developed that cordycepin 
is toxic to larvae and may act on the gut over time to reduce appetite. 
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It was determined that the effect of applying B. bassiana 433.99 and cordycepin varied 
depending on the concentrations applied. At a higher concentration of cordycepin and 
B. bassiana 433.99 the interaction was synergistic, whereas low concentrations of B. 
bassiana 433.99 had an additive effect with a high concentration of cordycepin. At the 
lower concentration of cordycepin, B. bassiana 433.99 had either an additive or 
antagonistic effect, therefore cordycepin may need to reach a critical dose within the 
larva to have an effect on the immune system and facilitate infection by this EPF. Or 
this effect could be because a low concentration cordycepin may be turned over more 
rapidly in the larva or on the leaf surface by adenosine deaminase (Johns and 
Adamson, 1976). Importantly, the effect of co-application of 1x107 conidia ml-1 of B. 
bassiana 433.99 with both concentrations of cordycepin was either additive or 
synergistic. This is similar to the recommended field concentration of B. bassiana, 
which is 2.75x107 conidia ml-1 for Botanigard WP (product label, Certis, U.K). 
Therefore, B. bassiana and cordycepin may be compatible for use in the field, although 
glasshouse and field trials would need to be performed in the future to determine this.  
 
Interactions between B. bassiana and insecticides have been previously documented 
(Appendix B.1). Additive effects have been identified between this EPF and the 
insecticides: abamectin, triflumuron, thuringiensin and carbaryl, when assessed in 
laboratory and field cage studies against Colorado Potato Beetle (Anderson et al., 
1989). Synergistic, additive and antagonistic effects have been identified between B. 
bassiana and Cry toxins or B. thuringiensis (Wraight and Ramos, 2005; Ma et al., 
2008). Synergy has also been observed between B. bassiana and the insecticides 
deltamethrin (Bahiense and Bittencourt, 2004), imidacloprid (Furlong and Groden, 
2001; Purwar and Sachan, 2006), oxydemeton methyl (Purwar and Sachan, 2006) and 
neem (Mohan et al., 2007). However, identification of synergy varies between 
experimental conditions (Furlong and Groden, 2001). In fact, antagonistic effects have 
been observed between B. bassiana and imidacloprid in silverleaf whitefly (Bemisia 
argentifolii) (James and Elzen, 2001), whilst they have synergistic interactions in 
Colorado Potato beetle (Furlong and Groden, 2001). This illustrates that there can be 
considerable variation in the interactions of B. bassiana with chemicals and this can 
vary between experimental conditions, as such it is important to understand the 
mechanism behind any interactions. 
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The reason for synergistic interactions between cordycepin and B. bassiana 433.99 at 
higher doses may be that this chemical interacts with P. xylostella in a way that 
facilitates infection or colonization by B. bassiana. Cordycepin inhibits transcription 
of certain genes, including those that are involved in the immune and inflammatory 
responses (Kondrashov et al., 2012), so it may inhibit the immune response in insects 
(Chapters 4 and 5), facilitating growth of B. bassiana. Additionally, P. xylostella 
larvae treated with cordycepin showed reduced food consumption over time (although 
it did not act as an antifeedant at the concentrations tested) which could stress the P. 
xylostella larvae, potentially increasing their susceptibility to infection. Starvation of 
the Colorado Potato beetle has been found to increase susceptibility to B. bassiana 
infection (Furlong and Groden, 2003). Likewise, starvation of the green lacewing 
(Chrysoperla carnea) significantly increases mortality caused by B. bassiana 
infection (Donegan and Lighthart, 1989). This is postulated to be due to starvation 
increasing the moulting period, which would give B. bassiana longer to penetrate the 
insect cuticle. It may also be due to starved insects having lower energy reserves, 
which might impede the immune response (Furlong and Groden, 2003). 
Immunosuppression following mechanical stress has been observed in crickets 
(Gryllus texensis) (Adamo and Parsons, 2006), suggesting that stress itself can 
increase susceptibility to infection and this may be the mechanism by which higher 
concentrations of cordycepin interact synergistically with high concentrations of B. 
bassiana 433.99 conidia to increase mortality.  
 
Future work would be needed to determine the mechanisms by which cordycepin 
interacts with P. xylostella to cause mortality, including whether it causes mortality 
through interactions with the larval gut or whether it is transported out of the gut to 
affect other tissues. Furthermore, glasshouse and field trials would need to be 
performed to determine its potential, either alone or with EPF, for IPM on a large 
scale. A particular area for development would be the formulation of cordycepin for 
application onto leaves. It is degraded by adenosine deaminase (Johns and Adamson, 
1976), which is produced by plants, mammals, microorganisms and invertebrates, 
hence any formulation would need to reduce the activity of this enzyme (Cristalli et 
al., 2001). Additionally, cordycepin is likely to be sensitive to UV light as nucleoside-
5’-monophosphates have a similar structure and breakdown when exposed to UV light 
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(Cavaluzzi and Borer, 2004). However, neem oil, a non-traditional insecticide, is 
sensitive to degradation by UV light, but different formulations can significantly 
increase its stability (da Costa et al., 2014). This suggests that similar techniques could 
be developed to increase the stability of cordycepin.     
 
6.4.1 Conclusions  
 
This chapter aimed to identify the potential of cordycepin as a biopesticide either alone 
or in conjunction with EPF. It was found that cordycepin is toxic to P. xylostella 
larvae, both administered over a long period of time or as a short-term treatment. High 
concentrations of cordycepin and B. bassiana 433.99 have either an additive and 
synergistic effect when applied together to cause mortality in P. xylostella, which 
suggests that they have potential to be used together in an IPM strategy to improve 
control by EPF alone. These effects may be due to cordycepin interacting with the P. 
xylostella immune system. However, lower concentrations of cordycepin and B. 
bassiana had either antagonistic or additive effects, which suggests that more research 
needs to be performed into the potential of cordycepin as a biopesticide. 
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Chapter 7- General discussion 
 
7.1 Conclusions  
 
This project has begun to elucidate the natural function of cordycepin and characterise 
its potential as a biopesticide. It has developed a platform to further investigate 
cordycepin and other secondary metabolites of entomopathogenic fungi by 
establishing experimental procedures to characterise their interactions with insects. 
There is currently a lack of understanding about the natural function of EPF secondary 
metabolites, particularly those involved in the infection process as they may be 
produced transiently or in low quantities (Soukup et al., 2016). Improving 
understanding of secondary metabolites will increase understanding of EPF biology 
and inform potential medicinal or agricultural uses for these metabolites in the future. 
In particular it is becoming increasingly important to develop new techniques for pest 
control, as it is predicted that losses of crop yields due to insects will increase 
dramatically as a result of global warming (Deutsch et al., 2018). 
 
The main findings of this project were: 
• Cordycepin has insecticidal activity: 
– Concentrations of cordycepin greater than 6 mg ml-1 (120 µg per larva) 
caused death in G. mellonella larvae when administered by injection, 
possibly by increasing susceptibility to bacterial infection.  
– Concentrations of cordycepin greater than 50 µM (approximately 12.6 
µg ml-1) caused death of D. melanogaster S2r+ cells after 48 h. 
– Concentrations of cordycepin greater than approximately 0.75 mg     
ml-1 applied onto leaves caused mortality in P. xylostella larvae when 
administered by feeding. 
• Cordycepin reduces the expression of the immune-related genes gallerimycin, 
galiomicin, IMPI and lysozyme in G. mellonella and metchnikowin and attacin 
in D. melanogaster S2r+ cells. It is hypothesised that this is its natural function 
during C. militaris infection.  
• High concentrations of cordycepin can interact synergistically with when co-
applied, suggesting that they have potential to be used together as biopesticides 
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in a novel strategy. However, this response was dose-dependent and further 
research is required. 
– Cordycepin (3 mg ml-1; 90µg per larva) potentiated the effect of B. 
bassiana 433.99, C. militaris 11703 and M. brunneum 275.86 when 
applied against G. mellonella larvae. 
– Synergism was identified between B. bassiana 433.99 and cordycepin 
when applied together against P. xylostella, although the precise nature 
of the effect of co-application was dependant on the concentration of 
cordycepin and the duration of cordycepin exposure. 
 
This project has developed procedures to begin to elucidate the natural function of 
cordycepin, which could be applied to other EPF secondary metabolites. There have 
been few previous studies into the impact of cordycepin on insects (Kim et al., 2002), 
with most research focusing on its medicinal potential (Nakamura et al., 2005; 
Nakamura et al., 2006; Jeong et al., 2011; Lu et al., 2014) rather than natural function. 
The G. mellonella bioassays in this project built on those described by Harding et al. 
(2013) and were adapted for use with EPF, allowing both larval mortality and gene 
expression to be monitored following topical application or injection of an 
EPF/secondary metabolite. There are many benefits to using G. mellonella as a system 
to study the impact of chemicals on insects and the insect immune system. Their large 
size allows injection of known doses of a test agent (Ramarao et al., 2012), although 
in this project the wounding response resulting from injection was found to complicate 
analysis of immune-related gene expression. G. mellonella are also small enough that 
it is possible to homogenise a whole larva to monitor gene expression in all tissues 
(Altincicek and Vilcinskas, 2006). Additionally, they are highly susceptible to 
infection by EPF, which can be therefore be applied topically, eliminating the issues 
arising from the wounding response following injection (Chandler et al., 1997; Wojda 
et al., 2009). Another key experimental procedure developed in this project was the 
use of a D. melanogaster S2r+ cell system to elucidate the function of secondary 
metabolites. This provides a high-throughput means of assessing the toxicity of 
metabolites and allow identification of their activity at a cellular level. 
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The natural function of cordycepin was initially investigated through the treatment of 
G. mellonella larvae, P. xylostella larvae and D. melanogaster S2r+ cells with this 
metabolite. Injection of G. mellonella larvae with concentrations of cordycepin greater 
than 6 mg ml-1 (90 µg per larva) caused indirect mortality which is postulated to be 
caused by opportunistic bacterial infection. The types of bacteria isolated from G. 
mellonella cadavers following cordycepin treatment were consistent with those 
isolated from the guts (from the crop to the hindgut) of insects by Yun et al. (2014). 
This suggests that cordycepin is able to prevent the normal functioning of the insect 
gut as a barrier to infection by bacteria that reside within the gut lumen. Mortality was 
also observed in P. xylostella larvae fed cordycepin, cadavers appeared dark black or 
brown which is consistent with the symptoms of bacterial infection, although this was 
not confirmed by culturing bacteria from the haemolymph or using molecular 
identification. This further supports the hypothesis that cordycepin has indirect 
toxicity by inhibiting the insect immune response, allowing infection by opportunistic 
microorganisms. However, in a sterile system, cordycepin also caused D. 
melanogaster S2r+ cell death, which suggests that it can be directly toxic depending 
on the concentration of cordycepin applied. Overall these results indicate that 
cordycepin may act as a virulence factor, that impairs the insect immune system to 
increase susceptibility to infection. However, it could also function to deter feeding 
on the fruiting body by animals or other insects due to its direct toxicity, so could have 
multiple effects.  
 
In this project it was hypothesised that cordycepin affects the expression of immune-
related genes in insects to facilitate infection by C. militaris, because it has been found 
to reduce inflammatory gene expression in mammals (Kondrashov et al., 2012). In 
order to investigate the interactions of cordycepin with the insect immune system, the 
expression of immune-related genes was monitored using RT-qPCR in G. mellonella 
larvae and D. melanogaster S2r+ cells. Both experiments found that expression of 
immune-related effector genes was reduced by treatment with sub-lethal doses of 
cordycepin. These genes are likely to be controlled by different immune pathways, for 
example gallerimycin and galiomicin are controlled by the Toll pathway (Schuhmann 
et al., 2003; Lee et al., 2004), whereas lysozyme production is likely to be controlled 
by additional pathways since it has been reported to be constitutively expressed in 
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Lepidoptera (Kong et al., 2016) and IMPI expression is likely to be regulated 
separately as its expression increases following detection of metalloproteases directly 
(Altincicek and Vilcinskas, 2006). Therefore, this implies that cordycepin impacts 
multiple immune pathways and naturally it may act as a virulence factor to facilitate 
infection of insects by C. militaris. To investigate how cordycepin interacts with the 
insect immune system in more detail, the expression of immune pathway-activating 
transcription factors DIF and Relish was monitored in D. melanogaster S2r+ cells 
using RT-qPCR. Their expression was not affected by cordycepin, which is consistent 
with its activity in mammalian cells. In human cells, cordycepin prevents the 
phosphorylation of IkB, halting activation of NFUB so it can no longer enter the 
nucleus and drive transcription of inflammatory genes (Ren et al., 2012). However, it 
is not known to alter the expression of NFUB itself. Therefore, cordycepin may impact 
Relish and DIF via a post-translational mechanism in insect cells, through a similar 
mechanism to that in human cells, but further research needs to be done to determine 
this (Section 7.1.2). Furthermore, cordycepin may directly impact mRNA stability 
through incorporation into the poly(A) tail during transcription (Kondrashov et al., 
2012), therefore it could impact mRNA transcription directly or act through multiple 
mechanisms. 
 
This project attempted to quantify B. bassiana 433.99 and C. militaris 11703 growth 
during infection of G. mellonella larvae in order to relate the progression of infection 
to the production of AMPs by the host. Although this was only successful for C. 
militaris 11703, the progression of infection appeared to follow a similar pattern to 
that for B. bassiana observed in another study (Bell et al., 2009). There was a slow 
increase in the number of C. militaris genomes early in infection, which then increased 
rapidly shortly prior to host death (Figure 7.1). Furthermore, expression of the 
immune-related genes gallerimycin, IMPI and lysozyme were seen to increase 
significantly in G. mellonella larvae at 48 or 72 h following injection with C. militaris 
11703 conidia (Chapter 4). Taken together with the findings of Chapter 3, there 
appears to be a lag time for the expression of immune-related genes following EPF 
infection. Based on these observations, hypotheses can be developed regarding the 
importance of cordycepin and other secondary metabolites during EPF infection 
(Figure 7.1). Firstly, if the natural function of cordycepin is to reduce the immune-
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related gene expression of the host, it may be produced at high concentrations 
following the initial stages in infection. It could then reduce expression of immune-
related effector genes and once the levels of immune effectors become low enough, 
rapid C. militaris growth can occur. However, it may take time for concentrations of 
cordycepin to accumulate to levels that are able to reduce immune-related gene 
expression, since C. militaris biomass is initially low and adenosine deaminase may 
break down cordycepin in the haemolymph. Alternatively, cordycepin may not play a 
large role in the reduction of immune-related gene expression and C. militaris may 
overcome these effectors by another mechanism. For example, M. anisopliae produces 
metalloproteases that are thought to degrade AMPs (Qazi and Khachatourians, 2007; 
Mukherjee and Vilcinskas, 2018), C. militaris may similarly degrade AMPs or other 
immune-related effector proteins. Insect cellular immunity also has a key role in 
preventing infection and limiting the growth of pathogens (Figure 7.1; Lavine and 
Strand 2002), additionally it is necessary for coordinating the humoral response to 
infection (Basset et al., 2000; Shia et al., 2009). EPF including B. bassiana and M. 
anisopliae s.l. have been found to inhibit the insect cellular immune response 
(Vlicinskas et al., 1997b,c) and C. militaris may have a similar activity during 
infection. This illustrates that C. militaris is likely to interact with the insect immune 
response through multiple mechanisms and further research is needed to determine the 
function of cordycepin in these interactions.  
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Figure 7.1 - Diagram illustrating the progression of EPF infection and the expression of immune-
related genes. The increase of EPF biomass (blue) compared to the expression of immune-related genes 
by the host insect (red). If the EPF reduces the expression of immune related effector genes e.g. through 
the production of cordycepin, immune-related gene expression will decrease (short dashes), if not it 
will remain at a high level (long dash). 
 
Not only is cordycepin insecticidal, but at 6 mg ml-1 it reduces germination of the EPF 
B. bassiana 433.99 and M. brunneum 275.86. This is consistent with work by Sugar 
and McCaffrey, (1998), who found that cordycepin had anti-fungal activity against 
Candida spp. It has also been found to have anti-bacterial properties (Rottman and 
Guarino, 1964), particularly against B. subtilis. The anti-microbial activity of 
cordycepin might prevent C. militaris being out-competed within an insect, or prevent 
infection of its fruiting body and mycelia in the environment. However, since high 
concentrations of cordycepin were required to inhibit growth of other EPF, this could 
indicate that this is not its primary function.  
 
Treatment with cordycepin appeared to facilitate infection of G. mellonella larvae 
(Chapter 4) and P. xylostella larvae (Chapter 6) by EPF. This supports the hypothesis 
that cordycepin interacts with the insect immune system, increasing susceptibility to 
infection. Interactions between EPF and cordycepin varied between EPF species. In 
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particular, interactions between cordycepin and B. bassiana 433.99 were investigated 
against P. xylostella as this EPF isolate is a commercially available biopesticide in the 
U.K (Botanigard, Certis, U.K). These experiments showed that synergistic 
interactions between cordycepin and B. bassiana 433.99 were dose-dependent. EPF 
are currently used as commercial biopesticides, but their lag time and lower lethality 
relative to synthetic pesticides has limited their uptake for use in pest control (Johnson 
and Goettel, 1993; Jaros-Su et al., 1999; Benjamin et al., 2002; Peng et al., 2008). The 
combination of cordycepin with these biopesticides could potentially increase the rate 
of mortality, and hence efficacy, in the field facilitating the use of EPF in IPM. 
However, further work would need to be done to determine the optimum dose of 
cordycepin and EPF to apply and the formulation of these mixtures. The toxicity of 
cordycepin alone against P. xylostella seen in this project confirms the findings of Kim 
et al. (2002), who observed that cordycepin caused mortality in P. xylostella when 
administered by feeding and recognised it as a potential biopesticide. Furthermore, 
this project has found that this may be due to the indirect effect of cordycepin 
inhibiting the insect immune response, facilitating infection by opportunistic bacteria. 
This might be a concern for the future development of cordycepin as a biopesticide, 
particularly whether any of these opportunistic bacteria pose a risk to human health, 
hence this would need to be investigated further.  
 
7.1.2 Future work 
 
In order to better understand the natural function of cordycepin, the experiments 
described in this project could be taken further. In particular D. melanogaster S2r+ 
cell experiments (Chapter 5) would need to be repeated to confirm differences 
identified in RpL32 expression following cordycepin treatment. Furthermore, these 
could be expanded on to identify the mechanism of cordycepin activity, in particular 
to test the hypothesis that cordycepin affects the stability of the NFUB homologs DIF 
and Relish or their transport to the nucleus. Western blotting could be used to monitor 
the degradation and localisation of DIF/Relish and other proteins that interact with 
them such as Cactus (IUB homolog) and IKK (Kondrashov et al., 2012; Ren et al., 
2012). For example, nuclei of D. melanogaster cells can be separated from other 
organelles by subcellular fractionation (Zhang et al., 2000), then western blotting 
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could be used to determine in which cellular fraction DIF/Relish is localised following 
cordycepin treatment. Western blotting could also monitor the progression of Cactus 
degradation, which may be expected to reduce in the presence of cordycepin, as this 
has been observed in human cells (Kondrashov et al., 2012). RT-qPCR and other 
transcriptomic experiments in G. mellonella could be expanded on to monitor the 
expression of other immune-related genes as its whole genome sequence has recently 
become available (Lange et al., 2018). It would be especially important to examine 
the potential impact of cordycepin on other immune-pathways such as the Jak-Stat and 
IMD pathways. It could also be informative to determine the impact of cordycepin on 
the cellular immune response, such as expression of genes involved in the PPO 
cascade.  
 
This project used three insect species to elucidate the natural function of cordycepin 
and its potential as a biopesticide: D. melanogaster, G. mellonella and P. xylostella. 
In the future it would be beneficial to select one species for all experiments, although 
there are challenges that must be overcome to develop this system. Final instar G. 
mellonella were selected for experiments as they could be injected (Harding et al., 
2013) and it was possible to purchase large numbers at the same age. However, final 
instar G. mellonella do not feed and are not an agricultural pest, hence they were not 
suitable for assessing the potential of cordycepin as a biopesticide. In the future, 
rearing G. mellonella would allow earlier instars to be used for feeding experiments 
although it may still be beneficial to select an agricultural pest for experiments as this 
would be more relevant in the field. Furthermore, a D. melanogaster cell line was 
chosen to assess the effect of cordycepin on insect cells in this project as it has been 
reported to possess macrophage-like characteristics (Rämet et al., 2001), making it 
appropriate to investigate the immune response. Cell lines able to respond to immune 
system stimuli have not yet been developed from P. xylostella or G. mellonella tissue, 
although other cell lines from these insects are available (Lynn, 2007). Therefore, in 
the future it would be beneficial if a macrophage-like cell line could be developed 
from these insects.  
 
This project focused on introducing cordycepin into insects to begin to understand its 
natural function during C. militaris infection. Whilst this has indicated a potential role 
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of cordycepin as a virulence factor due to its impact on the insect immune system, the 
doses of cordycepin administered to insects during this project were likely higher than 
that produced during natural infection. When grown in culture C. militaris mycelia 
produce cordycepin at 750-16500 µg g-1 (Huang et al., 2003; Li et al., 2004; Yang and 
Li, 2008), suggesting that the 90 µg applied during G. mellonella RT-qPCR 
experiments would be produced by 5.5 mg-120 mg of C. militaris. However, it is likely 
that during infection cordycepin would be secreted locally by growing mycelium and 
the concentration produced at this small scale is not known at this time. In order to 
develop stronger proof of the role of cordycepin as a virulence factor it would be 
necessary to engineer C. militaris strains that do not produce this metabolite and 
observe its impact on virulence. Although, it is possible that a significant reduction in 
virulence of C. militaris would not be observed following knockout of cordycepin 
genes, even if it is a virulence factor, due to a redundancy with other virulence factors. 
For example, a study has been performed to elucidate the natural function of 
bassianolide (Xu et al., 2009) and beauvericin (Xu et al., 2008) in B. bassiana, by 
developing knockout strains that did not produce these secondary metabolites. The 
result was that knocking out either metabolite caused a significant reduction in 
virulence of B. bassiana, but knocking out both did not reduce virulence more than 
when a single gene was knocked out (Xu et al., 2008; Xu et al., 2009). This suggests 
that there are complex interactions between secondary metabolites, which can make it 
difficult to ascertain their natural function. The genes that are thought to be responsible 
for the production of cordycepin (cns1-4) have been knocked out of a strain of C. 
militaris (CGMCC 3.14242) previously, but virulence of this strain was not tested (Xia 
et al., 2017). Future work could consist of knocking out cns1-4 from a strain of C. 
militaris using Agrobacterium-mediated transformation (Feng et al., 2015; Xia et al., 
2017), then assessing the virulence of this strain through the insect bioassays 
developed in this project. 
 
In addition to investigating the natural function of cordycepin, this project also 
explored the potential of cordycepin as a biopesticide using P. xylostella. This work 
could be developed further to investigate the use of cordycepin alone and in 
conjunction with EPF on a larger scale and to control other insect pests. Cordycepin 
is degraded by adenosine deaminase (Johns and Adamson, 1976), an enzyme produced 
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by plants, mammals, microorganisms and invertebrates (Cristalli et al., 2001) and is 
also likely to be sensitive to UV light, similarly to nucleoside-5’-monophosphates 
(Cavaluzzi and Borer, 2004). Therefore, the first challenge to its use on a large scale 
would be the formulation to slow its breakdown. Following this, trials could be done 
using cordycepin against P. xylostella in glasshouses or in the field (Vandenberg et 
al., 1998a; Godonou et al., 2009). Additionally, cordycepin could be considered for 
use against other insects, particularly chewing pests such as Coleoptera or 
Lepidoptera, because it needs to be ingested to cause mortality (Kim et al., 2002). The 
potential of co-application of cordycepin and other microbial biopesticides, such as 
EPF and B. thuringiensis could also be explored further in laboratory bioassays and 
field trials.  
 
As C. militaris is a teleomorph the ability to perform crosses between isolates 
(Shrestha et al., 2012a; Zhang and Liang, 2013) would facilitate genetic manipulation. 
Crosses have been performed between isolates to investigate fruiting body formation, 
particularly to identify the interaction between different mating types (Zheng et al., 
2011; Shrestha et al., 2012a; Zhang and Liang, 2013). In these studies, C. militaris 
isolates of different mating types were crossed, then the effect on fruiting body 
formation and cordycepin production assessed. A similar technique could be used to 
determine whether certain alleles are important to virulence or other characteristics. 
For example, crosses could be done between a highly virulent C. militaris strain and 
a less virulent strain. The virulence of the progeny could be determined through 
bioassays and genetic differences characterised.    
 
The experimental pipelines developed in this project can be used to identify the natural 
function of secondary metabolites from other entomopathogenic species and 
determine whether they have potential as biopesticides. However, in order for this 
approach to be used, a metabolite would need to be extracted from the organism in 
large quantities, which may not always be possible if they are produced transiently or 
in low quantities. There are many fungal secondary metabolites that are presumed to 
exist due to the presence of biosynthetic gene clusters in EPF genomes, particularly 
polyketide synthases and nonribosomal peptides synthases (Keller et al., 2005). These 
genes could be identified as important virulence factors through proteomics or 
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transcriptomics (Doyle, 2011; Gao et al., 2011). Additionally, a biosynthetic gene 
cluster could be transformed into S. cerevisiae allowing production of these 
metabolites on a larger scale (Xia et al., 2017). Once the secondary metabolite is 
obtained, procedures described in this project could be used to elucidate their natural 
function and potential as biopesticides.  
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Appendix A 
 
Appendix A.1- Reference sequences for phylogenetic tree construction. Reference sequences from 
the National Center for Biotechnology Information (Harding et al., 2013; NCBI, 2017) used for 
construction of phylogenetic trees based on elongation factor 1-alpha, ITS and large ribosomal rRNA 
sequences.  
Gene Species Strain Accession number Reference 
Elongation Factor 
1 alpha 
Beauveria 
bassiana 4362 AY531934 
Rehner and Buckley, 
(2005) 
Elongation Factor 
1 alpha 
Cordyceps 
militaris ATCC 34164 CP023324 
Kramer and Nodwell, 
(2017) 
Elongation Factor 
1 alpha 
Metarhizium 
brunneum 
EAMb 09/01-
Su KJ158746 Yousef et al., (2014) 
Elongation Factor 
1 alpha 
Lecanicillium 
muscarium VI 11 MF359590 Mitina et al., (2017) 
Elongation Factor 
1 alpha 
Isaria 
fumosorosea 
CHE-
CNRCB 393 KT225597 Gallou et al., (2016) 
Elongation Factor 
1 alpha Aspergillus niger CBS 101697 KT965677 Badali et al., (2016) 
ITS Beauveria bassiana Bb 2016-120 KY697196 
Balachandran et al. 
unpublished 
ITS Cordyceps militaris Minfu30 MF379267 Fu et al.  unpublished 
ITS Metarhizium brunneum KVL16-25 MF063329 
Thapa et al. 
unpublished 
ITS Lecanicillium muscarium IRAN 684C EF641892 
Zare and Gams, 
(2008) 
ITS Isaria fumosorosea IfTS01 KX057375 Dong et al., (2016) 
ITS Aspergillus niger CICR CBE KX290301 Chakrabarty et al. unpublished 
Large ribosomal 
subunit 
Beauveria 
bassiana not specified AB027382 
Nikoh and Fukatsu, 
(2000) 
Large ribosomal 
subunit 
Cordyceps 
militaris ATCC 34164 CP023322 
Kramer and Nodwell, 
(2017) 
Large ribosomal 
subunit 
Metarhizium 
anisopliae Isolate 5B KX255642 
Gowrilakshmi and 
Sundari, unpublished 
Large ribosomal 
subunit 
Lecanicillium 
muscarium CBS 143.62 KM283798 
Park and Shin, 
unpublished 
Large ribosomal 
subunit Isaria farinosa MY01338 JN940901 Schoch et al., (2012) 
Large ribosomal 
subunit Aspergillus niger CBS 513.88 AM270052 Pel et al., (2007) 
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Appendix A.2- Reference sequences for phylogenetic tree construction. Reference sequences from 
the National Center for Biotechnology Information (Harding et al., 2013; NCBI, 2017) used for 
construction of phylogenetic trees based on 16S rRNA sequences. 
 
 
 
 
 
 
 
 
 
 
 
 
Gene Species Strain Accession number Reference 
16S Enterococcus mundtii NT-1 KT723001 Wang, unpublished 
16S Enterococcus mundtii M-4 KT722993 Wang, unpublished 
16S Pantoea vagans HMF2842 KP099965 Kang et al. unpublished 
16S Bacillus cereus S8 KT241012 Lakshmi et al., (2014) 
16S Bacillus thuringiensis yy-23 FJ463780 Zhang et al. unpublished 
16S Pantoea agglomerans PGHL1 EF050808 Morales-Rodriguez and Peck, (2009) 
16S Pantoea agglomerans NSI KT075174 Yang and Zhao, unpublished 
16S Pantoea agglomerans NSF KT075171 Yang and Zhao, unpublished 
16S Pantoea sp. CanR-85 KT580675 Chen, unpublished 
16S Enterobacter sp. M03 KT964804 Zhang, unpuplished 
16S Pantoea agglomerans PGHL1 EF050808 Morales-Valenzuela et al., (2017) 
16S Serratia liquefaciens LZ-24 KU950364 Han, unpublished 
16S Serratia liquefaciens B7 KJ781948 Lou et al. unpublished 
16S Enterobacter sp. V16 GU064368 Garcia-Bartolomei et al. unpublished 
16S Enterobacter sp. Sn-08 KJ716535 Liu et al. unpublished 
16S Serratia liquefaciens ZMT-1 KU999993 Zheng et al. unpublished 
16S Enterobacter sp. M03 KT964804 Zhang, unpublished 
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Appendix B 
 
 
Appendix B.1- Studies in which the EPF B. bassiana or M. anisopliae s.l. have been assessed for synergistic interactions with pesticides or biopesticides. 
Fungus Chemical/ Treatment Insect Interaction Methodology Reference 
B. bassiana Imidacloprid Diaprepes abbreviatus Synergy Soil treated with three doses of B. bassiana and a sub lethal dose of imidacloprid. 
Quintela and 
McCoy, 
(1998) 
B. bassiana Permethrin Anopheles gambiae Synergy 
Insects treated with different sequences of 
insecticide and B. bassiana, then survival 
assessed. Synergy determined by combined 
mortality being greater than the sum of 
individual treatments. 
Farenhorst et 
al., (2010) 
B. bassiana Deltamethrin Hyalomma anatolicum 
Synergy (not 
identified using 
statistical method) 
Tics treated with a range of acaricide doses and 
B. bassiana. Survival monitored over time. 
Sun et al., 
(2011) 
B. bassiana Spriodiclofen Tetranychus urticae Synergy 
Mites treated with acaricide and B. bassiana. 
Synergy determined by combined mortality 
being greater than the sum of individual 
treatments. 
Seyed-Talebi 
et al., (2014) 
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Fungus Chemical/ Treatment Insect Interaction Methodology Reference 
B. bassiana Neem Spodoptera litura Synergy 
Insects treated with a single concentration of 
Neem and B. bassiana. Synergy assessed using 
a chi-square test. 
Mohan et al., 
(2007) 
B. bassiana Bacillus thuringiensis Leptinotarsa decemlineata Synergy 
Insects treated with Bacillus thuringiensis and 
B. bassiana in the field. Synergy assessed 
using an ANOVA to compare mortality of 
combined treatments with individual 
treatments. 
Wraight and 
Ramos, 
(2005) 
B. bassiana Imidacloprod Bemisia argentifolii Antagonism 
Insects sprayed with pesticide and B. bassiana. 
Mortality monitored and ANOVA used to 
identify synergy. 
James and 
Elzen, (2001) 
B. bassiana 
Endosulfan, imidacloprid, 
lufenuron,diflubenzuron, 
dimethoate, oxydemeton 
Spilarctia obliqua Additive or no interaction 
LC50 of B. bassiana administered with range 
of pesticide doses. Chi-squared test used to 
identify significance of synergy. 
Purwar and 
Sachan, 
(2006) 
B. bassiana Triflumeron, thuringiensin, abamectin, carbaryl Leptinotarsa decemlineata Additive 
Combinations of B. bassiana and insecticide 
were given and mortality monitored. 
Anderson et 
al., (1989) 
B. bassiana Cry toxin Ostrinia furnacalis Additive or antagonistic 
Insects were treated with a range doses of Cry 
toxin and B. bassiana. Survival was assessed 
on one day and the CTF (cotoxicity factor) 
calculation was used to assess synergy. 
Ma et al., 
(2008) 
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Fungus Chemical/ Treatment Insect Interaction Methodology Reference 
B. bassiana Diflubenzurin Orthoptera spp. Additive 
Insects exposed in the field to B. bassiana and 
pesticide. Survival monitored up to 2 weeks 
after treatment 
Delgado et 
al., (1999) 
M. anisopliae 
s.l.  Imidacloprid Diaprepes abbreviatus Synergy 
Soil treated with three doses of M. anisopliae 
s.l.  and a sub lethal dose of imidacloprid. 
Quintela and 
McCoy, 
(1998) 
M. anisopliae 
s.l.  
Fenitrothion, 
Treflubenzuron Anomala cuprea Synergy 
Soil treated with insecticide and M. anisopliae 
s.l. . Survival, haemocyte activity and 
phenoloxidase activity assessed for synergy. 
Hiromori and 
Nishigaki, 
(2001) 
M. anisopliae 
s.l.  
Endosulfan, imidacloprid, 
lufenuron,diflubenzuron, 
dimethoate, oxydemeton 
Spilarctia obliqua Additive or no interaction 
LC50 of M. anisopliae s.l.administered with 
range of pesticide doses. Chi-squared test used 
to identify significance of synergy. 
Purwar and 
Sachan, 
(2006) 
M. anisopliae 
s.l.  Permethrin Anopheles gamibae Synergy 
Insects treated with different sequences of 
insecticide and M. anisopliae s.l. , then survival 
assessed. Synergy determined by combined 
mortality being greater than the sum of 
individual treatments. 
Farenhorst et 
al., (2010) 
M. anisopliae 
s.l.  Imidacloprid Blatella germanica 
Synergy (not 
identified using 
statistical method) 
Insects fed imidacloprid and treated with M. 
anisopliae s.l . Mortality monitored over time. 
Kaakeh et al., 
(1997) 
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Fungus Chemical/ Treatment Insect Interaction Methodology Reference 
M. anisopliae 
s.l.  
Entomopathogenic 
nematodes Coptognathus curtipennis Synergy 
Insects exposed to M. anisopliae s.l.  for a long 
period, then treated with nematodes 
Anbesse et 
al., (2008) 
M. anisopliae 
s.l.  
Entomopathogenic 
nematode Otiorhynchus sulcatus Synergy 
Insects were treated with nematodes and M. 
anisopliae s.l.  in glasshouse trials. Mortality 
was monitored and chi-squared test used to 
identify synergy. 
Ansari et al., 
(2004) 
  238 
Appendix B.2- P-values for comparisons between expression (2-DDCt values) of galiomicin following 
treatment with B. bassiana 433.99 conidia or Triton X-100 at 48 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
Galiomicin 48h Uninjected B. bassiana Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  1 0.002* 0.034* 1 
B.
 ba
ssi
an
a 
0 mg ml-1   0.004* 0.06 1 
3 mg ml-1    1 0.017* 
Tr
ito
n X
- 10
0 
0 mg ml-1     0.204 
3 mg ml-1      
 
Appendix B.3- P-values for comparisons between expression (2-DDCt values) of gallerimycin 
following treatment with B. bassiana 433.99 conidia or Triton X-100 at 48 h after treatment. 
Expression was normalized against S7e expression and expression of each gene prior to injection. 
Stimulation without cordycepin is shown by dark grey bars and with cordycepin by light grey bars, 
expression in uninjected insects is also included. N=13-15 per treatment. P-values marked with asterisks 
are statistically significant (p<0.05). 
Gallerimycin 48h Uninjected B. bassiana Triton X-100 0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  1 0.951 0.202 1 
B.
 ba
ssi
an
a 0 mg ml-1   0.044* 1 0.226 
3 mg ml-1    <0.001* 1 
Tr
ito
n X
-10
0 0 mg ml-1     <0.001* 
3 mg ml-1      
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Appendix B.4- P-values for comparisons between expression (2-DDCt values) of IMPI following 
treatment with B. bassiana 433.99 conidia or Triton X-100 at 48 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
IMPI 48h Uninjected B. bassiana Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  <0.001* 1 <0.001* 1 
B.
 ba
ssi
an
a 0 mg ml-1   <0.001* 1 <0.001* 
3 mg ml-1    <0.001* 1 
Tr
ito
n X
-10
0 
0 mg ml-1     <0.001* 
3 mg ml-1      
 
Appendix B.5- P-values for comparisons between expression (2-DDCt values) of lysozyme following 
treatment with B. bassiana 433.99 conidia or Triton X-100 at 48 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
Lysozyme 48h Uninjected B. bassiana Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  <0.001* 1 <0.001* 1 
B.
 ba
ssi
an
a 0 mg ml-1   <0.001* 1 <0.001* 
3 mg ml-1    0.002* 1 
Tr
ito
n X
-10
0 
0 mg ml-1     <0.001* 
3 mg ml-1      
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Appendix B.6- P-values for comparisons between expression (2-DDCt values) of galiomicin following 
treatment with B. bassiana 433.99 conidia or Triton X-100 at 72 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
Galiomicin 72h Uninjected B. bassiana Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  0.254 1 1 0.409 
B.
 ba
ssi
an
a 0 mg ml-1   0.006* 1 <0.001* 
3 mg ml-1    0.107 1 
Tr
ito
n X
- 10
0 0 mg ml-1     0.003* 
3 mg ml-1      
 
 
Appendix B.7- P-values for comparisons between expression (2-DDCt values) of gallerimycin 
following treatment with B. bassiana 433.99 conidia or Triton X-100 at 72 h after treatment. 
Expression was normalized against S7e expression and expression of each gene prior to injection. 
Stimulation without cordycepin is shown by dark grey bars and with cordycepin by light grey bars, 
expression in uninjected insects is also included. N=13-15 per treatment. P-values marked with asterisks 
are statistically significant (p<0.05). 
Gallerimycin 72h Uninjected B. bassiana Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  0.001* 1 1 1 
B.
 ba
ssi
an
a 0 mg ml-1   0.012* 0.182 0.001* 
3 mg ml-1    1 1 
Tr
ito
n X
-10
0 0 mg ml-1     1 
3 mg ml-1      
 
 
  241 
Appendix B.8- P-values for comparisons between expression ( 2-DDCt values) of IMPI following 
treatment with B. bassiana 433.99 conidia or Triton X-100 at 72 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
IMPI 72h Uninjected B. bassiana Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  0.001* 1 0.205 0.151 
B.
 ba
ssi
an
a  0 mg ml-1   <0.001* 1 <0.001* 
3 mg ml-1    0.006* 1 
Tr
ito
n X
-10
0 0 mg ml-1     <0.001* 
3 mg ml-1      
 
 
Appendix B.9- P-values for comparisons between expression (2-DDCt values) of lysozyme following 
treatment with B. bassiana 433.99 conidia or Triton X-100 at 72 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
Lysozyme 72h Uninjected B. bassiana Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  <0.001* 1 0.021* 1 
B.
 ba
ssi
an
a 0 mg ml-1   <0.001* 0.121 <0.001* 
3 mg ml-1    1 1 
Tr
ito
n X
-10
0 
0 mg ml-1     0.267 
3 mg ml-1      
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Appendix B.10- P-values for comparisons between expression (2-DDCt values) of gallerimycin 
following treatment with C. militaris 11703 conidia or Triton X-100 at 48 h after treatment. 
Expression was normalized against S7e expression and expression of each gene prior to injection. 
Stimulation without cordycepin is shown by dark grey bars and with cordycepin by light grey bars, 
expression in uninjected insects is also included. N=13-15 per treatment. P-values marked with asterisks 
are statistically significant (p<0.05). 
Gallerimycin 48h 
Uninjected C. militaris Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  0.135 1 1 0.068 
C.
 m
ilit
ar
is 0 mg ml-1   0.005* 0.933 <0.001* 
3 mg ml-1    0.654 0.953 
Tr
ito
n X
-10
0 
0 mg ml-1     0.004* 
3 mg ml-1      
 
 
Appendix B.11- P-values for comparisons between expression (2-DDCt values) of galiomicin 
following treatment with C. militaris 11703 conidia or Triton X-100 at 48 h after treatment. 
Expression was normalized against S7e expression and expression of each gene prior to injection. 
Stimulation without cordycepin is shown by dark grey bars and with cordycepin by light grey bars, 
expression in uninjected insects is also included. N=13-15 per treatment. P-values marked with asterisks 
are statistically significant (p<0.05). 
Galiomicin 48h 
Uninjected C. militaris Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  1 0.003* 1 0.239 
C.
 m
ilit
ar
is 0 mg ml-1   <0.001* 1 0.002* 
3 mg ml-1    <0.001* 1 
Tr
ito
n X
-10
0 0 mg ml-1     0.038* 
3 mg ml-1      
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Appendix B.12- P-values for comparisons between expression ( 2-DDCt values) of IMPI following 
treatment with C. militaris 11703 conidia or Triton X-100 at 48 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
IMPI 48h 
Uninjected C. militaris Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  0.042* 1 <0.001* 1 
C.
 m
ilit
ar
is 0 mg ml-1   0.005* 0.965 0.012 
3 mg ml-1    <0.001* 1 
Tr
ito
n X
-10
0 0 mg ml-1     <0.001* 
3 mg ml-1      
 
 
Appendix B.13- P-values for comparisons between expression (2-DDCt values) of lysozyme following 
treatment with C. militaris 11703 conidia or Triton X-100 at 48 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
Lysozyme 48h 
Uninjected C. militaris Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  <0.001* 1 <0.001* 1 
C.
 m
ilit
ar
is 0 mg ml-1   0.002* 1 <0.001* 
3 mg ml-1    0.001* 1 
Tr
ito
n X
- 10
0 
0 mg ml-1     <0.001* 
3 mg ml-1      
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Appendix B.14- P-values for comparisons between expression (2-DDCt values) of gallerimycin 
following treatment with C. militaris 11703 conidia or Triton X-100 at 72 h after treatment. 
Expression was normalized against S7e expression and expression of each gene prior to injection. 
Stimulation without cordycepin is shown by dark grey bars and with cordycepin by light grey bars, 
expression in uninjected insects is also included. N=13-15 per treatment. P-values marked with asterisks 
are statistically significant (p<0.05). 
Gallerimycin 72h 
Uninjected C. militaris Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  0.007* 1 1 1 
C.
 m
ilit
ar
is 0 mg ml-1   0.007* 0.535 0.013* 
3 mg ml-1    1 1 
Tr
ito
n X
-10
0 
0 mg ml-1     1 
3 mg ml-1      
 
 
 
Appendix B.15- P-values for comparisons between expression (2-DDCt values) of galiomicin 
following treatment with C. militaris 11703 conidia or Triton X-100 at 72 h after treatment. 
Expression was normalized against S7e expression and expression of each gene prior to injection. 
Stimulation without cordycepin is shown by dark grey bars and with cordycepin by light grey bars, 
expression in uninjected insects is also included. N=13-15 per treatment. P-values marked with asterisks 
are statistically significant (p<0.05). 
Galiomicin 72h 
Uninjected C. militaris Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  0.162 0.224 1 0.227 
C.
 m
ilit
ar
is 0 mg ml-1   <0.001* 1 <0.001* 
3 mg ml-1    0.001* 1 
Tr
ito
n X
-10
0 0 mg ml-1     0.001* 
3 mg ml-1      
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Appendix B.16- P-values for comparisons between expression (2-DDCt values) of IMPI following 
treatment with C. militaris 11703 conidia or Triton X-100 at 72 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
IMPI 72h 
Uninjected C. militaris Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  0.002* 0.567 0.227 0.136 
C.
 m
ilit
ar
is 0 mg ml-1   <0.001* 1 <0.001* 
3 mg ml-1    <0.001* 1 
Tr
ito
n X
-10
0 0 mg ml-1     <0.001* 
3 mg ml-1      
 
 
Appendix B.17- P-values for comparisons between expression (2-DDCt values) of lysozyme following 
treatment with C. militaris 11703 conidia or Triton X-100 at 72 h after treatment. Expression was 
normalized against S7e expression and expression of each gene prior to injection. Stimulation without 
cordycepin is shown by dark grey bars and with cordycepin by light grey bars, expression in uninjected 
insects is also included. N=13-15 per treatment. P-values marked with asterisks are statistically 
significant (p<0.05). 
Lysozyme 72h 
Uninjected C. militaris Triton X-100 
0 mg ml-1 0 mg ml-1 3 mg ml-1 0 mg ml-1 3 mg ml-1 
Un
inj
ec
ted
 
0 mg ml-1  <0.001* 1 0.013* 1 
C.
 m
ilit
ar
is  0 mg ml-1   <0.001* 0.6 <0.001* 
3 mg ml-1    0.439 1 
Tr
ito
n X
-10
0 
0 mg ml-1     0.205 
3 mg ml-1      
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Appendix C 
 
Appendix C.1- Models fitted to P. xylostella survival following treatment with cordycepin. 
Regression models fitted to percentage mortality on day seven of P. xylostella larvae (n=10 for each 
dose in each of three replicates) following A) 24 h of feeding with cordycepin at: 0, 0.375, 0.75, 1.5, 3 
and 6 mg ml-1, B) 24 h of feeding with cordycepin (and 1 µM pentostatin) at: 0, 0.375, 0.75, 1.5, 3 and 
6 mg ml-1C) daily feeding cordycepin (and 1 µM pentostatin) at: 0, 0.093, 0.1875, 0.375, 0.75 and 1.5 
mg ml-1. Regression models were fitted in R, adjusted R-squared value and p-values are shown.  
Treatment Model Adjusted R-squared P-value 
A) Cordycepin 
without 
pentostatin 
Second order polynomial 0.503 0.002 
 
B) Cordycepin 
with 
pentostatin 
Second order polynomial 0.274 0.035 
 
C) Continuous 
feeding of 
cordycepin 
Second order polynomial 0.561 <0.001 
 
 
 
 
 
Appendix C.2- Models fitted to P. xylostella feeding following 24 h of feeding with cordycepin. 
Regression models fitted to percentage of leaf disc eaten per individual P. xylostella larva on days five, 
six and seven of (n=10 for each dose in each of three replicates) with cordycepin at: 0, 0.375, 0.75, 1.5, 
3 and 6 mg ml-1. Regression models were fitted in R, adjusted R-squared value and p-values are shown.  
 
Day  Model Adjusted R-squared P-value 
5 Linear 0.053 0.182 
6 Linear 0.062 0.165 
7 Linear  0.134 0.075 
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Appendix C.3- Models fitted to P. xylostella feeding following 24 h of feeding with cordycepin 
(plus pentostatin). Regression models fitted to percentage of leaf disc eaten per individual P. xylostella 
larva on days five, six and seven of (n=10 for each dose in each of three replicates) following 24 h of 
feeding with cordycepin at: 0, 0.375, 0.75, 1.5, 3 and 6 mg ml-1. Regression models were fitted in R, 
adjusted R-squared value and p-values are shown. 
Day  Model Adjusted R-squared P-value 
5 Linear 0.053 0.180 
6 Linear 0.096 0.114 
7 Linear 0.212 0.031 
 
 
 
 
 
 
Appendix C.4- Models fitted to P. xylostella feeding whilst being fed cordycepin (plus pentostatin) 
daily. Regression models fitted to percentage of leaf disc eaten per individual P. xylostella larva on 
days five, six and seven of (n=10 for each dose in each of three replicates) when fed cordycepin (and 1 
µM pentostatin) at: 0, 0.093, 0.1875, 0.375, 0.75 and 1.5 mg ml-1. Regression models were fitted in R, 
adjusted R-squared value and p-values are shown. 
Day  Model Adjusted R-squared P-value 
5 Second order polynomial 0.690 <0.001 
 
6 
 
Second order polynomial 
 
0.536 
 
0.001 
 
7 
 
Linear 
 
0.311 
 
0.010 
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Appendix C.5- Survival of P. xylostella larvae when fed 1.5 mg ml-1of cordycepin for 24 h and 
treated with 1x107 B. bassiana 433.99 conidia ml-1. The cumulative survival of P. xylostella larvae 
(n=30 per treatment) when fed leaf discs coated in 1.5 mg ml-1 of cordycepin or a Triton X-100 for 24 
h following topical application of 1x107 B. bassiana 433.99 conidia. 
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Appendix C.6- Interactions between a range of B. bassiana concentrations and short-term 
cordycepin treatment on day five after treatment. Mortality of P. xylostella larvae on day five after 
treatment following spraying with B. bassiana 433.99 conidia and feeding 1.5 mg ml-1cordycepin (with 
1 µM pentostatin) for 24 h. Chi-squared values are presented and the effects of treatments identified as 
additive or synergistic using a chi-squared test. 
Concentration of B. 
bassiana 433.99 
(conidia ml-1) 
Measurement Mortality (±SEM) Chi-squared Effect  
1.00E+03 Observed 23 ±18.7 1.82 Additive Expected 30.5 
1.00E+04 Observed 29.7±10.3 0.21 Additive Expected 27.3 
1.00E+05 Observed 25.5 ± 7.3 1.35 Additive Expected 32 
1.00E+06 Observed 39.4 ±20.3 0.65 Additive Expected 44.8 
1.00E+07 
Observed 100 ±0  
24.79 Synergistic 
Expected 61.1 
 
 
Appendix C.7- Interactions between a range of B. bassiana concentrations and short-term 
cordycepin treatment on day six after treatment. Mortality of P. xylostella larvae on day six after 
treatment following spraying with B. bassiana 433.99 conidia and feeding 1.5 mg ml-1 cordycepin (with 
1 µM pentostatin) for 24 h. Chi-squared values are presented and the effects of treatments identified as 
additive or synergistic using a chi-squared test. 
Concentration of 
B. bassiana 
433.99 (conidia 
ml-1) 
Measurement Mortality (±SEM) Chi-squared Effect  
1.00E+03 Observed 29.1 ±17.3 0.65 Additive Expected 33.8 
1.00E+04 Observed 33.0 ±12.3 0.19 Additive Expected 35.6 
1.00E+05 Observed 41.4 ±14.2 0.08 Additive Expected 39.7 
1.00E+06 Observed 52.4 ±19.1 0.02 Additive Expected 51.5 
1.00E+07 
Observed 100 ± 0 
11.19 Synergistic 
Expected 71.7 
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Appendix C.8- Survival of P. xylostella larvae when fed 0.1 mg ml-1of cordycepin daily and treated 
with 1x107 B. bassiana 433.99 conidia ml-1. The cumulative survival of P. xylostella larvae (n=30 per 
treatment) when fed leaf discs coated in 0.1 mg ml-1 of cordycepin or a Triton X-100 control daily for 
seven days following topical application of 1x107 B. bassiana 433.99 conidia. 
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Appendix C.9- Interactions between a range of B. bassiana concentrations and prolonged 
cordycepin treatment on day five after treatment. Mortality of P. xylostella larvae on day five after 
treatment following spraying with B. bassiana 433.99 conidia and feeding 0.1 mg ml-1 cordycepin (with 
1 µM pentostatin) throughout the experiment. Chi-squared values are presented and the effects of 
treatments identified as additive or synergistic using a chi-squared test.  
Concentration 
of B. bassiana 
433.99 (conidia 
ml-1) 
Measurement Mortality (±SEM) Chi-squared Effect  
1.00E+03 Observed 23.3 ±7.4 3.25 Additive 
Expected 16.1 
1.00E+04 Observed 12 ±7.2 5.31 Antagonistic 
Expected 23.1 
1.00E+05 Observed 22.2 ±8.3 0.13 Additive 
Expected 23.9 
1.00E+06 Observed 24.1 ± 14.5 1.28 Additive 
Expected 19.1 
1.00E+07 Observed 30 ±11.5 4.61 Antagonistic 
Expected 44.3 
          
 
Appendix C.10- Interactions between a range of B. bassiana concentrations and prolonged 
cordycepin treatment on day six after treatment. Mortality of P. xylostella larvae on day six after 
treatment following spraying with B. bassiana 433.99 conidia and feeding 0.1 mg ml-1 cordycepin (with 
1 µM pentostatin) throughout the experiment. Chi-squared values are presented and the effects of 
treatments identified as additive or synergistic using a chi-squared test.  
Concentration of 
B. bassiana 433.99 
(conidia ml-1) 
Measurement Mortality (±SEM) Chi-squared Effect  
1.00E+03 Observed 30.8 ± 10.8 1.30 Additive 
Expected 25.1 
1.00E+04 
 
Observed 15.7 ±7.9 4.03 Antagonistic 
Expected 26.0 
1.00E+05 
 
Observed 28.3 ± 5.1  1.27 Additive 
Expected 34.9 
1.00E+06 
 
Observed 31.9 ± 15.6  0.68 Additive 
Expected 27.6 
1.00E+07 
 
Observed 56.7 ± 21.9 0.63 Additive 
Expected 51.0 
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